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7General Introduction 
All living cells are enclosed by biological 
membranes that separate the interior cytoplasm 
from the outer environment. Composed of a 
phospholipid bilayer with embedded proteins 
biological membranes act as insulators and 
filters. The transfer of selected substances and 
information across the membrane is controlled 
and mediated through membrane proteins. As a 
result, membrane proteins are central to almost 
all cellular processes. They play key roles in 
signalling between cells, in transport across cell 
membranes and in energy transduction processes. 
To accomplish these versatile cell functions, 
membrane proteins are available in an abundant 
diversity. Accordingly, it’s not astounding that 
about 30% of all genes encoded in the human 
genome are membrane proteins. However, only 
158 (Status: May 2008) unique membrane protein 
structures, mainly from bacterial membrane 
proteins, have been deposited thus far in the 
Protein Data Bank (PDB), compared to the more 
than 10’000 soluble protein structures. These 
numbers highlight the enormous structural work 
that remains to be done in the field of membrane 
proteins. From a biomedical perspective, 
membrane proteins constitute about 50% of 
possible targets for novel drugs. The three-
dimensional (3D) structure of a protein is an 
essential starting point for the investigation of 
its molecular mechanisms of action, the basis for 
drug design. Therefore structural information of 
membrane proteins is of fundamental importance 
for human health.
High-resolution structure determination of 
membrane proteins is currently one of the greatest 
challenges in cell biology. Membrane proteins 
possess a hydrophobic belt that is required for 
their incorporation into lipid membranes. For the 
extraction and purification of membrane proteins 
detergents are used to keep the proteins in a 
solubilized state. The lack of structural information 
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on membrane proteins is mainly related to their low 
expression levels, the instability in the detergent 
solution and their resistance to crystallization. 
The latter is a considerable limitation because 
X-ray crystallography, which at the present time 
is the most powerful technique for determining 
protein structures, requires highly ordered 3D 
protein crystals. Besides structure determination 
by X-ray crystallography and nuclear magnetic 
resonance (NMR) spectroscopy, the method 
of electron crystallography on 2D crystals has 
become increasingly important in membrane 
protein research. The striking advantage of 2D 
crystals is that the membrane protein is analyzed 
in its native environment, the lipid bilayer. 
However, as with 3D crystals, the production of 
highly ordered 2D crystals is a major barrier.
Electron crystallography was first applied 
in 1975 by Henderson and Unwin to study 
the structure of bacteriorhodopsin in purple 
membranes (1, 2). Since then, substantial progress 
has been made in further development of electron 
crystallography, especially in sample preparation, 
cryo-transmission electron microscopy (cryo-
TEM) imaging and data processing. Thus, 
improved cryo-TEM in combination with electron 
diffraction of 2D crystals is used to establish the 
3D protein structure (3). The recent structure 
determination of the mammalian aquaporin-0 
(AQP-0) at the remarkable resolution of 1.9 
Å demonstrated impressively the potential of 
the cryo-TEM approach. So far seven atomic 
models (<4 Å) of membrane proteins have 
been determined by high-resolution electron 
crystallography (plant light harvesting complex 2 
(4), AQP-1 (5, 6), nicotinic acetylcholine receptor 
(7, 8), AQP-0 (9, 10), AQP-4 (11), glutathione 
transferase 1 (2)). Thereby one has to notice that 
less than two dozen groups are pursuing electron 
crystallography, compared to the hundreds of 
groups in X-ray crystallography. Even more 
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important, 2D crystallization combined with TEM 
is not an all-or-nothing approach, meaning that 
also from poorly ordered crystals low resolution 
structures are obtainable. In conclusion, electron 
crystallography presents a highly favourable and 
successful method to explore the structures of 
membrane proteins (13).
The atomic force microscope (AFM) is a 
powerful tool to investigate the surface topography 
of membrane proteins embedded in lipid bilayers 
under near-physiological conditions, i.e., in buffer 
solution, at room temperature and under normal 
pressure. The high lateral (≥5 Å) and vertical 
resolution (~1 Å), and the high signal-to-noise 
ratio of the topographs acquired by AFM make 
this instrument unique to study surface structure 
and dynamics of single functional membrane 
proteins.
Besides high-resolution surface imaging, 
structural and mechanical properties of single 
membrane proteins can be studied by single 
molecule force spectroscopy (SMFS), an AFM-
related technique. In a typical SMFS experiment 
the cantilever tip approaches the membrane 
protein, pushes on it and then retracts. During 
this approach-retraction cycle the force acting 
on the molecule is measured and plotted as a 
function of the tip-surface distance: the so-called 
‘force curve’ is thus obtained. Such force curves 
reveal details about inter- and intra-molecular 
interactions, unfolding barriers and energy 
landscapes in membrane proteins. Because 
these measurements take place in solution at 
physiological conditions, the binding of ligands 
and the subsequent alteration within the protein 
may be detected and visualized. This offers the 
unique possibility to directly monitor structural 
changes related to biological processes.
The structural studies of amino acid and peptide 
transporters by TEM and AFM reported in this 
thesis became possible thank to an European 
initiative called Eugindat (European genomics 
initiative on disorders of plasma membrane 
amino acid transporters, http://www.ub.es/
eugindat/). In Eugindat biological and medical 
scientists with various backgrounds were united 
in one consortium to concentrate the research on 
amino acid and peptide transporters.
The transport of amino acids into cells is 
a crucial process for all living species from 
bacteria to humans. Defects on proteins involved 
in this transport lead to strong disturbances in the 
amino acid metabolism of the organism. Humans 
strongly rely on amino acids in their diet, since 
nine essential amino acids cannot be synthesized 
from other precursors. Consequently, it’s all 
the more important that systems for the uptake, 
distribution and reabsorption of amino acids 
work properly. Thereby, the proximal tubule 
plays a central role by reabsorbing over 95% of 
the filtered amino acid load. In the case where 
elevated levels (>5%) are detected in urine, the 
term aminoaciduria is applied. Primary Inherited 
Aminoacidurias (PIA) is a group of rare diseases 
arisen from genetic defects in amino acid 
transporters expressed in the plasma membrane of 
renal epithelial cells. PIA members are classified 
by the target amino acid or acids involved. The 
group includes Cystinuria, Lysinuric Protein 
Intolerance (LPI), Dicarboxylic Aminoaciduria 
(DA), Hartnup Disorder (HDis), Iminoglycinuria 
(IG) and unlabeled aminoacidurias. Cystinuria 
and LPI are the best studied PIAs. It was 
demonstrated that members of the heteromeric 
amino acid transporter family (HAT family) are 
the molecular base of cystinuria and LPI. HATs 
are composed of a heavy subunit (HSHAT) and 
the corresponding light subunit (LSHAT) that are 
liked together by a disulfide bridge. HSHATs are 
N-glycosylated type II membrane glycoproteins, 
whereas LSHATs are nonglycosylated polytopic 
membrane proteins with twelve putative 
transmembrane segments (TMS) (14-16). Two 
genes rBAT (HSHAT) and b0,+AT (LSHAT) could 
be identified responsible for cystinuria (17, 18) 
while mutations in the system 4F2hc (HSHAT) 
and y+LAT1 (LSHAT) lead to LPI (19, 20).
To acquire a thorough knowledge of the 
structure of relevant transporters for PIA and 
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renal reabsorption of amino acids, 2D and 3D 
crystallization of membrane and soluble proteins 
for structure determination was addressed 
within Eugindat. Recently, Eugindat members 
reported the X-ray structure of 4F2hc protein at 
2.1 Å (monoclinic) and 2.8 Å (orthorhombic) 
resolutions (21). In contrast, there are no 
structures from eukaryotic or human amino acid 
transporters available. So far, only two structures 
of bacterial transport proteins with homology to 
their eukaryotic counterparts were successfully 
solved: the atomic structures of a bacterial 
leucine transporter (22) and of a bacterial 
glutamate transporter (23). Despite the awarded 
effort, these two transporters do not correspond 
to the class of LSHAT proteins. However, these 
examples indicate that important information to 
understand structure-function relationships of 
amino acid transporters is gained from prokaryotic 
homologues. In pursuit of our aim to reveal first 
structural information of PIA related amino acid 
transporters, we searched and studied prokaryotic 
homologues of LSHAT.
The LSHAT membrane proteins b0,+AT and 
y+LAT1 are members of the L-type amino acid 
transporter family (LAT) that is a subfamily of 
the amino acid/polyamine/organocation (APC) 
transporter superfamily. The APC superfamily 
counts nearby 250 members in prokaryotes 
and eukaryotes that function as solute cation 
symporters and solute cation antiporters (17). 
Most APC members are predicted to possess 
twelve α-helical transmembrane segments 
(TMS) with cytosolic located N- and C-termini 
(24, 25). According to the high sequence identity 
and homology to eukaryotic and human APC 
transporters, we selected after an exhaustive search 
for structural (TEM/AFM) and functional studies 
the two prokaryotic amino acid transporters 
AdiC and SteT. As shown in the presented 
thesis, the L-arginine/agmatine antiporter AdiC 
and the threonine/serine exchange transporter 
SteT represent excellent proteins to elucidate the 
molecular architecture of transporters from the 
APC superfamily.
Within Eugindat, structural and functional 
studies were extended to cover other important 
transporters involved in human health, i.e. peptide 
transporters. Members of this second class of 
transport proteins were extensively studied in 
the past and belong to the peptide transporter 
(PTR) family (26, 27). Peptide transporters are 
integral membrane proteins that mediate the 
cellular uptake of di- and tripeptides. Similar to 
the amino acid transport, peptide transport is of 
fundamental importance in all species. In human 
peptide transport at the brush border membranes 
of small intestine, kidney and lung is handled by 
two members from the PTR family designated as 
PEPT1 and PEPT2. PEPT1 is considered as the 
major route by which protein digestion products 
enter the body. Previous studies demonstrated 
that peptide transporters have broad substrate 
specificity transporting essentially all 400 
possible dipetides, 8000 possible tripeptides and 
a large spectrum of peptidomimetics into the cell 
(i.e. pharmacologically active compounds) (28-
31). Peptide transporters are therefore potent 
drug delivery systems. Substrate translocation 
is coupled to the proton movement down 
an electrochemical proton gradient with the 
membrane potential as the main driving force.
In contrast to the wealth of functional 
information, no structural information on peptide 
transporters is available. For our structural and 
functional studies within Eugindat, we selected 
from several possible candidates the bacterial 
PTR family members YbgH, YdgR (TppB, 
DtpA) and YhiP (DtpB) from Escherichia coli. 
The structural work on these bacterial peptide 
transporters presented in this thesis represents 
the first published structural information of these 
important class of transport proteins.
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2.1 ABBREVIATIONS 
APC, amino acid/ polyamine/ organocation; BN-PAGE, blue native-polyacrylamide gel 
electrophoresis; DDM, n-dodecyl-β-D-maltoside; gi, GenInfo; ITC, isothermal titration calorimetry; 
MFS, major facilitator superfamily; SDS-PAGE, sodium dodecylsulphate-polyacrylamide gel 
electrophoresis; TEM, transmission electron microscopy
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2.2 ABSTRACT
The L-arginine/agmatine antiporter AdiC 
is a key component of the arginine-dependent 
extreme acid resistance system of Escherichia 
coli. Phylogenetic analysis indicated that 
AdiC belongs to the amino acid/polyamine/
organocation (APC) transporter superfamily 
having sequence identities of 15-17% to 
eukaryotic and human APC transporters. For 
functional and structural characterization, 
we	 cloned,	 overexpressed	 and	 purified	 wild-
type AdiC and the point mutant AdiC-
W293L. Detergent-solubilized AdiC particles 
were dimeric in agreement with previous 
observations. Reconstitution experiments 
yielded 2D crystals of AdiC-W293L diffracting 
below 7 Å resolution from which we determined 
the projection structure at 6.5 Å resolution. The 
projection map showed 10-12 density peaks 
per monomer and suggested mainly tilted 
helices with the exception of one perpendicular 
membrane	 spanning	 α-helix.	 Comparison	 of	
AdiC-W293L with the projection map of the 
oxalate/formate antiporter from Oxalobacter 
formigenes, a member from the major 
facilitator superfamily, indicated different 
structures and consequently different folds. 
Thus, 2D crystals of AdiC-W293L yielded 
the	 first	 detailed	 view	 of	 a	 transport	 protein	
from the APC superfamily at sub-nanometer 
resolution.
2.3 INTRODUCTION
Enteric pathogens such as Shigella, Salmonella, 
Yersinia spp. and certain Escherichia coli (E. 
coli) strains can survive the extremely acidic 
conditions of the human stomach and cause 
intestinal diseases (1). To overcome the protective 
barrier of the gastric acidity, pathogenic and 
nonpathogenic strains of E. coli have developed 
acid resistance systems. One of these systems 
requires arginine to protect E. coli during low pH 
exposure. This arginine system is composed of 
an arginine-agmatine exchange transporter and 
of an acid-activated arginine decarboxylase (2). 
Acidification of the cytosol is prevented by the 
consumption of protons through decarboxylation 
of arginine to agmatine and carbondioxide. 
Agmatine is then exported out of the cytosol 
and new arginine imported through the arginine-
agmatine transporter in a one-to-one exchange 
stoichiometry (2). This recently identified 
transport protein is the product of the adiC gene 
(3, 4). In vitro, AdiC-mediated exchange transport 
of arginine and agmatine is tightly coupled, 
electrogenic and acid-activated (5). AdiC forms 
stable homodimers in detergent and phospholipid 
membranes as determined by gel filtration and 
glutaraldehyde cross-linking experiments (5).
The origin of AdiC is somehow controversial 
since it was assigned to two families of transport 
proteins, i.e. the amino acid/polyamine/
organocation (APC) transporter superfamily (6) 
and the major facilitator superfamily (MFS) (5, 
7). The APC superfamily of transporters consists 
of nearly 250 members that function as solute-
cation symporters and solute-solute antiporters 
(6). According to hydropathy profile analysis and 
biochemically established topological features of 
most prokaryotic and eukaryotic APC superfamily 
members, both the N- and C- termini of the 
proteins are located in the cytoplasm with a twelve 
transmembrane segment topology (6, 8-11). Two 
subfamilies of the APC transporter superfamily, 
i.e., the cationic amino acid transporters (CATs) 
and the L-type amino acid transporters (LATs), 
have human members involved in relevant 
physiological functions and diseases. CAT2 
provides arginine for NO synthesis (12) and 
for arginase (13) in classical and alternative 
activation of macrophages respectively, and 
CAT1 is required for macrophage proliferation 
(14). LAT1 is overexpressed in a wide spectrum 
of primary human cancers and plays important 
roles in the growth and survival of cancer cell 
lines (15). Mutations in the human LAT members 
b0,+AT (and in its associated heavy subunit 
rBAT) and y+LAT1 cause the primary inherited 
aminoacidurias cystinuria and lysinuric protein 
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intolerance, respectively (16-19). Another LAT 
transporter, xCT, is a Kaposi’s sarcoma-associated 
herpesvirus fusion-entry receptor (20).
Structural information on amino acid 
transporters is sparse. Only two high-resolution 
structures have been reported so far, that of the 
bacterial glutamate transporter Gltph (21) and 
that of the bacterial leucine transporter LeuTAa 
(22). Thus, besides low-resolution transmission 
electron microscopy (TEM) data on single 
detergent-solubilized Ser/Thr exchanger transport 
proteins (SteT) (23), no structural information 
is available for other members of the APC 
transporter superfamily. The low number of amino 
acid transporter structures and of membrane 
proteins in general is related to the difficulty 
in growing highly-ordered three-dimensional 
(3D) membrane protein crystals for structure 
determination by X-ray crystallography. Cryo-
TEM combined with electron crystallography of 
2D crystals to establish the 3D protein structure is 
an attractive alternative to X-ray crystallography 
and 3D crystals (24). An important advantage of 
2D membrane protein crystals is that the protein 
is embedded in its native environment, the lipid 
bilayer. Recently, the first 2D crystals of an amino 
acid transporter, i.e. Gltph, have been reported 
(25).
Here, we present for the first time structural data 
at sub-nanometer resolution of the L-arginine/
agmatine antiporter AdiC. Phylogenetic analysis 
and comparison of the projection structure of 
AdiC, as obtained by cryo-TEM of 2D crystals, 
with the projection and 3D structures of members 
from the MFS indicated that AdiC belongs to 
the APC superfamily. To grow 2D crystals, we 
overexpressed AdiC and the mutant AdiC-W293L 
in E. coli and purified to homogeneity. Negative-
stain TEM and blue native-polyacrylamide gel 
electrophoresis (BN-PAGE) of both detergent-
solubilized AdiC proteins revealed a homodimeric 
state. Reconstitution experiments yielded first 
well-ordered 2D crystals of AdiC-W293L 
suitable for structure analysis by cryo-TEM. The 
projection map calculated from unstained 2D 
crystals revealed the structure of AdiC-W293L 
at 6.5 Å resolution. The present work sets the 
basis for the structural analysis of AdiC at high-
resolution using 2D crystals and cryo-TEM/
electron crystallography. Importantly, AdiC 
represents an excellent model for understanding 
the molecular architecture of transporters from 
the APC superfamily.
2.4 MATERIALS AND METHODS
Chemicals – E. coli polar lipids were purchased 
from Avanti Polar Lipids (Alabaster, AL, USA) 
and n-dodecyl-β-D-maltopyranoside from 
Anatrace (Maumee, OH, USA). Radiolabeled 
L-[3H] arginine was from American Radiolabeled 
Chemicals (St. Louis, MO, USA), and amino 
acids and amines from Sigma-Aldrich (St. Louis, 
MO, USA).
Phylogenetic analysis of AdiC – Comparative 
searches of the AdiC gene (NCBI’s GenInfo 
(gi): 16131941) were performed using NCBI’s 
BLASTp algorithm (www.ncbi.nlm.nih.gov/
blast/) against the default nr protein database 
(GenBank CDS translations + RefSeq Proteins + 
PDB + SwissProt + PIR + PRF) and using default 
parameters. To build the phylogenetic tree, 
we first performed a multiple alignment using 
PROBCONS (26) with the AdiC protein sequence 
and other protein sequences collected from NCBI 
and http://www.tcdb.org/tcdb/superfamily.php 
(6) that are representatives of the following APC 
subfamilies: APA (PotE/gi: 26246666 from E. coli, 
CadB/gi: 536977 from E. coli, ArcD/gi: 254827 
from Pseudomonas aeruginosa, LysI/gi: 38233510 
from Corynebacterium glutamicum and YvsH/gi: 
16080387 from Bacillus subtilis), ACT (GabA/gi: 
4972245 from Emericella nidulans and Uga4/gi: 
6319991 from Saccharomyces cerevisiae), CAT 
(CAT1/gi: 161016790 from Mus musculus, CAT2/
gi: 113680130 from Mus musculus, AAT1/gi: 
30685317 from Arabidopsis thaliana and YfnA/
gi: 16077801 from Bacillus subtilis), GGA (XasA/
gi: 33241625 from Chlamydophila pneumoniae), 
17
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AGT (yveA/gi: 16080500 from Bacillus subtilis, 
ybeC/gi: 16077281 from Bacillus subtilis) and 
LAT (SteT/gi: 16078351 from Bacillus subtilis, 
and eukaryotic LATs: LAT2/gi: 33286428 from 
Homo sapiens, LAT1/gi: 71979932 from Homo 
sapiens, y+LAT-1/gi: 21361563 from Homo 
sapiens, and  b0,+AT from Monodelphis domestica 
( E N M S E B L : E N S M O D P 0 0 0 0 0 0 1 5 3 4 9 ) , 
from Canis familiaris (ENMSEBL: 
ENSCAFP0000001-1140) and from Rattus 
norvegicus (ENMSEBL: ENSRNOP00000016-
919). As outgroup for the tree, we selected Mmup/
gi: 172051482 of E .coli that belongs to the AAT 
family. We next evaluated this alignment and 
obtained the tree using the Bayesian phylogenetic 
method (GTR model, 5 million generations and 
excluding 40% of the initial trees; (27)). The tree 
was elaborated and prepared for proper display 
with the iTOL online tool (http://itol.embl.de/) 
(28).
Cloning, mutagenesis and overexpression 
of AdiC and AdiC-W293L – AdiC was cloned 
from genomic E. coli strain DH5α DNA as 
previously described for other transporters (23). 
Briefly, the following primers (5’-3’) were used 
to amplify the AdiC open reading frame by 
PCR: ATGAGAATTCACTATCGAATGCAGG-
CGTATG and TCATCTCGAGGTTGGCTTTT-
ATGTTTGCTGGA. PCR products were 
digested with EcoRI and XhoI and ligated into 
a pBlueScript vector (Stratagene, La Jolla, CA, 
USA). Another PCR with the following primers 
(5’-3’) was performed to subclone the AdiC open 
reading frame into the EcoRI and PstI sites of 
a modified version of the vector pTTQ18 (29), 
thereby placing its expression under the control 
of the tac promoter: TGATGAATTCGATG-
TCTTCGGATGCTGATGC and ACCGCCT-
G C A G A AT C T T T G C T TAT T G G T G C A . 
Mutation W293L in AdiC was introduced in 
AdiC cloned into pTTQ18 using QuickChange 
site-directed mutagenesis kit (Stratagene) with 
primer 5’GCTTAGGTTCACTGGGCGGC-
T[T]GACGTTGCTGGCGGGTC3’ and its 
complementary reverse primer. For ITC studies 
AdiC was amplified from the pBlueScript 
construct using as primers (5’-3’) CAAT-
GGATCCATGTCTTCGGATGCTGATGCTC 
and TCATCTCGAGGTTGGCT-TTTATGTTT-
GCTGGA and subcloned into BamHI and XhoI 
sites of pTrcHisA vector. All DNA constructs were 
verified by sequencing. Expression experiments 
were carried out with freshly transformed E. 
coli BL21(DE3) harbouring pTTQ18-His6-
AdiC, pTTQ18-His6-AdiC-W293L or pTrcHisA-
AdiC. In cultures grown in LB medium, optimal 
expression of the AdiC proteins occurred after 3 h 
at 37 ºC after induction at A600 of 0.5 with 0.5 mM 
isopropyl-β-D-thiogalactoside. Routinely, four to 
six liters of medium in flasks were inoculated 
with the corresponding AdiC construct and after 
3 h of growth at 37 ºC, cells were harvested. Cell 
pellets were resuspended in lysis buffer (20 mM 
Tris-HCl pH 8.0, 0.5 mM EDTA).
Preparation of E. coli membranes – Cell 
pellets were disrupted by passage through a 
French pressure cell (20,000 psi). Unbroken cells 
were removed by centrifugation (10 min at 10,000 
g, 4 ºC). The supernatant was ultracentrifuged 
(1 h at 100,000 g, 4 ºC), and the pellet was 
resuspended and homogenized (30 ml glass 
homogenizer) in lysis buffer and ultracentrifuged 
again. Peripheral membrane proteins were 
removed by homogenization in 20 mM Tris-HCl 
pH 8.0, 300 mM NaCl and ultracentrifugation. 
Finally, the membrane pellet was resuspended 
in 20 mM Tris-HCl pH 8.0, 150 mM NaCl at a 
protein concentration between 13 and 25 mg/ml. 
Aliquots were frozen in liquid nitrogen and stored 
at -80 ºC until use.
Purification of AdiC and AdiC-W293L, and 
determination of protein concentration – Frozen 
E .coli total membranes containing overexpressed 
AdiC or AdiC-W293L were thawed and 
solubilized for 2 hours at 4 °C under gentle 
agitation in 1% DDM, 20 mM Tris-HCl pH 8, 
300 mM NaCl, 10% glycerol, 0.01% NaN3. The 
protein concentration during solubilization was 
between 2-3 mg/ml. After ultracentrifugation 
(100,000 g, 50 min at 4°C) the supernatant was 
diluted two-fold with 20 mM Tris-HCl pH 8, 
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300 mM NaCl, 0.04% DDM, 5 mM histidine, 
10% glycerol, 0.01% NaN3 (washing buffer) and 
bound for 2 h at 4 °C to Ni-NTA Superflow beads 
(Qiagen, Hilden, Germany). The beads were then 
loaded onto a spin column (Promega, Madison, 
WN, USA), washed with washing buffer and 
eluted with the same buffer containing 200 mM 
histidine. For  ITC studies the beads were washed 
twice with 20 mM imidazole in 20 mM Tris-HCl 
pH 7.6, 150 mM NaCl, 0.01% DDM. AdiC-W293L 
was eluted with 300 mM imidazole in the same 
buffer. Untagged AdiC was eluted by overnight 
digestion at room temperature with enterokinase 
(Invitrogen, Carlsbad, CA, USA) (5 U/ mg protein) 
in  20 mM Tris-HCl pH 7.6, 10 mM CaCl2 and 
0.01% DDM. Then, protein was further purified 
by size-exclusion chromatography with Superdex 
200 (10/300) (Pharmacia) and concentrated 
with Vivaspin MWCO100 (Sigma-Aldrich, St. 
Louis, MO, USA).  Protein concentration was 
determined spectrophotometrically measuring 
the absorbance at 280 nm and using a molar 
extinction coefficient of 85,830 M-1 cm-1 (AdiC), 
91,830 M-1 cm-1 (untagged AdiC)  and of 80,330 
M-1 cm-1 (AdiC-W293L). These values were 
calculated from the amino acid sequence of the 
different AdiC versions using the ProtParam tool 
from the ExPASy proteomics server (http://www.
expasy.org/tools/protparam.html).
Transport measurements – For functional 
studies, purified AdiC proteins were reconstituted 
into proteoliposomes as previously described 
(23). L-[3H] arginine influx measurements into 
AdiC and AdiC-W293L proteoliposomes were 
performed according to Reig et al, 2007. All 
experimental values were corrected by subtracting 
zero time values and are reported as means ± 
S.E.M. (standard error of the mean).
Isothermal titration calorimetry (ITC) – All 
solutions were thoroughly degassed before 
titration in an ITC instrument (MicroCal). A 
solution of AdiC or AdiC-W293L (0.11 mM in 
1.4 ml of buffer 150 mM NaCl, 20mM Tris-HCl, 
pH 7.5, 0.01% DDM) was loaded into the sample 
cell, 2.5 mM titrant (L-arginine in the same 
buffer) was loaded into the injection syringe, and 
the system was equilibrated at 25 °C. Titration 
curves were generated by 30 successive 10 µl 
injections at 240 sec intervals. Control injections 
were done in the absence of protein to determine 
background corrections. The data were fit to 
single-site binding isotherms with the Origin 
software.
2D crystallization of AdiC-W293L – Purified 
AdiC-W293L protein solubilized in DDM was 
mixed with E. coli polar lipids solubilized in 
the same detergent (stock solution: 5 mg/ml E. 
coli polar lipids , 1% DDM, 20 mM Tris-HCl pH 
8, 150 mM NaCl, 10% glycerol, 0.01% NaN3) 
to achieve a lipid-to-protein ratio (LPR) of 0.3 
(w/w). The final AdiC/AdiC-W293L protein 
concentration was adjusted to about 1 mg/ml. 
The protein/lipid/detergent mix was dialyzed 
against detergent-free buffer, i.e. 20 mM citric 
acid NaOH pH 5, 250 mM NaCl, 10% glycerol, 
0.01% NaN3, 5 mM arginine for about two weeks 
at room temperature.
Blue native gel electrophoresis – Linear 5–12% 
gradient gels for BN-PAGE were prepared and run 
as previously described (30). Thyroglobulin (669 
kDa), ferritin (440 kDa), lactate dehydrogenase 
(140 kDa), and bovine serum albumin (66 kDa) 
were used as standard proteins.
Negative stain TEM – DDM-solubilized AdiC 
or AdiC-W293L protein at ~3 µg/ml was adsorbed 
for ~10 sec to parlodion carbon-coated copper 
grids rendered hydrophilic by glow discharge 
at low pressure in air. Grids were washed with 
three drops of double-distilled water and stained 
with 2 drops of 0.75% uranyl formate. Grids of 
negatively stained 2D AdiC-W293L crystals 
(Figure 5) were prepared similarly, but included 
a longer adsorption time of ~60 sec. Electron 
micrographs were recorded at a magnification 
of 50,000x on Eastman Kodak Co. SO-163 sheet 
films with a Hitachi H-7000 electron microscope 
operated at 100 kV.
Cryo-TEM – 2D crystals of AdiC-W293L were 
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adsorbed to a thin carbon film on a molybdenum 
grid and frozen in liquid nitrogen in the presence 
of 7% (w/v) trehalose (31). Frozen grids were 
transferred onto a Philips CM200-FEG electron 
microscope using a Gatan 626 cryo-holder. 
Electron micrographs were recorded on Eastman 
Kodak Co. SO-163 films at an accelerating 
voltage of 200 kV, a magnification of 50,000x 
using a low-dose system (~10 electrons per Å2) 
and a measured specimen temperature of about 
-175 °C.
Image processing – Electron micrographs 
of selected AdiC-W293L crystals were scanned 
using a Heidelberg Primescan D7100 scanner 
with a sampling of 1 Å/pixel at the sample level. 
The images were processed using the IPLT 
image processing toolkit (32, 33) to correct for 
the contrast transfer function (CTF) and crystal 
distortions. The parameters of the CTF and the 
crystal lattice were fitted manually using the 
graphical user interface provided by IPLT. The 
five best images were scaled using one image as 
reference and merged to produce the final data set 
from which the projection represented as a contour 
map was generated within IPLT. To generate 
the improved projection map of AdiC-W293L 
(Figure 6B), the projection of one downside-up 
oriented dimer was flipped, translationally and 
rotationally aligned with respect to the projection 
of one upside-down oriented dimer, averaged 
and two-fold symmetrized exploiting the internal 
symmetry of the AdiC-W293L dimer (2D 
crystals consist of alternating rows of downside-
up and upside-down oriented dimers in the lipid 
bilayer).
Figure 1. Origin and evolutionary relationship of AdiC with other APC transport proteins. The Bayesian tree shows the position of the AdiC protein 
sequence (within a box) in the context of other members of the APC transporters superfamily. The abbreviation of each of the subfamilies is on 
the right side of the tree: see Jack et al, 2000 and http://www.tcdb.org/tcdb/superfamily.php for a description of each of the subfamilies displayed. 
The tree was rooted using the MmuP protein of E. coli. Probabilities given by Bayesian analysis are displayed at each of the tree nodes. The bar 
shows the evolutionary distance in number of expected substitutions per site.
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2.5 RESULTS
Phylogenetic analysis of AdiC – The origin 
and evolution of the AdiC protein appears to be 
controversial, as it has been reported to belong 
to two distant groups of membrane transporters: 
MFS (5, 7) and the APC superfamily (6). To 
clarify this issue, we have analyzed de novo the 
phylogenetic relationship of AdiC with known 
transport proteins. We have combined two rounds 
of computational searches and comparisons with 
different levels of sensitivities and accuracies 
(see materials and methods). As an initial and 
rough approximation, we first used BLAST to 
compare the AdiC protein sequence against 
a non-redundant protein sequence database 
and observed that closest matches (other than 
predicted, potential or hypothetical) were 
prokaryotic amino acid/polyamine antiporters, 
e.g. the proteins with the gi’s: 152969070, 
44886079, 10801580, 123443711 (PotE) at the 
National Center for Biotechnology Information 
(NCBI) data base. These transporters belong to 
the basic amino acid/polyamine antiporter (APA) 
family, a subgroup of the APC superfamily (6, 
23). Next, and similarly to our previous work 
with SteT (23), we selected a number of protein 
sequences representing APC subfamilies that are 
close to APA, and calculated a Bayesian tree. 
As seen in Figure 1, the tree indicated that AdiC 
clearly clusters with members of the APA family. 
In addition, the phylogenetic analysis revealed 
that eukaryotic and human APC transporters 
closest related to AdiC are members from the 
L-amino acid transporter (LAT) family, e.g. xCT, 
y+LAT1 and b0,+AT, with sequence identities of 
15-17%.
Cloning, expression and purification of AdiC 
and AdiC-W293L – The AdiC gene from E. 
coli was amplified from genomic DNA by PCR 
using gene-specific primers. The W293L point 
mutation in transmembrane 8 was introduced 
in order to diminish the number of possible 
conformations of AdiC to foster crystallization. 
The corresponding substitution (W292L) in 
the related APA transporter PotE (putrescine/
ornithine exchanger from E. coli) results in 
an inactive transporter (34). For homologous 
overexpression the AdiC and AdiC-W293L 
genes were cloned into the pTTQ18 vector fused 
with a C-terminal His6-tag. Isolated E. coli total 
membranes containing overexpressed AdiC or 
AdiC-W293L were solubilized with n-dodecyl-
β-D-maltoside (DDM), and the corresponding 
protein purified in a single step by nickel affinity 
chromatography. The high purity of the isolated 
Figure 2. SDS- and BN-PAGE of AdiC and AdiC-W293L. (A) 13.5% 
SDS-PAGE of DDM-solubilized E. coli total membranes containing 
overexpressed AdiC protein (lane 1) and of purified protein after nickel 
affinity chromatography (lane 2). AdiC runs as a prominent band at ~39 
kDa in SDS/polyacrylamide gels. (B) BN-PAGE of purified AdiC protein 
in a linear 5–12% gradient gel. (C) Same as in (A) but for AdiC-W293L. 
(D) Same as in (B) but for AdiC-W293L. All gels were stained with 
Coomassie Brilliant Blue R-250. Applied amount of protein per lane: ~9 
µg (lane 1, panel (A)), ~6 µg (lane 2, panel (A)), ~12 µg (B), ~8 µg (lane 
1, panel (C)), ~5 µg (lane 2, panel (C)) and ~5 µg (D).
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proteins is reflected in the SDS/polyacrylamide 
gels: AdiC (Figure 2A, lane 2) and AdiC-W293L 
(Figure 2C, lane 2). Both proteins run at ~39 kDa 
by SDS-PAGE. This was further confirmed by 
Western blot analysis using an anti-His antibody 
(data not shown). Because of the high expression 
levels, both AdiC forms were also visible in the 
DDM-solubilized E. coli total membranes: AdiC 
(Figure 2A, lane 1) and AdiC-W293L (Figure 2C, 
lane 1), see band at ~39 kDa. Typically, about 3 
mg and 1 mg of pure AdiC and AdiC-W293L 
protein, respectively, were purified from 1 liter of 
bacterial cell culture.
Characterization of purified AdiC and 
AdiC-W293L by BN-PAGE and negative-stain 
TEM – To determine whether AdiC exists in 
a monomeric or oligomeric state, detergent-
solubilized protein was subjected to BN-PAGE 
and negative stain TEM. On BN-gels, purified 
AdiC (Figure 2B) and AdiC-W293L (Figure 2D) 
migrated as single bands between 140 and 160 
kDa depending on the experimental conditions. 
Denaturation of AdiC with SDS prior BN-PAGE 
resulted in an additional band at ~70 kDa (data 
not shown). To assess the shape, dimensions 
Figure 3. TEM of negatively stained AdiC and AdiC-W293L particles. (A) 
The homogeneity of the purified AdiC protein is reflected in the electron 
micrograph. Selected top views of AdiC (B) and AdiC-W293L particles 
(C) are displayed in the corresponding gallery. The scale bar represents 
750 Å, and the frame size of the magnified particles in the galleries is 
190 Å.
and low-resolution structure of purified AdiC 
and AdiC-W293L, proteins were adsorbed on a 
parlodion carbon-coated grid, washed, negatively 
stained and examined by TEM. Figure 3A shows 
the high homogeneity of AdiC after purification 
by nickel affinity chromatography. Single AdiC 
particles were discerned and displayed an 
elliptical shape with a major axis of 121±7 Å and 
a minor axis of 76±6 Å (n=100). The elongated 
particles had a dimeric appearance comparable to 
two connected ring-like structures. The central, 
stain-filled indentation in each ring was clearly 
visible on AdiC top views (Figure 3B, gallery). 
As documented in Figure 3C, AdiC-W293L had 
similar dimensions and appearance as AdiC.
Transport, inhibition pattern and binding in 
AdiC and AdiC-W293L – Transport of L-arginine 
via AdiC reconstituted in proteoliposomes is 
characteristic of an obligatory exchanger. Thus, 
transport is dependent on the presence of substrate 
(L-arginine) inside AdiC proteoliposomes 
(Figure 4A). In the absence of substrate inside 
AdiC proteoliposomes influx of L-[3H] arginine 
most probably occurs by simple diffusion (Figure 
4A). Thus, this transport is very low and similar 
to that of L-serine with SteT (the LAT exchanger 
of Ser/Thr from B. subtilis) proteoliposomes 
under similar conditions (23). The exchange 
L-[3H] arginine/L-arginine has a larger flux 
that the exchange L-[3H] arginine/agmatine 
(Figure 4B) in agreement with previous results 
(5). The inhibition profile of L-[3H] arginine/
arginine exchange by 5 mM substrate analogs 
suggest the following affinity pattern: L-arginine, 
agmatine > cadaverine > putrescine > L-lysine, 
L-ornithine, L-glutamate, 1,3-diaminopropane > 
L-glutamine, aminoguanidine (Figure 4C). This 
is in agreement with the previously reported 
transport competence profile for reconstituted 
AdiC: L-arginine > cadaverine > L-lysine, 
L-ornithine (5). Moreover, our results indicate 
that substitution of the agmatine guanidine group 
by amine is recognized by AdiC depending on the 
size of the aliphatic chain (Figure 4C; cadaverine 
> putrescine > 1,3-diaminopropane).
22
Results Projection structure of an APC transporter 
AdiC-W293L proteoliposomes showed no 
L-[3H] arginine/L-arginine exchange (Figure 4B, 
right). Similarly mutation to cysteine in the same 
residue (W293C) render a transporter that is 
expressed but inactive (data not shown). In order 
to dissect whether W293L mutation disrupts 
substrate recognition or translocation, substrate 
binding to AdiC-W293L in detergent solution 
was analyzed by ITC. AdiC without His-tag, with 
full exchange activity (data not shown), was used 
as a control in these studies. In agreement with 
a previous report using untagged AdiC (5) for 
both Arg and Agm, substrate titrations produce 
signals of heat absorption, showing that binding 
is enthalpically unfavorable (ΔHo > 0), and thus 
entropy-driven (ΔSo  = 24 and 22 cal/mol-K for 
Arg and Agm respectively ), with Arg showing 
substantially larger binding enthalpy  (1.5 kcal/
mol ) than Agm (0.4 kcal/mol). The titration data 
are fit well by isotherms saturating at one binding 
site (0.96) per AdiC monomer, with equilibrium 
dissociation constants of 100 µM for Arg and 
30 µM for Agm. AdiC-W293L showed head 
adsorption upon Arg and Agm titration with a 
equilibrium dissociation constant similar to AdiC 
(data not shown). 
2D crystallization and projection structure of 
AdiC – Purified AdiC and AdiC-W293L protein 
was reconstituted into lipid bilayers as described 
in materials and methods. Both AdiC proteins 
yielded tubular 2D crystals diffracting better 
than 20 Å by negative stain. However, AdiC-
W293L crystals, in contrast to AdiC, diffracted 
Figure 4. AdiC transport activity. (A) Time course of L-arginine transport in AdiC proteoliposomes. Influx of 10 µM L-[3H] arginine into AdiC 
proteoliposomes lacking (open circles) or containing 2 mM L-arginine (closed circles). Data (mean ± S.E.M) correspond to a representative 
experiment with three replicas. Error bars when not visible are smaller than symbols. (B) Influx of 10 µM L-[3H] arginine into AdiC and AdiC-
W293L proteoliposomes. Transport was measured in AdiC proteoliposomes (left) containing no substrate (control), 2 mM L-arginine (L-Arg) or 2 
mM agmatine (Agm). Exchange activity in AdiC (wt) and AdiC-W293L (W293L) proteoliposomes (right) was calculated by subtracting transport 
in the corresponding proteoliposomes with no substrate inside to that in proteoliposomes containing 2 mM L-arginine. Data (mean ± S.E.M.) 
correspond to a representative experiment with three replicas. A second experiment gave similar results. (C) Inhibition pattern of AdiC transport in 
proteoliposomes. The residual exchange activity of 10 µM L-[3H] arginine (outside) and 2 mM L-arginine (inside) in the presence of the indicated 
substrate analogs (5 mM) in the external medium is shown. Exchange activity was calculated as in (B) and is expressed as the percentage of 
transport in AdiC proteoliposomes in the absence of inhibitors. Data are from four to six experiments with three replicates per condition. 
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significantly better by cryo-TEM and were, 
importantly, much more reproducible. Therefore, 
we focused on the determination of the projection 
structure of AdiC-W293L. Figure 5A shows 
typical 2D crystals of AdiC-W293L, measuring 
0.4-0.6 μm in width and up to 2 μm in length. 
The lattice lines of such 2D crystals are barely, 
but still visible on noisy electron micrographs 
(Figure 5B). Upon adsorption on carbon film, 
tubular crystals became flattened into two layers, 
one usually diffracting better than the other in 
cryo-TEM. The best micrographs from cryo-
TEM displayed reflections below 7 Å resolution 
(Table 1).
A 6.5 Å projection density map of AdiC-W293L 
was calculated by merging the data from five 
images (Figure 6A; see also Table 1 for statistics). 
The unit cell, which harbored four AdiC dimers, 
had dimensions of a=184 Å, b=119 Å, γ= 90° 
and a crystallographic p2 symmetry. As visible 
in Figure 6A, 2D crystals consisted of horizontal, 
alternating rows of upside-down and downside-
up oriented AdiC-W293L dimers (upside-down 
is the mirror image of the downside-up dimer 
Figure 5. TEM of negatively stained 2D crystals of AdiC-W293L. (A) 
Overview electron micrograph of tubular AdiC crystals. The area marked 
by the white broken box was magnified and is displayed in panel (B). 
The scale bars represent 0.6 µm (A) and 0.15 µm (B).
and vice versa). Therefore, 2D AdiC-W293L 
crystals expose both protein surfaces, i.e. the 
cytoplasmic and periplasmic side. Although not 
evident at first glance, small packing differences 
between these in the unit cell differently oriented 
dimers excluded a screw axis of symmetry. To 
further improve the projection structure of AdiC-
W293L, one upside-down oriented dimer was 
flipped, translationally and rotationally aligned 
with respect to a downside-up oriented dimer, 
averaged and two-fold symmetrized exploiting 
the intrinsic symmetry of the AdiC-W293L 
dimer. The latter, improved the resolution of the 
projection map as documented in Figure 6B.
The overall shape of the AdiC dimer was 
elliptical with dimensions of ~95 × ~55 Å. 
From the 10-12 density peaks in the projection 
structure of the AdiC-W293L monomer, most of 
the densities were elongated with the exception 
of one single strong density peak (Figure 6B, 
arrowheads). The dimer interface appeared to 
consist of two main interacting sites between the 
monomers (Figure 6B, stars).
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Figure 6. Projection structure of AdiC-W293L. (A) p2-symmetrized projection map of AdiC-W293L at 6.5 Å resolution calculated from five electron 
micrographs. The black rectangle marks the unit cell, lattice dimensions: a=184 Å, b=119 Å,  γ= 90°, which contains four AdiC-W293L dimers (two 
upside-down and two downside-up oriented dimers). (B) Improved projection map of AdiC-W293L after averaging of the two in the lipid bilayer 
differently oriented AdiC-W293L dimers (e.g. the two dimers marked by asterisks) and subsequent two-fold symmetrization. The only strong density 
peak in the projection structure of the AdiC-W293L monomer is marked by an arrowhead. The intradimeric contact sites are indicated by stars. The 
scale bar represents 20 Å.
Figure 7. Comparison of the AdiC-W293L and OxlT projection structures. 
(A) Projection map of the AdiC monomer at a resolution of 6.5 Å, a 
member of the APC transporters superfamily. The asterisk indicates the 
two-fold symmetry axis of the AdiC dimer. (B) Projection map of the OxlT 
monomer at 6 Å resolution (41), a member of the MFS. The scale bar 
represents 10 Å.
2.6 DISCUSSION
From the literature, the origin of the AdiC 
protein is unclear, as it has been reported to belong 
to two distant groups of membrane transporters: 
the MFS (5, 7) and the APC superfamily (6). A 
de novo analysis of the phylogenetic relationship 
of AdiC with known transport proteins clearly 
indicated that AdiC belongs to the APC 
superfamily (Figure 1). On our aim to elucidate 
the structure of membrane transporters from the 
APC superfamily using 2D crystals and cryo-
TEM, we cloned, overexpressed, purified, and 
biochemically and functionally characterized 
wild-type AdiC and the point mutant AdiC-
W293L. For 2D crystallization, overexpression of 
AdiC and AdiC-W293L yielded large quantities 
of pure protein (Figure 2A and 2C), i.e. 1-3 mg 
per liter of bacterial cell culture. BN-PAGE of 
purified AdiC and AdiC-W293L indicated an 
apparent molecular mass between 140 and 160 
kDa, depending on the experimental conditions. 
Assuming an average mass of ~48.5 kDa for both 
AdiC forms and a DDM/coomassie brilliant blue 
G-250 micelle of ~45 kDa bound to the proteins 
during BN-PAGE (35), AdiC and AdiC-W293L 
exist as dimers when solubilized in DDM. The 
latter was supported by TEM of negatively stain 
AdiC and AdiC-W293L proteins that showed 
elongated particles resembling to two connected 
rings (Figure 3B and 3C). Furthermore, the 
elliptical shape of AdiC with dimensions of ~120 
× ~75 Å is about twice as long as that of detergent-
solubilized SteT monomers (SteT is also a 
member of the APC superfamily), which have 
dimensions of ~70 × ~60 Å (23). Interestingly, 
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also the overall low-resolution structures of SteT 
and AdiC monomers are similar being round-
shaped with a central indentation. Finally, our 
results on the dimeric nature of AdiC are in line 
with a recent report by Fang et al., 2007.
Reconstitution of AdiC into proteoliposomes 
confirmed the L-arginine/agmatine exchanger 
activity of the transporter (Figures 4A and 4B) 
and indicated relevant substrate recognition 
similarities to PotE. Thus, in both transporters 
the inhibition competence of substrate analogs 
depends on the size of the aliphatic chain 
connecting the two primary amino groups: 
cadaverine > putrescine > 1,3-diaminopropane 
in AdiC (Figure 4C) and putrescine > 1,3-
diaminopropane in PotE (34). In PotE the 
mutation W292L abolishes the transport activity 
of the protein (34). The same was the case for 
AdiC when introducing the corresponding point 
mutation, i.e. W293L (Figure 4B). Based on the 
crystal structure and mutational analysis of PotF, 
a periplasmic substrate-binding protein of the 
putrescine-specific ABC transport system in E. 
coli (36), and on the absence of transport activity 
in the mutant PotE-W292L, it was proposed that 
W292 is one of the key residues in the recognition 
of the butane moiety of putrescine in PotE (34). 
The high amounts of pure and homogeneous 
protein formed an excellent basis for the 2D 
crystallization of AdiC and AdiC-W293L. Both 
AdiC proteins had the propensity to form 2D 
crystals. However, AdiC-W293L 2D crystals 
were much more reproducible and better ordered 
diffracting below 7 Å resolution. Similar to the 
lactose permease mutant LacY-C154G (37), the 
introduction of a point mutation in AdiC, i.e. 
AdiC-W293L, improved the crystal quality and 
reproducibility considerably compared to wild-
type AdiC crystals. Therefore, we focused on 
the determination of the projection structure of 
AdiC-W293L.
2D crystals of AdiC-W293L yielded the first 
detailed view in projection of a transport protein 
from the APC superfamily. Although the exact 
number of transmembrane helices and their 
relative orientations within the molecule cannot 
be determined from the projection structure of 
AdiC-W293L, meaningful information is gained 
when comparing with known membrane protein 
structures. For instance, the elongated density 
peaks suggest that the fold of AdiC consists 
mainly of tilted helices with the exception of 
one single strong density peak (Figure 6B, 
arrowheads) which suggests a perpendicular 
membrane spanning α-helix. This is based on the 
projection and 3D structures of aquaporins (38) 
and bacteriorhodopsin (39) that mainly consist 
of tilted or vertical transmembrane helices, 
respectively. As mentioned above, it is unclear 
from the literature, if AdiC belongs to the MFS 
or APC superfamily. To verify our results from 
phylogenetic analysis (Figure 1), indicating that 
AdiC is a member of the APC superfamily, we 
compared our AdiC projection structure with that 
of the oxalate/formate antiporter from Oxalobacter 
formigenes (OxlT). OxlT is a typical twelve 
transmembrane helix transport protein from the 
MFS (40) (Figure 7) and the molecular mass is 
comparable to that of AdiC. The difference of the 
two proteins is striking supporting the notion that 
AdiC does not belong to the MFS. Interestingly, 
the packing of the structural elements in OxlT is 
dense in contrast to AdiC. This is also reflected 
in the protein density area in the projection map 
of AdiC, which is distinctly larger than that of 
OxlT (Figure 7). The OxlT monomer contains 
a near-two-fold symmetry that is evident in the 
projection map (Figure 7B), relating two sets of 
six membrane-spanning helices, consistent with 
the clear homology between the first six and last 
six transmembrane segments in the MFS (33). This 
intrinsic near-two-fold symmetry is not present 
in the AdiC-W293L monomer (Figure 7A). In 
summary, we predict based on this comparison a 
markedly different fold for APC family members 
compared to transporter proteins from the MFS.
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3.1 ABSTRACT
Atomic force microscopy-based single 
molecule force spectroscopy (SMFS) is 
a powerful tool to study the mechanical 
properties, inter- and intra-molecular 
interactions, unfolding pathways and energy 
landscapes of membrane proteins. One limiting 
factor for the large-scale applicability of SMFS 
on	membrane	proteins	 is	 its	 low	efficiency	 in	
data acquisition. We have developed a semi-
automated high-throughput (HT)-SMFS 
procedure	 for	 efficient	 data	 acquisition.	
In	 addition,	 we	 present	 a	 coarse	 filter	 to	
efficiently	 extract	 protein	 unfolding	 events	
from large data sets. The HT-SMFS procedure 
and	the	coarse	filter	were	validated	using	the	
proton pump bacteriorhodopsin (BR) from 
Halobacterium salinarum and the L-arginine/
agmatine antiporter AdiC from the bacterium 
Escherichia coli. To screen for molecular 
interactions between AdiC and its substrates, 
we recorded data sets in the absence and in 
the presence of L-arginine, D-arginine and 
agmatine. Altogether ~400,000 force-distance 
curves were recorded. Application of coarse 
filtering	to	this	wealth	of	data	yielded	six	data	
sets with ~200 (AdiC) and ~400 (BR) force-
distance spectra in each. Importantly, the raw 
data for most of these data sets were acquired 
in one to two days opening new perspectives 
for HT-SMFS applications.
3.2 INTRODUCTION
The atomic force microscope (AFM) has 
become a versatile tool to image the surface 
topography of biological membranes at a lateral 
resolution of ~5 Å and a vertical resolution of ~1 
Å under near native conditions (1). In addition, 
the AFM is successfully used to probe mechanical 
properties of proteins down to the single molecule 
level. Such single molecule force spectroscopy 
(SMFS) has developed into a powerful technique 
to study the unfolding of individual membrane 
proteins incorporated into lipid bilayers (2). 
SMFS unfolding curves have a saw-tooth 
pattern appearance that is characteristic of the 
investigated protein. The unique ‘fingerprint’ 
of a specific protein allows localizing and 
quantifying molecular interactions that stabilize 
the assembly of secondary structure elements. 
Furthermore, SMFS has been used to measure 
interactions of membrane proteins with ligands 
and small molecules as well as their activation (2). 
Additionally, kinetical parameters of membrane 
protein unfolding, e.g. unfolding rates, were 
extracted from such experiments (3). Sapra and 
co-workers (4) have demonstrated by SMFS 
that the oligomeric state of bacteriorhodopsin 
influences the intrinsic stability of the structural 
elements within the monomer but not its unfolding 
pathway. However, the unfolding pathway of 
an entire protein complex cannot be studied by 
SMFS, because of the lack of covalent catenation 
between the proteins forming the complex.
The procedure of SMFS on membrane proteins 
can be divided into several steps: membranes 
containing the integral protein of interest have 
first to be localized by AFM imaging. Then, 
force-distance (F-D) curves are recorded by 
pushing the AFM tip onto membrane proteins and 
retraction after a short delay. If a protein adheres 
strongly to the cantilever with one of its termini, 
it can be mechanically unfolded upon cantilever 
retraction. Subsequent data processing involves 
(i) data coarse filtering to extract F-D curves 
that show unfolding events, (ii) classification 
of the latter, (iii) alignment of F-D curves and 
(iv) their analysis based on polymer chain 
models. Large-scale applicability of SMFS on 
membrane proteins is, however, restricted by 
its low efficiency: not every F-D curve leads 
to an unfolding event. For the bacterial sodium/
proton antiporter it was estimated that complete 
protein unfolding occurred in only ~3% of 
the approaches (5), and this when using two-
dimensional (2D) crystals where the membrane 
proteins are packed at the highest possible 
density. When applying SMFS to a more realistic 
system, i.e. non-crystalline proteoliposomes 
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or even native membranes, the probability for 
protein adhesion to the tip is considerably lower 
than with 2D crystals. In addition, membrane 
proteins may follow different unfolding 
pathways with occurrence probabilities below 
10% (2). This requires performing a considerable 
number of experiments and makes the analysis 
of such large data sets challenging. Furthermore, 
ions, small molecules or the environment, e.g. 
temperature, all influence the unfolding behavior 
of membrane proteins, giving rise to subtle 
changes in the distribution of unfolding pathways 
(6, 7). Consequently, not only one but several 
large data sets have to be recorded, i.e. one for 
each experimental condition. For these reasons, 
high-throughput (HT) protocols for each of the 
SMFS procedure steps are desirable. To date, 
fully automated SMFS procedures on membrane 
proteins are not feasible. The main reason for this 
is that lipid membranes containing the protein of 
interest have first to be located by AFM imaging 
and eventually manipulated before SMFS, e.g. 
to remove aggregates or the upper layer of a 
collapsed vesicle to expose areas where force 
spectra can be recorded. Therefore, imaging 
and sample manipulation by AFM prior to force 
spectroscopy are currently the limiting steps 
towards a fully automated HT-SMFS procedure 
for membrane proteins. 
Automated alignment and pattern-recognition 
algorithms have been described in the past (8-10). 
However, the preceding data recording and 
coarse filtering has not been optimized yet. Data 
acquisition is a bottleneck towards HT-SMFS: 
recording of a single F-D curve takes about one 
second, but the manual recording of a complete 
data set, consisting of ~200 spectra, with an 
unfolding efficiency of less than 1% is laborious 
work. Furthermore, manual recording comprises 
online filtering by the operator leading to the 
loss of relevant force spectra and consequently 
to a decrease in the data acquisition efficiency. 
In the worst case, one or several classes of force 
spectra might even be ignored if the operator is 
biased towards a specific ‘fingerprint’. Such bias 
is eliminated by the application of an automated 
acquisition and saving procedure. The acquired 
data is subsequently filtered to extract the F-D 
curves of completely unfolded proteins, i.e. pulled 
from one of their termini. This filtered data is then 
used for further processing and classification.
In this work, we present a HT-SMFS 
procedure, which addresses the semi-automated 
recording of F-D curves and the off-line coarse 
filtering of the acquired data. The method was 
validated by its application to 2D crystals of 
the proton pump bacteriorhodopsin (BR) from 
Halobacterium salinarum and to proteoliposomes 
of the L-arginine/agmatine antiporter AdiC from 
Escherichia coli (E. coli). While the atomic 
structure of BR has been elucidated (11, 12), 
the structure of AdiC is unknown. Furthermore, 
BR has been extensively characterized by SMFS 
(6, 13-15) and other methods, whereas for AdiC 
only very few functional and structural data are 
available. AdiC is a component of the bacterial 
acid resistance mechanism (16) and a member of 
the amino acid/polyamine/organocation (APC) 
transporter superfamily. It is a 445 amino acid 
(aa) protein with a molecular mass of ~47 kDa and 
expected to fold into 12 transmembrane α-helices 
with cytoplasmic N- and C-termini (17, 18). 
Recently, Fang et al. (19) have over-expressed, 
and functionally and biochemically characterized 
the AdiC exchange transporter showing among 
other things that it forms homodimers. 
We have taken BR as well-characterized 
control and the AdiC protein as test case for our 
HT-SMFS procedure. Two main classes of force 
spectra were obtained for AdiC and attributed to 
proteins unfolded by pulling from the N- and from 
the C-terminus, respectively. Importantly, the 
assignment of a main class to a terminus was made 
possible by the use of two different recombinant 
forms of the AdiC protein differing in the length of 
their termini. To screen for molecular interactions 
between AdiC and its substrates, we recorded 
data sets in the absence and in the presence of 
L-arginine, D-arginine and agmatine. This means 
that ~400,000 F-D curves had to be recorded to 
obtain six data sets (including the BR control), 
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3.3 MATERIALS AND METHODS
Cloning, expression, purification, 
reconstitution and transport measurement of 
AdiC – AdiC was cloned from genomic E. coli 
strain DH5α DNA as previously described for other 
transporters (20). Shortly, the following primers 
(5’-3’) were used to amplify the AdiC open reading 
frame by PCR: ATGAGAATTCACTATCGA-
ATGCAGGCGTATG and TCATCTCGAGGTT-
GGCTTTTATGTTTGCTGGA. PCR products 
were digested with EcoRI and XhoI and 
ligated into a pBlueScript vector (Stratagene, 
La Jolla, CA, USA). Another PCR with the 
following primers (5’-3’) was performed to 
subclone the AdiC open reading frame into 
the EcoRI and PstI sites of a modified version 
of the vector pTTQ18 (21), thereby placing its 
expression under the control of the tac promoter: 
TGATGAATTCGATGTCTTCGGATGCT-
GATGC and ACCGCCTGCAGAATCTTTGC-
TTATTGGTGCA. To subclone AdiC into the 
pTrcHisA vector another PCR was performed with 
the pBlueScript construct using as primers (5’-3’): 
CAATGGATCCATGTCTTCGGATGCTG-
ATGCTC and TCATCTCGAGGTTGGCTTTT-
AT-GTTTGCTGGA. Digestion of the PCR 
product with BamHI and XhoI and ligation 
allowed to subclone AdiC into the new vector. 
All DNA constructs were verified by sequencing. 
The two AdiC constructs with either an N-terminal 
(pTrcHis-construct: N-His6-AdiC; 481 aa long) 
or C-terminal (pTTQ18-construct: AdiC-His6-C; 
461 aa long) His6-tag were expressed in E. coli, 
purified by nickel affinity chromatography, 
reconstituted into E. coli lipid bilayers and assayed 
for transport function as previously described 
(20). Proteoliposomes for AFM and SMFS were 
reconstituted by dialysis (dialysis buffer: 150 
mM NaCl, 10% glycerol, 0.01% NaN3, 20 mM 
Tris-HCl pH 8) at lipid-to-protein ratios between 
0.5 and 1.0 using dodecylmaltoside-solubilized 
AdiC and E. coli polar lipids (Avanti Polar Lipids 
Inc., Alabaster, AL, USA).
High-throughput single molecule force 
spectroscopy (HT-SMFS) – HT-SMFS 
experiments were performed on a commercial 
AFM (NanoWizard® II Ultra, JPK Instruments, 
Berlin, Germany) equipped with a 30 µm x 
and y closed-loop controlled piezo-scanner. To 
reduce noise from the surroundings, the AFM 
was placed on an active damping table (MOD-1L 
plus, Halcyonics GmbH, Göttingen, Germany) 
and acoustically shielded. Rectangular silicon 
nitride cantilevers (ORC8-PS, knominal = 0.05 
N·m-1, Olympus Ltd., Tokyo, Japan) were used. 
The deflection sensitivity (DS) was determined 
from the slope of the linear regime of F-D curves 
recorded on bare mica in buffer solution (150 
mM NaCl, 20 mM citric acid pH 5.0). The spring 
constant, k, of the cantilevers was determined 
using the thermal noise method (22). BR crystals 
were adsorbed onto mica as previously described 
(23). Lipid vesicles containing densely packed 
AdiC were adsorbed onto freshly cleaved mica in 
buffer solution (150 mM NaCl, 20 mM citric acid 
pH 5.0) at room temperature. After adsorption, 
the sample was rinsed several times with the 
same buffer to remove non-adsorbed membranes. 
HT-SMFS experiments were performed in the 
following buffer solutions: 150 mM KCl, 20 
mM Tris-HCl pH 7.8 (BR) and 150 mM NaCl, 
20 mM citric acid pH 5.0 (AdiC). To investigate 
AdiC-substrate interaction, vesicles containing 
densely packed AdiC were incubated in substrate 
containing buffer solution (150 mM NaCl, 20 mM 
citric acid pH 5.0, 10 mM substrate; substrate: 
L-arginine, agmatine or D-arginine) for 30 min 
at 4 °C and then adsorbed on mica in the same 
substrate containing buffer at room temperature. 
All buffers were prepared from ultrapure 
water from a NANOpure DiamondTM system 
(Barnstead, Dubuque, IA, USA, resistivity ≥ 18 
MΩ·cm). Proteoliposomes densely packed with 
AdiC were located by contact mode AFM prior to 
force spectroscopy. Where necessary, the AFM tip 
was used as a nanoscalpel to remove aggregates 
with ~200 force spectra in each (except for BR 
with ~400 curves), demonstrating the usefulness 
of the HT-SMFS protocol presented here.
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or the upper layer of a collapsed vesicle (24) 
thus exposing suitable membrane areas for 
force spectroscopy. For SMFS experiments the 
force spectroscopy tool of the NanoWizard® 
II Ultra AFM was used. A point grid with an 
edge length of 150 - 300 nm and a linear point 
density of 0.125 nm-1 was placed on 2D BR 
crystals (a kind gift of Dr. Georg Büldt, Jülich, 
Germany) or single-layered densely packed AdiC 
membranes (Figure 1). At each point of the grid 
ten successive measurements were performed. 
Membrane proteins were attached to the AFM 
tip by pushing the cantilever ten times onto the 
membrane at each grid point with a force of 1 nN 
for 0.1 - 0.6 s. The cantilever was then retracted 
for 0.25 s with a velocity of 0.53 µm·s-1 (BR) 
and 0.78 µm·s-1 (AdiC), respectively. All F-D 
curves were saved and consisted of 4096 data 
points corresponding to a sampling frequency of 
16.4 kHz. The cantilever deflection was detected 
with a position-sensitive photodiode (PSD). Its 
output voltage, VPSD, was converted into a metric 
deflection by multiplication with the cantilever 
DS, and into a force by subsequent multiplication 
with the spring constant.
Data filtering and data analysis – For F-D 
curve analysis only retraction data were used. 
F-D curves were shifted vertically so that the 
Figure 1. The cantilever deflection image shows a single-layered 
membrane (marked 1), densely packed with AdiC proteins (dots on 
this surface type) and the mica surface (marked 2). The white box on 
the AdiC proteoliposome shows the area (frame size: 200 nm), where 
F-D curves were recorded. The zoomed area contains 625 positions 
at which ten measurements per position were performed yielding 6250 
F-D curves per area.
average force in the baseline, defined as the 
final 5% of the data points in the tail part of the 
spectrum, was zero. The actual cantilever DS of 
each F-D curve was calculated from the slope 
of the deflection regime between 300 pN and 1 
nN where the force increased linearly with piezo 
movement. Tip-sample separation values (tss) 
were computed by subtracting the corrected 
metric cantilever deflection from the position of 
the z-piezo. The average tss value of the points 
used for the actual DS determination was defined 
as zero distance between tip and surface, i.e. tss 
= 0. For representation purpose all force spectra 
were flipped vertically so that pulling force peaks 
faced upwards. Therefore, negative and positive 
forces in force spectra represent pushing and 
pulling forces, respectively.
A coarse data filtering process (Figure 2) was 
applied to the acquired data sets to extract 
unfolding events. Filtering was performed using 
a home-written macro for IGOR Pro (IGOR Pro 
6.0.1.0, Wavemetrics Inc., Portland, OR, USA) 
run on a PC with an Intel CoreTM2 CPU T7400 
2.16 GHz processor equipped with 2 GB RAM. 
The following filtering criteria were used:
1) The standard deviation of the force, σF, of 
the final 5% of the data points in F-D curves was 
taken as a measure of the flatness of the non-
contact region. To ensure that only F-D curves 
with flat non-contact region were imported, the 
maximum allowed σF was set to Fthr1 = 20 pN.
2) The maximal tss beyond which no significant 
pulling forces should be found was set to tssmax. 
This value is based on the contour length, LC,max, 
of the corresponding protein amino acid sequence. 
Because the final unfolding event occurs before 
the protein is fully extended, tssmax was chosen 
slightly below LC,max. The introduction of tssmax 
allowed omitting F-D curves having force peaks at 
positions beyond the full-length of the protein.
3) Because the AFM tip can adsorb at different 
positions along the protein termini, e.g. first or 
last amino acid of a terminus, individual force 
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spectra are shifted horizontally with respect to 
each other in a given tss range. This range is 
defined by the tssmin and tssmax parameters in the 
filtering algorithm. Naturally, the last force peak 
indicating complete unfolding of the protein is 
located between tssmin and tssmax.
4) F-D curves revealing pushing (negative) 
force peaks should not be considered in the 
analysis. Therefore, the tss interval between 
tsslow = 5 nm and tssmax was searched for pushing 
(negative) forces below a critical threshold. tsslow 
was set to 5 nm because the front part of a F-D 
curve is often dominated by nonspecific tip-
sample interactions that impede correct threshold 
determination.
With the exception of the determination of the 
force noise σF, deflection data were flattened by 
a 5 points binomial smoothing before threshold 
testing. In summary, curves were identified as 
possible unfolding events when they fulfilled the 
following selection criteria:
σF < Fthr1 for  (1-frac)·tssend < tss < tssend
FSMFS,max < Fthr2·σF for tssmax < tss < tssend
FSMFS,max > Fthr3·σF for tssmin < tss < tssmax
FSMFS,min > -Fthr4·σF     for tsslow < tss < tssmax
where frac is the fraction of points, which is used 
to determine the baseline of the F-D curve. Fthr2-4 
are dimensionless numbers, which yield filtering 
force thresholds in picoNewtons when multiplied 
with σF. Here, tssend is the maximal tss value of 
Figure 2. Flow chart describing the HT-SMFS procedure. It starts with data acquisition and an automated/manual data filtering part. Force 
spectra of the protein of interest are aligned with respect to an exemplary curve and then the WLC model (25, 26) is fitted to each curve to 
determine the contour length, LC, of each stretched polypeptide segment as well as the required unfolding force. For visualization, a scattering 
plot of the aligned curves is computed. The contour length in number of amino acids is compared with a sequence-based topology model of 
the investigated membrane protein (e.g. Figure 10 for AdiC) to map the locations of the unfolding barriers. The automation of the shaded part is 
addressed in this work.
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the force spectrum and FSMFS,max and FSMFS,min are 
the maximal and minimal forces of a spectrum 
after binomial smoothing on the selected interval. 
F-D curves, which fulfilled the above selection 
criteria, were automatically exported as force 
versus tip-sample separation data for further 
analysis.
After coarse filtering, a manual fine filtering and 
classification (Figure 2) based on the repetitively 
found ‘fingerprint’ pattern of AdiC was performed. 
This step removed curves with not interpretable 
unfolding patterns that had passed the coarse 
filtering. Data acquisition was continued until 
~200 classifiable AdiC unfolding traces were 
recorded. All traces were aligned with respect to 
the most prominent unfolding peaks at tss ≈ 25 
nm for BR, tss ≈ 40 nm for N-His6-AdiC and tss 
≈ 90 nm for AdiC-His6-C (Figure 6). Deflection 
data were binomially smoothed and subsequently 
all force peaks were fitted using the WLC model 
choosing a persistence length of 0.4 nm. The 
contour length, LC, was the only free fitting 
parameter in the worm-like chain (WLC) model 
(25, 26). The contour length was divided by the 
backbone length per aa, 0.36 nm·aa-1, to obtain a 
contour length in aa. Histograms of the obtained 
LC values and unfolding forces were computed, 
and Gaussian curves were fitted to the peaks in 
the histograms. Contour lengths were correlated 
with the sequence-based topology model of 
AdiC (Figure 10) to map the unfolding barriers 
within the protein. Certain unfolding barriers 
were found on the opposite side of the pulling tip 
(periplasmic side). Since the polypeptide chain 
goes through the membrane that has a thickness 
of ~4.8 nm, unfolding barriers were shifted by 13 
aa (4.8 nm / 0.36 nm·aa-1 ≈ 13 aa) to compensate 
for the thickness of the membrane (14, 27). 
This procedure allowed the entire length of the 
stretched polypeptide to be calculated. Scattering 
plots of the aligned BR and AdiC force spectra 
were used to highlight common features (Figure 
6). They were computed using a home-written 
macro for IGOR Pro with a box size of 1 pN·0.25 
nm for BR and 1 pN·0.5 nm for AdiC. The number 
of pixels in each box was counted and converted 
3.4 RESULTS
Cloning, expression, purification, 
reconstitution and functional characterization 
of AdiC – Both recombinant forms of AdiC, i.e. 
N-His6-AdiC and AdiC-His6-C, were successfully 
cloned, over-expressed, purified, reconstituted 
and assayed for transport function according to 
Reig et al. (20). Transport activity for L-arginine 
and agmatine was for both AdiC constructs 
similar to the values obtained by Fang et al. 
(19). Thus, transport of 10 µM L-[3H] arginine 
into proteoliposomes containing either tagged 
version of AdiC was completely dependent on the 
presence of L-arginine (~1-2 pmols / µg protein 
and min) or agmatine (~0.4 pmols / µg protein 
and min) in the inside (data not shown).
Data acquisition and validation of the filtering 
process – Before HT-SMFS data acquisition, 
reconstituted lipid membranes containing densely 
packed AdiC were adsorbed onto mica and located 
by contact mode AFM (Figure 1). If necessary, 
collapsed vesicles or aggregated membranes were 
dissected using the AFM tip as a nanoscalpel to 
expose flat membrane areas suitable for SMFS. 
This localization and manipulation step of target 
proteoliposomes limited the full automation of 
our HT-SMFS data acquisition.
Figure 1 describes a typical HT-SMFS 
experiment with AdiC: an area densely packed 
with protein was first selected (white square). 
The selected area was then subdivided into 625 
positions (highlighted by the grid in Figure 1), at 
which ten F-D curves per position were recorded 
yielding 6250 F-D per area. The DS (in nm/volt) 
was determined for each recorded F-D curve by 
linear regression to the first 5-10% of the deflection 
curve during retraction of the cantilever. Figure 
into a gray scale value. The gray scale range of 
all scattering plots of AdiC was normalized with 
respect to the number of force spectra in the data 
set.
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3(a) illustrates the long-term drift and the short-
term fluctuations of DS, both likely to be related 
primarily to short- and long-term variations of 
the laser beam position on the photodiode. For 
the latter, ~12’000 F-D curves were recorded in 
batches of 625 points on a densely packed AdiC 
membrane and the DS values determined (see 
Figure 3(a)). The step in the DS around 6250 
(arrow) originated from the manual adjustment of 
the laser beam to its original position, which was 
done after F-D curves had been recorded on an 
area comprising 625 points. The comparable drift 
after repositioning of the laser beam highlights 
Figure 3. Changes in cantilever DS (a), cantilever deflection noise (b) 
and force noise (c) extracted from F-D curves taken on densely packed 
AdiC membranes. The step in (a) at force spectrum no. 6250 (arrow) 
originates from manually adjusting the laser beam to the original 
position on the photodiode. The force noise (σF), representing the real 
deflection noise of the cantilever, was between 10 and 18 pN.
the reproducible character of the DS change. 
Monitoring the cantilever deflection noise σV 
(in volts) by analysing the last 5% of the F-D 
curve (~200 values) exhibits a long-term drift as 
well, including the step after readjustment of the 
laser beam (Figure 3(b)). However, the average 
noise level increases for decreasing DS. The 
force noise (σF) of the cantilever (Figure 3(c)), 
which is calculated from the cantilever deflection 
noise σV and the DS of the same F-D curve, does 
not exhibit a drift over time. This demonstrates 
that forces calculated by our approach are not 
impaired by long-term drifts.
 
The coarse filter (see materials and methods) 
was validated by comparing two sets of filtering 
parameters. The first filter was only sensitive 
for the presence of a pulling force over a certain 
threshold (FSMFS,thr) at a minimal tip-sample 
separation (tssmin), as indication for a completely 
unfolded protein. Figure 4(a) shows the filtering 
result with tssmin = 95 nm and FSMFS,thr = 3.5·σF. 
Such loosely defined selection criteria imported 
all useful unfolding traces from the data set, but 
also useless curves that arose from contaminants 
attached to the AFM stylus, e.g. unfolding 
curves longer than the fully stretched AdiC 
protein. Curves exhibiting tip contaminations 
were partly filtered out by excluding F-D curves 
with negative (pushing) forces between 5 – 150 
nm (compare Figure 4(a), arrow with Figure 
4(b) where negative (pushing) forces have been 
filtered out). The first part of the F-D curve (tss 
< 5 nm) was not considered because it is often 
dominated by negative forces arising from non-
specific tip-sample interactions. The introduction 
of an additional parameter tssmax beyond which no 
peak should be present led to further improvement 
by excluding more non-interpretable F-D curves 
(Figure 4(b)). The value for tssmax was defined 
based on the working topology model of AdiC 
(see Figure 10). Filtering the AdiC data sets using 
the parameters: tsslow = 5 nm, tssmin = 90 nm, tssmax 
= 150 nm, Fthr1 = 20 pN, Fthr2 = 3, Fthr3 = 3.5, Fthr4 
= -3 yielded a considerably smaller set of force 
spectra without losing good F-D curves (Figure 
4(b)). Figure 4(c) shows the useful force spectra 
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contained in the two preceding data sets (Figures 
4(a) and (b)) after manual filtering. BR data sets 
were filtered with the parameters: tsslow = 5 nm, 
tssmin = 60 nm, tssmax = 80 nm, Fthr1 = 20 pN, Fthr2 = 
3, Fthr3 = 3.5, Fthr4 = -3. To collect enough data for 
unfolding of AdiC (and the control, BR) under all 
selected conditions (see above) a total of ~400,000 
F-D curves were recorded. Our pre-processing 
algorithm allowed ~99% of all recorded F-D 
curve to be eliminated without loss of useful data. 
About 70% of the remaining F-D curves were 
then rejected by manual fine filtering yielding 
five data sets for AdiC consisting of ~200 spectra 
each and one data set for BR with 398 spectra. 
Since all data are stored, they are amenable to 
data refined pre-processing if one of the filter 
parameters was suspected to be too tight. Thus, 
our method combines the advantage of recording 
all F-D curves and the unbiased reduction of 
this overwhelming data set to a number of force 
spectra that can be analyzed manually.
HT-SMFS results – Up to now, the transport 
protein AdiC has not been studied by SMFS. 
Therefore, we also tested our HT-SMFS 
procedure on BR, a membrane protein that 
has been extensively characterized by force 
spectroscopy (6, 13-15). As shown in Figure 6(a), 
our procedure yielded the same results as those 
published previously (13, 14), validating our 
HT-approach. In contrast to the latter papers, our 
data set (Figure 6(a)) consisting of 398 complete 
unfolding events of BR was recorded in only one 
day. With this amount of curves even unfolding 
pathways with a probability as low as 2.5% should 
be detected at least 4 times (binomial distribution 
with P > 0.99).
In a second step, our HT-SMFS procedure 
consisting of semi-automated data acquisition 
and efficient data filtering was used to study 
the mechanical unfolding of the bacterial 
L-arginine/agmatine antiporter AdiC. Although 
2D membrane protein crystals were used in most 
SMFS studies (5, 13, 28, 29), crystals are not a 
prerequisite for SMFS. Since the probability for 
an unfolding event decreases with decreasing 
Figure 4. Exemplary filtering of AdiC F-D curves using different filtering 
parameters. (a) Filtering with tssmin = 95 nm and a minimal force of 
FSMFS,thr = 3.5·σF resulted in the import of 190 out of 22,000 F-D curves. 
Curves where the tip was contaminated are highlighted by the arrow. 
(b) Filtering of the same data set as in (a) using tsslow = 5 nm, tssmin 
= 90 nm, tssmax = 150 nm, Fthr1 = 20 pN, Fthr2 = 3, Fthr3 = 3.5, Fthr4 = -3. 
These filtering parameters led to the import of 135 curves. (c) 75 Force 
spectra of N-terminally unfolded AdiC extracted from (a) and (b) by 
manual fine filtering. The dashed line indicates tssmax = 150 nm.
membrane protein density in lipid bilayers, semi-
automated procedures for fast data acquisition 
are particularly important for SMFS on non-
crystalline proteoliposomes. With densely packed 
vesicles of AdiC, the HT-SMFS procedure 
described here allowed collecting data sets 
comprised of ~200 F-D spectra (after filtering) in 
only one to two days.
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Unfolding of N-His6-AdiC resulted in two 
classes of F-D spectra, a major (Figure 5(a) and 
(b)) and a minor class (Figure 5(c) and (d)). 
Both classes of F-D spectra had a similar length 
suggesting complete protein unfolding from both 
termini. From a probabilistic point of view the 
attachment of the N-terminus to the cantilever is 
more likely than that of the C-terminus, because 
the former is predicted to be ~2.6 times longer than 
the latter. Another indication favouring pulling 
from the N-terminus was the pH-dependent 
interaction between AFM tip and the terminus: at 
pH 8 N-terminal unfolding events were observed 
in ~0.06% of the cases in contrast to pH 5, 
where the efficiency was ~0.32%. Protonation 
of the His6-tag (pKa,His ~6) at the N-terminal end 
introduces a positive charge. This might promote 
adhesion of the protein to the silicon nitride tip, 
which is negatively charged even at low pH 
(30). However, to prove that the curves shown 
in Figure 5(c) and (d) corresponded indeed to 
unfolding events pulled from the C-terminus of 
N-His6-AdiC, a second construct, AdiC-His6-C, 
with a long C-terminal (containing a His6-tag) and 
short N-terminal end (no His6-tag) was subjected 
to HT-SMFS. As for N-His6-AdiC the attachment 
of the protein to the AFM tip was pH-dependent: 
at pH 8 C-terminal force spectra were obtained 
in ~0.05% of the cases in contrast to at pH 5, 
where the efficiency was ~0.29%. This resulted 
in a single class of F-D spectra (Figure 6(e)) with 
a length of ~110 nm and the same ‘fingerprint’ as 
previously observed for the putative C-terminal 
unfolding of the N-His6-AdiC construct (Figure 
5(c) and (d)).
Figure 5. Representative force spectra obtained with the N-His6-AdiC construct. (a) Force spectra of the major unfolding class revealing different 
unfolding pathways. (b) Exemplary force spectrum of the major unfolding class. Each peak in the spectrum corresponds to the unfolding of one 
or more secondary structure elements. Worm-like-chain (WLC) curves (25, 26) were fitted to all peaks to determine the contour length, LC, in 
number of amino acids of the unfolded structural element(s). The given LC values next to the WLC curve were so that the blue peak had an LC 
of 129 aa. (c) Unfolding traces of the minor unfolding class of the N-His6-AdiC construct with a representative force spectrum (d). The scale bars 
in (a) and (c) represent 500 pN.
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AdiC unfolding experiments were performed 
until ~200 classifiable F-D spectra were obtained 
ensuring a statistically reliable data set. Figure 
6(c) shows a scattering plot of ~200 force spectra 
for the N-terminal unfolding of N-His6-AdiC, 
recorded during a single day using three different 
cantilevers. The histogram of the corresponding 
contour length values exhibited well-resolved 
peaks (Figure 6(d)). The mean contour length 
values of the main force peaks together with the 
average height are displayed in table 1. Three 
force peaks with LC = 129 aa (tss ≈ 40 nm), 387 
aa (tss ≈ 110 nm) and 455 aa (tss ≈ 130 nm) were 
highly conserved, while the other events had 
lower probabilities (table 1). In the diffuse front 
part (0 < tss < 20 nm) of the scattering plot in 
Figure 6(c) a peak with LC = 50 aa was found. 
Statistical analysis of the occurrence probability 
of this peak yielded a probability of 52%. 
However, this probability represents a lower 
Figure 6. Scattering plots and contour length histograms for BR, and the N-His6-AdiC and AdiC-His6-C constructs. Scattering plot (a) and contour 
length histogram (b) of 398 force spectra of BR unfolded from its C-terminal end. Used filtering parameters: tsslow = 5 nm, tssmin = 60 nm, tssmax = 
80 nm, Fthr1 = 20 pN, Fthr2 = 3, Fthr3 = 3.5, Fthr4 = -3. Force spectra were aligned with respect to the unfolding peak at tss ≈ 25 nm (denoted by star). 
(c) Scattering plot of 205 force spectra of the N-His6-AdiC construct unfolded from its N-terminal end. Force spectra were aligned with respect to 
the unfolding peak at tss ≈ 40 nm (denoted by star). The arrowhead highlights the presence of an unfolding peak with LC = 50 aa and the arrow 
shows the presence of a side peak with LC = 147 aa. (d) Contour length histogram obtained from fitting WLC curves to each force peak. Average 
LC values and peak heights are given in table 1. (e) Scattering plot of 190 force spectra of the AdiC-His6-C construct unfolded from its C-terminal 
end. All force spectra were aligned with respect to the unfolding peak at tss ≈ 90 nm (denoted by star). (f) Contour length histogram, values are 
given in table 2. The gray scale of the bars correspond to 70 (a), 90 (c) and 83 (e) counts.
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limit because this tss-regime is often obscured by 
non-specific adhesion between sample and AFM 
tip. Careful analysis of individual force spectra 
revealed that the unfolding peak at LC = 387 
aa (tss ≈ 110 nm) had a side peak at 404±5 aa 
with low occurrence. Due to its low probability 
(~10%) and close proximity to the main peak at 
387 aa it can neither be observed in the scattering 
plot nor in the contour length histogram.
Peak heights being between 210 and 70 pN 
in average were interpreted as a direct measure 
of the forces that hold the structural elements 
together (table 1). The height of the force peaks 
decreased with increasing number of unfolded 
elements. Comparison of the scattering plot 
(Figure 6(c)) with the contour length histogram 
(Figure 6(d)) revealed that the peak at LC = 147 aa 
(tss ≈ 45 nm, black arrow) was not clearly visible 
in the scattering plot. It generally occurred as a 
side event following the main unfolding peak 
at LC = 129 aa. Figure 6(e) shows a scattering 
plot of 190 aligned force spectra obtained from 
C-terminal unfolding of AdiC-His6-C. The peaks 
in the corresponding contour length histogram 
(Figure 6(f)) highlight the presence of unfolding 
Figure 7. Scattering plot and distribution of contour length values for N-terminal unfolding of N-His6-AdiC in the presence of 10 mM L-arginine, 
n = 193, panels (a)-(b); 10 mM agmatine, n = 197, panels (c)-(d); 10 mM D-arginine, n = 196, panels (e)-(f). The contour length values and the 
corresponding forces obtained from the WLC fit are given in table 3. The gray scale of the scattering plots corresponds to 90 counts.
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barriers with LC and force values given in (table 
2). The separation between the peaks at 158 aa 
(tss ≈ 45 nm) and 315 aa (tss ≈ 90 nm) was highly 
conserved, which is reflected by the low standard 
deviation of only ±8 aa. Unfolding forces of all 
peaks were in the range of values previously 
published for other membrane proteins (5, 13, 28, 
29, 31). However, unfolding barriers in the front 
part of F-D spectra were significantly weaker than 
in the case of N-terminal unfolding of the N-His6-
AdiC construct. The highest force, 135 pN, was 
measured for the peak with LC = 100 aa (tss ≈ 30 
nm), while the lowest barrier height was 57 pN 
for LC = 424 aa (tss ≈ 130 nm). Furthermore, HT-
SMFS was used to detect whether these forces 
in N-His6-AdiC may change in the presence of 
L-arginine, D-arginine and agmatine. No major 
changes were observed in the corresponding 
scattering plots (Figure 7(a)-(f)). The analysis 
of occurrence and average forces stabilizing the 
structural regions unfolded did not reveal major 
changes either (table 3).
Figure 8. Representation of the relative time required for each step of 
the here presented HT-SMFS procedure (see Figure 2) when applied 
to AdiC. As indicated in the chart, most of the time was required for 
data acquisition. However, it should be considered that during ~90% 
of the data acquisition time the presence of the operator was not 
required. Coarse data filtering (2) is completely automated in contrast 
to steps (3)-(5).
3.5 DISCUSSION
We have introduced and applied a new HT-
SMFS procedure to the bacterial proton pump BR 
and the L-arginine/agmatine antiporter AdiC from 
E. coli. As illustrated in Figure 8, data acquisition 
required most of the time in our HT-SMFS 
procedure. However, because of semi-automation, 
the presence of the operator was required at most 
for ~10% of data acquisition time. In contrast, 
pure manual data acquisition would have been 
an order of magnitude more time consuming and 
drudgery considering that AdiC attachment to the 
tip occurred in <1% of the cases under the given 
experimental conditions. The semi-automated 
method presented here allowed collecting up to 
~40,000 curves per day. The immense amount 
of data, thus generated, makes an efficient filter 
for extracting useful force spectra an absolute 
prerequisite.
Statistical estimates are helpful to plan HT-
SMFS experiments so that an appropriate number 
of F-D curves is available for analysis. The 
peak probability, p, and its detection at a given 
certainty, P, define the minimum number of F-D 
curves, which have to be collected. The number 
of F-D spectra, n, that have to be recorded so that 
at least κ force peaks that occur with probability, 
p, can be found with a certainty P(k ≥ κ) (k: 
number of observed force peaks) is calculated 
from binomial statistics:
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From numerous published F-D curves, it is 
reasonable to set up the SMFS experiment such 
that side peaks, which occur with p = 10% should 
be detectable. To find at least one occurrence of 
such a side peak with a certainty of P = 95%, only 
n > 29 F-D spectra revealing all conserved peaks 
have to be acquired. To reduce the standard error 
of the mean for the contour length measurement 
by a factor of 4, 16 such side peaks should be 
detected, in turn requiring the acquisition of at 
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least 227 F-D spectra. Based on this, we included 
~200 force spectra of fully unfolded proteins per 
data set.
In addition to unbiased data acquisition, HT-
SMFS considerably reduces the time required to 
collect a complete data set. This is particularly 
important when working with non-crystalline 
samples, e.g. native membranes or reconstituted 
proteoliposomes, where the density of the protein 
of interest is smaller than in 2D crystals. Our HT-
SMFS method has proven its ability to provide 
large data sets in a relatively short period of time 
on non-crystalline samples. Nevertheless, the 
measurements required continuous operation 
of the JPK AFM over many hours, and we 
had to investigate whether long-term drifts of 
pertinent calibration parameters would introduce 
uncontrolled experimental errors. As documented 
in Figure 3, the constant monitoring of DS ensured 
the force measurement to be correctly calibrated 
throughout the experiment. Interestingly, short-
term fluctuations of DS were not related to 
the accuracy of the linear regression, but to 
fluctuations of the deflection sensor. However, 
this noise turned out to be negligible compared 
to the noise introduced by the cantilever itself. 
The correction of the cantilever DS does not yet 
include the elasticity of the proteoliposomes. 
The latter over-estimates the DS by around 5% 
compared to measurements on mica (data not 
shown). However, the resulting difference is 
constant and smaller than the error from long-
term drift (Figure 3(a)). Furthermore, we have 
validated our approach using bacteriorhodopsin, 
which yielded the same results like published 
in earlier studies (6, 13-15). The design of the 
recombinant target protein is an important issue 
for successful data acquisition and interpretation. 
On the one hand, the identification of the terminus 
from which AdiC was unfolded was made possible 
by the use of two recombinant forms of AdiC, 
i.e. N-His6-AdiC and AdiC-His6-C, differing 
in the position of the His6-tag and the length 
of the termini. On the other hand, pH-induced 
protonation of the N- or C-terminally located 
His6-tag promoted the interaction between AFM 
tip and AdiC. Consequently, tags, which are often 
introduced into recombinant proteins for affinity 
purification, are also very helpful for the efficient 
collection of force spectra. Furthermore, we have 
demonstrated that the direction from which a 
membrane protein is unfolded can be controlled 
by the properties of its termini, e.g. length and 
His6-tag.
Figure 9. Unfolding forces for the N-His6-AdiC (a) and AdiC-His6-C (b) constructs in the absence (control) and presence of substrates (see Figure 
for substrates). Error bars represent the standard error of the mean. See also tables 1-3.
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Mechanical unfolding of AdiC from both termini 
provided highly reproducible F-D spectra. Since 
no major differences between unfolding in the 
absence and presence of substrates were observed 
(Figures 6, 7 and 9), AdiC SMFS experiments are 
discussed generally and not with respect to the 
substrates explored. Comparison of the contour 
length values of the most prominent force peaks 
with the working topology model (Figure 10) 
allowed the mapping of unfolding barriers within 
the N-His6-AdiC (Figure 10(a)) and AdiC-His6-C 
proteins (Figure 10(b)). For N-His6-AdiC, the 
main unfolding barriers were located at the 
cytoplasmic moieties of helices 1, 3, 5 and 7, 
at the periplasmic moiety of helix 10 and in the 
transmembrane part of the predicted helix 12 (see 
table 1 for details). The peak at LC = 147 aa (tss 
≈ 45 nm), which occurred as a side peak of the 
main peak at LC = 129 aa (tss ≈ 40 nm), indicated 
an unfolding barrier at the periplasmic moiety of 
helix 4. This illustrates that helices 3 and 4 do not 
exclusively unfold pairwise in a single step, but 
also individually whenever the side peak at 147 
aa (tss ≈ 45 nm) is observed.  Therefore, helices 
3 and 4 do not always act as one mechanical unit. 
According to our SMFS data, helices 7, 8 and 9 and 
their connecting loops were unfolded in a single 
step. A consensus amphipathic region (CAR) in the 
C-terminal half of helix 8 and the loop connecting 
helices 8 and 9, which are relevant for transport 
function, has been identified in several APC 
transporters (32-34). Minchin and McCoubrie 
proposed that PotE, a member of the same 
protein family (APC family) as AdiC, contains 
a re-entrant loop between helices 7 and 8 based 
on the presence of hydrophobic helix structures, 
which will preclude complete exposure to the 
aqueous periplasmic space (35). Thus, possibly, 
helix 8 is strongly interacting with neighbouring 
parts of the AdiC protein. Interestingly, joint 
unfolding of the “three-helix-bundle” formed by 
helices 7, 8 and 9 was only observed when AdiC 
was unfolded from its N-terminal end. However, 
there is an unfolding barrier located in this region, 
near the cytoplasmic moiety of helix 8, in force 
spectra from C-terminally unfolded AdiC. The 
interaction of helices 7 - 9 with helices 10, 11 and 
12 may contribute to the stability of the “three-
helix-bundle” formed by helices 7 – 9. When 
the C-terminal part is first removed, the bundle 
would thus not be stable any more. Moreover, 
in the C-terminal unfolding of AdiC, several 
helices unfold in a single step. This supports the 
hypothesis that the stability of the “three-helix-
bundle” is related to interacting partners, i.e. 
helices 10 – 12, for N-terminal unfolding. This 
would mean that helices 7 – 9 are intrinsically not 
a stable unit. However, this interpretation for the 
joint unfolding of helices 7, 8 and 9 remains to be 
confirmed, e.g. by the high-resolution structure 
of AdiC or a related APC family member.
Comparison of N- and C-terminal unfolding 
provided insights into the topology and stability 
of AdiC. C-terminal unfolding resulted in main 
unfolding barriers at the cytoplasmic side of 
the predicted helices 2, 4, 8 and 10 (see table 
2 for details). Several force spectra exhibited a 
plateau-like unfolding event between LC = 80 
aa (tss ≈ 20 nm) and 100 aa (tss ≈ 30 nm) (see 
Figure 5(d)): these LC values correspond to the 
cytoplasmic and periplasmic moieties of helix 
10 (Figure 10(b)). The plateau is tentatively 
interpreted as an unresolved force peak, because 
the force did not drop back as would be expected 
for the unfolding of a complete structural element 
(compare with the other force peaks). This 
assumption is corroborated by the existence of a 
low-probability side peak (~10%, LC = 404 aa) of 
the main unfolding peak with LC = 387 aa also in 
helix 10, when N-His6-AdiC was unfolded from 
its N-terminal end. Detection and analysis of this 
low probability peak at LC = 404 aa was only 
possible when working with large data sets. This 
example illustrates the need of large data sets 
and therefore HT-SMFS procedures to allow the 
detection of low probability unfolding events.
HT-SMFS experiments did not only yield 
topological information, but also information on 
the mechanical stability of structural elements 
within AdiC. The stability of secondary structure 
elements is reflected by the height of unfolding 
peaks. As demonstrated here for AdiC and 
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elsewhere for BR (14, 36), the height of force 
peaks decreases with the number of unfolded 
structural elements (Figure 9): for example, the 
force needed to unfold helix 1 differs whether it is 
the first or the last structural element to be pulled 
out of the membrane. In the former case the force 
is ~2.5 times higher than in the latter case, where 
helix 1 is the last unfolded structure (see tables 1 
and 2 for details).  This reflects the high stability 
of a membrane protein with (nearly) completely 
established intramolecular interactions. The more 
interactions are ruptured during unfolding, the 
lower the stability of the remaining protein. The 
steepest decrease was observed for N-terminal 
unfolding of N-His6-AdiC. Therefore, the force 
difference between N- and C-terminal unfolding 
gives a qualitative impression of how strong helix 
1 is stabilized by the other elements (5, 36). This 
observation is corroborated by the three-stage 
model of membrane protein folding describing 
the membrane insertion of transmembrane helices 
as independently stable units which are further 
condensed and stabilized in their functional 3D 
structure (37).
Figure 10. Topology predictions and locations of unfolding barriers for the unfolding of (a) N-His6-AdiC and (b) AdiC-His6-C. Residues highlighted 
by red circles reflect the average position of unfolding barriers (tables 1-3). Numbers in brackets show unfolding barriers that are found at low 
probabilities. The proline residue in helix 10 (P400 in N-His6-AdiC) that is highlighted in gray illustrates the location of an unfolding barrier 
corresponding to a side peak of the main unfolding peak at 387 aa. Gray arrows show the pulling direction. Red arrows show the shift in the 
position of the unfolding barriers caused by compensation for the thickness of the membrane. The sequence based topology prediction was 
computed using a hidden Markov model (43) and the AdiC amino acid sequence with the accession number spP60061 supplemented with the 
residues that were introduced by protein engineering. Loop 2 - 3 is assumed to fold back into the membrane because of AdiC’s sequence identity 
to xCT (35% amino acid identity within this loop), where this has been demonstrated (18).
48
Summary and Perspectives HT-SMFS for membrane proteins
Major differences between AdiC F-D spectra 
recorded in the absence and presence of substrates 
were not detected (Figures 6 and 7), although 
substrate concentrations were much higher than 
the Kd values for L-arginine and agmatine, which 
are ~100 µM and ~30 µM, respectively (19). 
Generally, molecules do not bind very strongly 
to a transporter since they must be released from 
the protein after transport. Often, substrates are 
bound to the protein by hydrogen bonds (e.g. in 
the lactose permease LacY (38)) whose rupture 
force are weak. If significant interactions between 
substrates and AdiC are located somewhere in 
helices 7 – 9 and their connecting loops, they would 
not be detected since these structural elements 
are pulled out of the membrane in a single step. 
It is likely that at least one of these structural 
elements interacts with the substrates, because 
several residues in this region have been shown 
to be essential for transport activity or relevant 
for substrate interaction in certain members of the 
APC family (e.g. CadB, PotE and xCT) (35, 39-
41). It is possible that dynamic HT-SMFS, which 
probes the stability of molecular interactions at 
different time scales, may give insights into how 
the energy barriers, stabilizing structural regions 
in AdiC, change their position, height or width 
(42). Such insights into the energy landscape of 
AdiC may reveal how substrate binding favours 
or disfavours functionally related conformations 
of the transporter.
3.6 SUMMARY AND PERSPECTIVES
With BR and AdiC we demonstrate that SMFS 
data acquisition and pre-processing can be 
automated to a large extent. Our procedure was 
used to acquire a data set comprising ~400,000 
F-D curves, which were corrected for variations 
in cantilever DS and filtered by a straightforward 
algorithm to select ~4,000 F-D curves. 
Subsequent manual selection yielded ~1,400 
interpretable spectra with high efficiency. This 
semi-automated data acquisition and processing 
protocol allowed a relevant data set to be collected 
ideally within a single day using a single sample 
of the reconstituted target protein. Therefore, HT-
SMFS can be performed speedily and with small 
amounts of sample. Although we applied coarse 
filtering to data acquired with an x and y closed-
loop controlled piezo-scanner, this procedure can 
also be applied to F-D curves recorded with an 
open-loop piezo-scanner.
As demonstrated with AdiC, HT-SMFS made 
the acquisition of AdiC unfolding spectra in the 
absence and presence of different compounds 
possible. Considering the wealth of data collected 
and the lack of any significant difference in the 
force spectra between different conditions suggest 
that AdiC and the substrates tested interact only 
weakly. Our HT-SMFS approach can be generally 
applied to a wide range of reconstituted or even 
native membrane proteins and specific mutants 
to study their fold as well as ligand binding, and 
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specifically to transport proteins for assessing 
their interaction with substrates or inhibitors, and 
their behaviour under different environmental 
conditions such as pH, ionic strength and 
temperature. The presented semi-automated HT-
SMFS procedure can also be adapted for dynamic 
SMFS experiments in order to explore the energy 
landscape of membrane proteins.
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4.1 ABBREVIATIONS
BN-PAGE, blue native-polyacrylamide gel electrophoresis; DDM, n-dodecyl-ß-D-
maltopyranoside; DM, n-decyl-ß-D-maltopyranoside; DMS, dimethyl suberimidate; BM(PEO)4, 
bis-maleimidotetraethylene glycol; DSP, dithiobis(succinimidyl)propionate; DST, disuccinimidyl 
tartarate; MTSET, 2-(trimethylammonium) ethylmethanethiosulfonate bromide; OG, ß-D-
octylglucoside; PL, proteoliposome; TEM, transmission electron microscopy.
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4.3 INTRODUCTION
The APC (amino acids, polyamines and 
choline for organocations) superfamily of 
transport proteins includes nearly 250 members 
that function as solute:cation symporters and 
solute:solute antiporters ((1) ; see also http://
www.tcdb.org). They occur in all phyla from 
prokaryotes to higher eukaryotes, and vary in 
length between 350-850 amino acid residues. 
The smaller proteins are generally of prokaryotic 
origin while the larger ones are of eukaryotic 
origin and have N- and C-terminal hydrophilic 
extensions. Most of APC members are predicted 
to possess 12 transmembrane (TM) α-helical 
domains.
The LAT (L-amino acid transporter) family 
belongs to the APC superfamily. LAT family 
members correspond to the light subunits of the 
Heteromeric Amino acid Transporters (HATs), 
also called glycoprotein-associated Amino acid 
Transporters (gpaAT) (2-4). HATs are composed 
of two subunits, a polytopic membrane protein 
(the light subunit) and a disulfide-linked 
N-glycosylated type II membrane glycoprotein 
(the heavy subunit). The light subunit is the 
catalytic component of the transporter, whereas 
the heavy subunit appears to be essential only for 
trafficking to the plasma membrane. Two types 
of heavy subunit (4F2hc and rBAT) and 10 types 
of light subunit have so far been identified. A 
number of human pathologies have highlighted 
the physiological roles of HATs. For example, 
two transporters of this family are responsible 
for inherited aminoacidurias: mutations in any of 
the two genes coding for the subunits of system 
b0,+ (b0,+AT and rBAT) lead to cystinuria (MIM 
220100) (5,6), whereas mutations in y+LAT1 
(a 4F2hc-associated system y+L) result in 
lysinuric protein intolerance (LPI) (MIM222700) 
(7,8). In addition, xCT, a LAT transporter that 
in association with 4F2hc mediates cystine 
uptake and glutamate efflux (9,10), has been 
recently identified as the receptor of Kaposi’s 
sarcoma-associated Herpesvirus (KSHV, human 
herpesvirus 8) (11). In vivo, this transport system 
is involved in cocaine relapse through the control 
of the basal levels of extrasynaptic glutamate 
(12), and it contributes to the maintenance of the 
plasma redox balance (13).
Despite the important roles attributed to HATs, 
only a few studies have addressed the structure-
function relationships of these transporters: i) 
most HATs are obligate antiporters with a 1:1 
stoichiometry (14), and a sequential mode of 
exchange has been proposed for system b0,+ 
(15); ii) light subunits appear to be sufficient for 
4.2 ABSTRACT
We	 have	 identified	 YkbA	 from	 Bacillus 
subtilis as a novel member of the LAT family of 
amino acid transporters. The protein is ~30% 
identical in amino acid sequence to the light 
subunits of human Heteromeric Amino acid 
Transporters	(HATs).	Purified	His-tagged	YkbA	
from Escherichia coli membranes reconstituted 
in proteoliposomes exhibited sodium-
independent, obligatory exchange activity for 
L-serine and L-threonine, and also for aromatic 
amino acids, albeit with less activity. Thus, 
we propose that YkbA be renamed SteT (Ser/
Thr Exchanger Transporter). Kinetic analysis 
supports a sequential mechanism of exchange 
for	SteT.	Freeze-fracture	analysis	of	purified,	
functionally active SteT in proteoliposomes, 
together with blue native-polyacrylamide gel 
electrophoresis and transmission electron 
microscopy (TEM) of detergent-solubilized 
purified	SteT,	suggest	that	the	transporter	exists	
in a monomeric form. Freeze-fracture analysis 
showed spherical particles of diameter 7.4 nm. 
TEM revealed elliptical particles (diameters: 
6 x 7 nm) with a distinct central depression. 
To	 our	 knowledge	 this	 is	 the	 first	 functional	
characterization of a prokaryotic member 
of	 the	 LAT	 family	 and	 the	 first	 structural	
data on an APC transporter. SteT represents 
an excellent model to study the molecular 
architecture of the light subunits of HATs and 
other APC transporters.
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4.4 MATERIALS AND METHODS
Identification and sequence analysis of 
SteT – Initial sequence analysis that led to the 
identification of prokaryotic homologs of LAT 
family transporters, was performed by using 
the BLAST algorithm (default settings; (22)) to 
compare all known members of the LAT family 
against a non-redundant protein sequence database 
(non-redundant GenBank CDS translations + 
RefSeq Proteins + PDB + SwissProt + PIR + PRF). 
In order to study the phylogenetic relationship of 
SteT and PotE relative to the APC superfamily of 
transporters (23), we first constructed a multiple 
protein sequence alignment of all known APC 
members (listed at http://www.tcdb.org/tcdb/
superfamily.php) with test sequences using 
ProbCons (24) in combination with manual 
refinements. All APC members that appeared to 
be too distant to provide information (i.e. that 
could not be properly aligned) were not further 
considered. The resulting alignment was further 
evaluated with G-BLOCKS (25) in order to select 
the most conserved, and hence, most informative 
regions of the multiple alignment. The latter were 
subsequently processed with CLUSTAL (26) to 
obtain a neighbor-joining phylogenetic tree (1000 
bootstraps with 111 random seeds).
Cloning of prokaryotic APC transporters – Genomic 
DNA from E. coli strain DH5α and from B. 
subtilis strain 168t+ was prepared from cells 
collected after an overnight liquid culture. Cell 
pellets were incubated for 1 h at 50ºC in 10 mM 
Tris-HCl pH 8, 0.1 M EDTA, 0.5% SDS with 0.1 
mg/ml of Proteinase K. Three extractions with 
the same volume of phenol were performed with 
centrifugations at 5,000 g. Next, a chloroform/
ethanol precipitation gave final pellets which 
were resuspended in 10 mM Tris-HCl pH 8.0 and 
1 mM EDTA. The following primers (5′-3′) were 
used to amplify open reading frames encoding the 
indicated proteins from genomic DNA by PCR: 
ATCTGAATTCTGATGCGCAAAGCACCCT-
GTT and CATTCTCGAGAGAAAGGGCGA-
TCATTCAATC for PotE, and ATCTGAA-
TTC-TCCTCCACATTACATAACATCA and 
CATTCTCGAGAGTCCACGGTGCTTTTA-
TCAAT for YhfM from E. coli; and 
ATCAGAATTCGAAGCTTCAACATCA-
TAGGAG and CTATCTCGAGTCCTGTCAA-
CTTT-TATCTTCTG for SteT and ATGTGA-
ATTCCAATATAATACA-ACAAGAACTGC 
and TCTACTCGAGTATCGCTTCATCTGTG-
TGTC for YfnA from B. subtilis. PCR products 
were digested with EcoRI and XhoI and ligated 
transport activity, as demonstrated for b0,+AT (16); 
iii) using xCT as a model for the light subunits, 
a membrane topology with 12 transmembrane 
segments and with a re-entrant loop between 
transmembrane segments 2 and 3 has been 
reported (17); and iv) the xCT residues His110 
and Cys327 have been shown to be crucial for 
function (17,18) while the cystinuria-specific 
mutation Ala354Thr inactivates b0,+AT (16). 
Similarly, structure-function studies on the APC 
superfamily as a whole have been very limited, 
and primarily related to membrane topology 
studies and the identification of relevant residues 
for substrate interaction (19-21).
The recent elucidation of atomic structures 
for several prokaryotic transporters has given 
key insights into the molecular dynamics of 
fundamental transport processes. Towards a 
similar increase in our understanding of amino acid 
transport, we describe here the identification and 
characterization, at the functional and structural 
levels, of the first example of a prokaryotic 
member of the LAT family: the orphan transporter 
YkbA (from here on referred to as SteT, see below) 
from B. subtilis. SteT shows significant similarity 
to the light subunits of eukaryotic HATs not only 
in amino acid sequence and putative membrane 
topology, but also in the characteristic sequential 
mode of obligatory exchange. Structural analyses 
of SteT revealed a monomeric structure with a 
“donut-like shape” of 7 x 6 nm in diameters and 
a distinct central depression. SteT represents an 
excellent model for structural studies of the LAT 
family, and of APC transporters in general.
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into a pBlueScript vector (Stratagene). Another 
PCR with the following primers (5′-3′) was 
performed to subclone each transporter open 
reading frame into the EcoRI and PstI sites 
of a modified version of the vector pTTQ18 
(27), thereby placing its expression under 
the control of the tac promoter: TGATGA-
ATTCGATGAGTCAGGCTAAATC and ACCG-
CCTGCAGAACCGTGTTTATTTTTCAGT 
for PotE, TGATGAATTCGATGACTGCAA-
ACTCTCCCCTA and ACCGCCTGCAGACGA-
CAAAGCGTTGAGCTGGC for YhfM, 
TG ATG A ATTC G ATG CATA C TG A A G A -
CAACGG and ACCGCCTGCAGAGCTTGC-
TTTT-CGTTTTTTCA for SteT and CGAT-
GAATTCGATGAGTTCATTATTTAGA and 
ACCGCCTGCAGATTTGTTTAATAAGCTG-
TGTT for YfnA. All DNA constructs were 
verified by sequencing.
Expression of prokaryotic APC transporters in 
E. coli – Expression experiments were carried out 
with freshly transformed cultures of E. coli strain 
BL21(DE3). Initially, the expression of the four 
APC transporters (PotE, YhfM, SteT and YfnA) 
was investigated in 50 ml samples cultured in LB 
medium containing 50 µg/ml ampicillin. When 
the OD600 had reached 0.5, protein expression 
was induced by addition of 0.5 mM isopropyl-
ß-D-thiogalactoside (IPTG; Roche). To estimate 
protein expression cells were harvested after 
incubation for different time periods (1, 2, 3, 4 h 
and overnight) at 30ºC or 37ºC. For biochemical 
or functional analyses of SteT and PotE, either 6 
x 0.8 L of medium in flasks or 10 L of medium in 
a fermentor were inoculated with E. coli cultures 
harbouring pTTQ18-His6-YkbA or pTTQ18-His6-
PotE. Cells were induced with 0.5 mM IPTG at 
an OD600 of 0.5 and harvested after 3 h growth at 
30ºC and 37ºC, respectively. In all cases, the cell 
pellet was resuspended in Lysis buffer (20 mM 
Tris-HCl pH 8, 0.5 mM EDTA) and stored frozen 
at -20ºC.
Preparation of E. coli membranes - Cell 
pellets were thawed and disrupted by passage 
through a French pressure cell (20,000 psi, 
three times). Unbroken cells were removed by 
centrifugation (10 min at 10,000 g and 4ºC). 
The supernatant was ultracentrifuged (1 h at 
100,000 g and 4ºC), the pellet resuspended and 
homogenised (30 ml glass homogenizer for 2 
min) in Lysis buffer and ultracentrifuged again. 
Peripheral membrane proteins were removed 
by homogenization in 20 mM Tris-HCl pH 8, 
300 mM NaCl and ultracentrifugation. Finally, 
the membrane pellet was resuspended in 20 
mM Tris-HCl pH 8, 150 mM NaCl at a protein 
concentration between 13-25 mg/ml. Aliquots 
were frozen in liquid nitrogen and stored at -80ºC 
until use.
Purification of APC transporters – To estimate 
protein expression and functional reconstitution 
of SteT and PotE, frozen membranes were thawed 
and solubilized in 0.5% DDM (n-dodecyl-ß-D-
maltopyranoside; Anatrace, USA), 20 mM Tris-
HCl pH 8, 20% glycerol, 50 mM NaCl on a roller 
shaker (1 h, 4ºC) at a protein concentration of ~2 
mg/ml. The supernatant after ultracentrifugation 
(1 h at 100,000 g, 4ºC) was incubated for 2 h at 
4ºC with equilibrated Ni-NTA Superflow beads 
(Qiagen) with washing buffer (20 mM Tris-
HCl pH 8, 20% glycerol, 200 mM NaCl, 0.05% 
DDM, 10 mM imidazole). The supernatant 
fraction (slurry) was removed by centrifugation 
(1 min at ~160 g). Protein-bound beads were 
washed three times with 10 ml of washing buffer 
and centrifuged as before. Then, columns were 
packed with 5 ml protein-bound beads each. Two 
more washes were performed with 15 ml washing 
buffer before elution with 10 ml of elution buffer 
(washing buffer supplemented with 500 mM 
imidazole). The purified protein was concentrated 
by centrifugation in an Amicon Ultra (10,000 
MWCO Millipore) at 3,220 g down to a volume 
of 1 ml. Imidazole was removed by addition of 10 
ml of 20 mM Tris-HCl pH 8, 20% glycerol, 200 
mM NaCl, 0.05% DDM and re-concentration to 
the desired final volume.
For negative stain transmission electron 
microscopy studies, frozen SteT-containing 
membranes were thawed and solubilized for 1 h 
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at 4 °C in 1% DM (n-decyl-ß-D-maltopyranoside; 
Anatrace, USA), 20 mM Tris-HCl pH 8, 300 mM 
NaCl, 10% glycerol, 0.01% NaN3. The protein 
concentration during solubilization was between 
2-3 mg/ml. After ultracentrifugation (100,000 g, 
45 min at 4°C) the supernatant was diluted two-
fold with 20 mM Tris-HCl pH 8, 300 mM NaCl, 
0.3% DM, 3 mM histidine, 10% glycerol, 0.01% 
NaN3 (washing buffer) and bound for 2 h at 4 °C 
to Ni-NTA Superflow beads (Qiagen). The beads 
were then loaded onto a spin column (Promega), 
washed with washing buffer and eluted with the 
same buffer containing 200 mM histidine.
Reconstitution into proteoliposomes – E. coli 
polar lipid extract (Avanti Polar Lipids) 
solubilized in chloroform (50 mg/ml) was dried 
under a stream of nitrogen to remove the solvent 
and to obtain a thin layer of dry lipids in a glass 
tube. The dried lipids were resuspended in dialysis 
buffer (120 mM KPi pH 7.4, 0.5 mM EDTA, 1 
mM MgSO4, 5 mM TrisSO4, 1% glycerol and 4 
mM of the desired amino acid, unless otherwise 
indicated) to yield a final lipid concentration 
of 40 mg/ml. After four 30 s sonication and 
vortexing cycles, the liposomes were extruded 
in a LiposoFast-Pneumatic Actuator (Avestin) 
through a 400 nm polycarbonate filter (Avestin) 
to obtain unilamellar vesicles of homogeneous 
size. Liposomes were mixed with purified protein 
at a 1:100 (occasionally 1:40) protein-to-lipid 
ratio (w/w). To destabilize the liposomes, 1.25% 
β-D-octylglucoside (OG; Roche) was added and 
incubated in ice with occasional agitation for 5 
min. DDM and OG were removed by dialysis for 
40 h at 4ºC against 100 volumes of dialysis buffer. 
Finally, proteoliposomes were ultracentrifuged 
(100,000 g, 1 h at 4ºC) and the pellet resuspended 
in a third of the initial volume of dialysis buffer 
without amino acids.
Transport measurements – Influx measure-
ments in proteoliposomes were made as described 
(16) with minor changes. Cold proteoliposomes 
(10 µl) were mixed with 180 µl of transport 
buffer (150 mM choline chloride, 10 mM Tris-
HEPES pH 7.4, 1 mM MgCl2, 1 mM CaCl2, 0.5 
µCi radiolabeled L-amino acid, and unlabeled 
amino acid to the desired final concentration) 
and incubated at room temperature for different 
periods of time. To test the effect of an imposed 
membrane potential, 2.8 µM valinomycin (Sigma) 
was added to the transport buffer. Reactions were 
stopped by the addition of 850 µl of ice-cold 
stop buffer (150 mM choline chloride, 10 mM 
Tris-HEPES and 5 mM L-serine or putrescine 
for SteT- and PotE-containing proteoliposomes, 
respectively) and filtration through membrane 
filters (Sartorius, 0.45 µm pore size). Filters were 
then washed three times with 2 ml of stop buffer 
and dried, and the trapped radioactivity was 
counted. All experimental values were corrected 
by subtracting zero-time values obtained by adding 
the stop solution before the proteoliposomes into 
the transport buffer. The following radiolabeled 
compounds (American Radiolabelled Chemicals) 
were used in this study: L-[3H] serine, [3H] 
putrescine, L-[3H] ornithine, L-[3H] arginine, 
L-[3H] lysine, [3H] glycine, L-[3H] proline, L-[3H] 
leucine, L-[3H] isoleucine, L-[3H] methionine, 
L-[3H] glutamate and L-[3H] alanine. 
For efflux measurements, proteoliposomes 
(400 µl) were mixed with 200 µl of three-fold 
concentrated transport buffer (450 mM choline 
chloride, 30 mM Tris-HEPES pH 7.4, 3 mM 
MgCl2, 3 mM CaCl2, 35 µCi L-[
3H] serine at a final 
concentration of 10 µM) and incubated at room 
temperature for 2 h. Then, the proteoliposome 
suspensions were divided into two halves (295 
µl each) and these were diluted 13-fold with 
transport buffer (without L-[3H] serine) with or 
without 7 mM L-serine. At the indicated times, 
aliquots (195 µl) were mixed with ice-cold stop 
buffer (850 µl), vortexed and filtered (Sartorius, 
0.45 µm pore size). Filters were then washed 
three times with 2 ml of stop buffer, dried and the 
trapped radioactivity counted.
Simulation of SteT exchange activity – Simula- 
tion of the time-course of transport of radiolabeled 
L-serine into proteoliposomes containing purified 
SteT (SteT-PLs) was performed using a model 
based on the following premises: 1) The induced 
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amino acid transport activity is an obligatory 
exchange process with a 1:1 stoichiometry. 2) 
An additional diffusive, protein-independent flux 
is necessary to explain transport observed in the 
absence of transporter (i.e., in proteoliposomes 
containing no SteT), or in the absence of 
exchangeable amino acids (SteT-PLs containing 
L-arginine instead of L-serine). The computer 
program, previously designed to simulate 
transport in oocytes (28) and membrane vesicles 
(15), was adapted to model amino acid exchange 
and simulated the experimental influx and efflux 
rates governed by a concerted (i.e., sequential) 
mechanism of exchange, as described in a 
previous study for system b0,+ (15). Different 
types of mechanisms (e.g., ping-pong), however, 
would produce similar results (data not shown). 
The computer program is available upon request. 
The simulations were set up using the following 
rules: i) Characteristics of the simulated system. 
The experimental setup was reproduced as two 
separate compartments. The outside compartment 
volume was set to 86 µl (taking 1 µg protein as 
reference). The inside volume, 62 nl, together 
with the Fick parameter, was deduced from 
extrapolation to infinity of non-specific influx 
measurements (SteT-PLs containing L-arginine), 
fitted to the Fick law by standard non-linear 
regression. ii) Kinetic parameters: Experimental 
parameters were used when available. Best 
values for the unknown parameters and 
transporter concentration were determined after 
a systematic search of the appropriate range of 
values. iii) Simulation procedure: Transport rates 
were evaluated from the relative concentrations 
of transporter complexes. Transport rates were 
estimated on the assumption that the limiting 
step is the translocation of the transporter bound 
to the substrate, as described for system y+L (29), 
and therefore all binding steps were considered 
as being at equilibrium. Possible inactivation of 
the transporter was included as an exponential 
first order law with the appropriate parameters. 
During simulation amino acid concentrations 
were calculated by numerical integration of the 
transport rates. Integration was performed with a 
constant time step of 0.02 min during the desired 
period. 
Freeze fracture and electron microscopy 
of proteoliposomes – Freeze-fracture electron 
microscopy study was performed as described 
(30). The suspension was sandwiched between 
two copper platelets using a 400-mesh gold grid 
as spacer. The samples were frozen by liquid 
propane immersion, at -189ºC, and fractured 
at -150ºC and 10-8 mbar in a BAL-TEC BAF 
060 freeze-etching system. The replicas were 
obtained by unidirectional shadowing at 45º with 
2 nm of Pt/C and at 90º with 20 nm of C, and 
subsequently floated on distilled water for 5 min. 
Electron micrographs (at 50,000x) were recorded 
in a Jeol 1010 electron microscope operated at 
80 kV.
Measurement of freeze-fracture particles – Particle 
diameters were measured from scanned electron 
micrographs using AnalySIS software. The 
diameter was obtained by measuring the width 
of the particle edge-to-edge in a direction 
perpendicular to the direction of the shadow. 
Duplicate measurements of individual particles 
of SteT and PotE revealed a ± 0.2 nm error of 
measurement. The accuracy of the diameter 
measurements was tested by measuring the 
diameter of 10-nm gold particles (Chemicon) 
placed directly on Formvar-coated copper grids 
(9.94 ± 0.04 nm; n = 125). All values are reported 
as mean ± standard error of the mean (SEM).
Negative stain TEM – DM-solubilized SteT 
protein as eluted from the Ni-NTA column was 
adsorbed for 10 s to parlodion carbon-coated copper 
grids rendered hydrophilic by glow discharge at 
low pressure in air. Grids were washed with four 
drops of double-distilled water and stained with 2 
drops of 0.75% uranyl formate. This washing step 
is to effectively remove the buffer solution and 
not adsorbed protein. The former, if not removed, 
can lead to precipitation of the uranyl salts with 
buffer components. Electron micrographs were 
recorded at a magnification of 50,000x and an 
underfocus of ~400 nm on Eastman Kodak Co. 
S0-163 sheet films with a Hitachi H-7000 electron 
microscope operated at 100 kV.
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Figure 1. a) Phylogenetic relationship of SteT with other prokaryotic and eukaryotic members of the APC transporter superfamily. The neighbor-
joining tree illustrates the phylogenetic relationships of SteT (YkbA from Bacillus subtilis) with all alignable members of the APC superfamily that 
are either functionally characterized or putative amino acid transporters. The abbreviation of each of the subfamilies is in bold; see Ref. (23) 
and http://www.tcdb.org/tcdb/superfamily.php for a description of the subfamilies. The tree was rooted using yeast VAL1 permease (YAT family). 
Bootstrap values (as a percentage of 1000 replicates) are indicated for each of the nodes. Thicker strokes denote branches supported with 
bootstrap values larger than 70%. In order to simplify the tree, clades with terminal branches that include clear orthologs were collapsed and 
labeled with the general name of the transporter followed by *. We have identified other bacterial protein sequences that were annotated during 
the course of our studies: the sequences were closely related to SteT (probably orthologs) and clustered with LAT members as well (data not 
shown; GenInfo Identifiers, gi: 37521919, 77543889, 67931606, 29898613 and 41582385). b) Membrane topology model of SteT. This model 
is based on the alignment of the amino acid sequence of SteT with the light subunits of mammalian HATs that interact with the heavy subunits 
rBAT or 4F2hc (see Suppl. Figure 1), the experimentally probed membrane topology of human xCT (17) and the predicted membrane topology 
of SteT (Suppl. Figure 1). The membrane topology model of SteT contains 12 transmembrane domains (TM 1 to 12) with intracellular N- and 
C-termini. Due to the high amino acid sequence similarity to human xCT (see Suppl. Figure 1) the intracellular loop connecting TM2 and TM3 is 
depicted as a re-entrant loop as demonstrated for human xCT (17). Conserved residues (circled) in SteT and the mammalian light subunits that 
interact functionally with rBAT or 4F2hc are distributed along the protein but are more frequent in the first part of the protein (TM1, TM2 and the 
re-entrant loop) (see also Suppl. Figure 1). The conserved Cys residue in the external loop between TM3 and TM4 involved in the disulfide bridge 
connecting the light and the heavy subunits of eukaryotic HATs is not present in SteT (see also Suppl. Figure 1).
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4.5 RESULTS
Screening for an appropriate prokaryotic 
homolog candidate of LAT transporters – In 
order to identify appropriate prokaryotic 
homolog candidates for studying the structure-
function relationships of the light subunits of 
HATs, an exhaustive search was made on several 
available protein sequence databases. Among the 
most significant matches, four candidates were 
selected for further investigation: PotE and YhfM 
from E. coli, and YkbA (SteT) and YfnA from B. 
subtilis. These proteins had amino acid sequence 
identities to the light subunits of HATs ranging 
from 17% to 29%. All these candidates were 
hypothetical proteins (32,33) with the exception 
of PotE, the putrescine/ornithine exchanger (34), 
from E. coli. In preliminary trials, each of these 
APC members was C-terminally tagged with 
His6 and successfully expressed in E. coli as 
described in Materials and Methods. However, 
detailed investigation was subsequently confined 
to PotE and SteT because of the high yield of 
purified protein: up to 3 and 1 mg/L of bacterial 
culture, respectively. In contrast, purified protein 
yield was lower than 0.5 mg/L for the other APC 
members (data not shown).
In a wide phylogenetic study of the APC 
superfamily of transporters, the PotE and SteT 
proteins were initially classified as basic amino 
acid/polyamine antiporters (APA) within one of 
the eleven independently defined APC subfamilies 
(1). To our surprise, and in disagreement with this 
existing classification, our BLAST comparisons 
of the SteT protein sequence with those of all 
other APC members clearly showed a preferred 
match with members of the LAT subfamily (with 
identities ranging between 31 and 29%) rather than 
with any other APC transporters, including PotE 
(with 22% identity). To solve this discrepancy 
we performed a new phylogenetic analysis of 
SteT and PotE using a restricted collection of 
closely related APC subfamilies that, in contrast 
to wide APC studies, allowed, not only the usage 
of a more accurate protein alignment algorithms 
(ProbCons), but also a manual examination and 
verification of the alignment results, which is 
therefore expected to provide a more consistent 
phylogenetic classification. The sequence 
comparisons and the constructed phylogenetic 
tree indicated that SteT clearly clusters with 
all the members of the LAT family (Figure 1a). 
Furthermore, these results are also in agreement 
with a revised analysis recently performed 
by Saier and co-workers (Milton H. Saier Jr., 
personal communication). Thus, SteT and the 
other related bacterial sequences described in 
the legend to Figure 1a can be considered as the 
first identified prokaryotic members of the LAT 
family. SteT is predicted to contain 438 amino 
acid residues (estimated molecular mass 48,879 Da) 
Figure 2. SteT purification and reconstitution into proteoliposomes. 
Purification of His-tagged SteT by nickel affinity chromatography. 
SDS-PAGE of the different purification steps: lane 1, E. coli total 
membranes containing overexpressed SteT; lane 2, supernatant after 
solubilization with 0.5% DDM and ultracentrifugation; lane 3, pellet 
after ultracentrifugation; lane 4, Ni2+-NTA flowthrough; lane 5, Ni2+-NTA 
elution. SDS-PAGE of SteT reconstituted into proteoliposomes (1:100 
protein-to-lipid ratio) with (lane 6) or without 4 mM L-serine (lane 7). 
The displayed gels were stained with Coomassie Brilliant Blue. Applied 
protein per lane: 8 µg (lanes 1-4), 4 µg (lane 5), 2 µg (lanes 6-7). SteT 
migrates as a prominent band at ~40 kDa (see lanes 5-7).
Blue native gel electrophoresis – Linear 5-12% 
gradient gels for blue native-polyacrylamide gel 
electrophoresis (BN-PAGE) were prepared and 
run as previously described (31). Thyroglobulin 
(669 kDa), ferritin (440 kDa), catalase (232 kDa), 
lactate dehydrogenase (140 kDa), and bovine 
serum albumin (66 kDa) were used as standard 
proteins.
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and its sequence can be aligned in its entirety 
with almost the full lengths of the sequences of 
all the eukaryotic LAT family members (Suppl. 
Figure 1). The estimated membrane topology of 
SteT (Suppl. Figure 1) is similar to that of these 
transporters and fits the experimental topology 
model of xCT, which contains 12 transmembrane 
(TM) domains (17). Totally conserved residues 
in SteT and the mammalian rBAT- or 4F2hc-
associated LAT family members (see selected 
transporters in Suppl. Figure 1) are indicated in 
Figure 1b. The regions most highly conserved 
between SteT and the eukaryotic LAT family 
members correspond to TM1, TM2 and the re-
entrant loop between TM2 and TM3. The main 
differences are shorter N- and C- termini in SteT 
and the absence of the cysteine residue, in the 
loop between TM3 and TM4, that is involved 
in the disulfide bridge between the light and the 
heavy subunits in the eukaryotic LAT family 
members.
Figure 3. Screening of amino acid substrates for SteT transport activity. 
a) Transport of the indicated mixture of 10 µM radioactive labeled amino 
acid (pooled by structural similarity) was tested in proteoliposomes 
containing SteT or PotE. Proteoliposomes were loaded (PotE +aa 
and SteT +aa) or not (PotE –aa and SteT –aa) with a mixture of ten 
representative L-amino acids, i.e., Arg, Orn, Gly, Pro, Ala, Leu, Met, 
Phe, Tyr, Glu; each at 2 mM. b) Transport of the indicated radiolabeled 
amino acid (at 10 or 100 µM) into proteoliposomes containing no 
amino acids (PotE –aa and SteT –aa), a mixture of ten representative 
amino acids as in a) (PotE +aa and SteT +aa) or 2 mM Ser (SteT 
+Ser). Transport (a, b) was measured for 15 min and is expressed 
as cpm / µl of proteoliposomes per 15 min in a) and as pmol / µl of 
proteoliposomes per 15 min in b). A representative experiment (a, b) 
with 3 replicates per condition is shown.
Figure 4. Time-course of L-serine transport in SteT proteoliposomes. 
a) Influx (pmol / µg protein) of 10 µM radiolabeled L-serine into SteT 
proteoliposomes (SteT-PLs) containing 4 mM L-serine (closed squares) 
or L-arginine (open squares). L-arginine is not a substrate for SteT (see 
Figure 6a, b) and was used as a negative control. Data correspond to 
a representative experiment, performed using 3 replicates. Errors bars 
(SEM) when not visible are smaller than symbols. Three additional 
experiments gave similar results. The continuous lines correspond 
to simulated progress curves assuming a 1:1 substrate exchange 
stoichiometry plus simple diffusion for transport in SteT-PLs containing 
4 mM L-serine and simple diffusion for transport in SteT-PLs containing 
4 mM L-arginine (see experimental procedures for details). b) Efflux of 
L-serine through SteT transporter: SteT-PLs containing 4 mM L-serine 
were loaded with 10 µM radiolabeled L-serine for 2 h. Then, SteT-
PLs were diluted 13-fold with medium containing (closed circles) or 
lacking (open circles) unlabelled 7 mM L-serine. Efflux of L-serine 
was dramatically stimulated by L-serine in the external medium. A 
representative experiment is shown. A second experiment gave similar 
results.
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Functional characterization of SteT – In order 
to characterize the function of SteT, C-terminally 
His6-tagged SteT was overexpressed in E. coli 
and purified by nickel affinity chromatography 
(Figure 2, lanes 1 to 5). Purified SteT migrates 
as a band of ~40 kDa, similar in its mobility 
to monomers of the mammalian LAT family 
members, which have a molecular mass of ~50 
kDa (17,35,36). The faster migration of these 
proteins in SDS-PAGE than would be expected 
from their predicted molecular masses probably 
reflects their hydrophobic nature and is commonly 
observed for membrane transport proteins. A 
higher molecular weight band (~115 kDa; Figure 
2, lane 5), visible in some but not all protein 
preparations, corresponded to a low-abundance 
contaminant since it was not detected with 
HisProbe-HRP (Qiagen) (i.e., His tag detection) 
(data not shown). From scanning densitometry of 
multiple Coomassie blue-stained gels, the purity 
of a typical SteT preparation was estimated to 
be >86%. Purified SteT was reconstituted in the 
presence of E. coli lipids to form proteoliposomes 
(SteT-PLs) at a protein-to-lipid ratio of 1:100. 
Again the ~40 kDa band is visible in SteT-PLs 
(Figure 2, lanes 6 and 7).
SteT was a hypothetical protein identified in 
the B. subtilis genome sequence (32). Based on 
its phylogenetic relationship with eukaryotic LAT 
family members we reasoned that SteT could be 
an amino acid exchanger. To identify the SteT 
transport activity a fast screening approach for 
amino acid exchanger activity was set up. The 
first step consisted in preparing SteT-PLs with 
or without a mixture of ten representative amino 
acids (L-Arg, L-Orn, Gly, L-Pro, L-Ala, L-Leu, 
L-Met, L-Phe, L-Tyr, L-Glu, at 1 mM each) 
contained inside the proteoliposomes. Then, influx 
of a group of radiolabeled, structurally-related 
amino acids was measured. In agreement with 
the proposed transport function determined in 
whole bacteria expressing PotE and in membrane 
vesicles derived from these cells (19,34), PotE 
reconstituted in liposomes (PotE-PLs) showed 
putrescine/ornithine and ornithine/ornithine 
exchange (Suppl. Figure 2). As expected, PotE-
PLs showed higher transport in the amino acid-
filled than in the empty proteoliposomes (i.e., 
trans-stimulation) with the group of radiolabeled 
L-arginine, L-lysine, L-ornithine and putrescine 
(Figure 3a). In contrast, SteT-PLs showed 
trans-stimulated uptake only with the group of 
Figure 5. Kinetic analysis of SteT transport. a) Transport of radiolabeled 
L-serine at different concentrations in the external (as indicated) 
and the internal (0.4, 1, 4 and 12 mM) medium was measured in 
SteT proteoliposomes (SteT-PLs) for 1 min under linear conditions. 
Trans-stimulated transport was calculated by subtracting transport in 
SteT-PLs containing no L-serine in the internal medium assayed at 
the three indicated external concentrations of L-serine. Lineweaver-
Burk linearization of the trans-stimulated transport with the different 
external and internal L-serine concentrations is shown. The lines 
converge to negative X-axis values supporting a sequential model of 
exchange. The reverse plot (external L-serine concentrations in the 
X-axis for each internal concentration of L-serine) gave a similar plot. 
The estimated apparent Km values (calculated from the intersection 
in the X-axis for each line) ranged between 1.2 to 5.3 and 1.5 to 3.1 
mM for internal and external L-serine, respectively. The estimated 
Vmax with 12 mM internal L-serine was 67 ± 3 pmol / µg protein 
. min 
(mean ± SEM). A representative experiment is shown with 3 replicates 
per condition. Errors bars (SEM) when not visible are smaller than 
symbols. b) Transport of radiolabeled L-serine at different external 
concentrations (0.01, 0.1, 0.5, 1, 2, and 7 mM) was measured in 
SteT-PLs containing 15 mM L-serine or L-arginine in linear conditions. 
Trans-stimulated transport was calculated by subtracting transport in 
SteT-PLs containing L-arginine from that in those containing L-serine. 
Non-parametric analysis (GraphPad; Sigma) estimated an external 
apparent Km of 1.2 ± 0.2 mM. The estimated Vmax was 67 ± 4 pmol / 
µg protein . min (mean ± SEM). A representative experiment is shown 
with 3 replicates per condition. Errors bars (SEM) when not visible are 
smaller than symbols.
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L-serine, glycine and L-proline (Figure 3a). 
Next, trans-stimulation of transport of these 
amino acids, including L-alanine, was measured 
individually with SteT-PLs (Figure 3b). Only 
L-serine transport was trans-stimulated in amino 
acid-filled SteT-PLs. Similarly, substitution of 
the intra-proteoliposome mixture of amino acids 
by L-serine as the unique internal substrate also 
showed trans-stimulation of L-serine transport in 
SteT-PLs (Figure 3b). Indeed, the initial velocity 
of transport of 10 µM L-serine was 11-fold 
higher in L-serine-filled than in L-arginine-filled 
SteT-PLs (2.12 ± 0.15 and 0.19 ± 0.05 pmol / µg 
protein per 10 min respectively; n=5 independent 
experiments). As expected, transport of the amino 
acids from this group was not trans-stimulated in 
PotE-PLs (Figure 3b). 
Trans-stimulation can result either from 
allosteric trans-activation or exchange activity. In 
order to distinguish between these two possible 
mechanisms, L-serine transport was examined 
over time in SteT-PLs containing L-serine or 
L-arginine (used as a negative control) (Figure 
4a). SteT showed accumulation of L-serine 
over the equilibrium levels, as indicated by the 
overshoot observed in L-serine-containing SteT-
PLs, which was not observed in L-arginine-
containing SteT-PLs. SteT capacity for active 
accumulation is characteristic of an exchanger 
and is not compatible with an allosteric trans-
activation mechanism. Moreover, the transport 
activity of SteT was bidirectional, as shown by 
L-serine efflux measurements from SteT-PLs 
(Figure 4b). Efflux of radiolabeled L-serine from 
preloaded SteT-PLs was dramatically trans-
stimulated by L-serine in the external medium. 
In contrast, L-serine was apparently transported 
by simple diffusion in SteT-PLs containing 
L-arginine: i) L-serine transport in PotE-PLs 
was indistinguishable from that in SteT-PLs 
when only L-arginine was present inside the 
proteoliposomes (data not shown). ii) Moreover, 
pretreatment with the cysteine-reactive reagent 
MTSET (1 mM for 5 min) inactivated L-serine 
transport in L-serine-containing (65% inhibition) 
but not in L-arginine-containing SteT-PLs (data 
not shown). SteT contains five cysteine residues, 
which have been mutated to serine to construct 
a cysteine-less version of the transporter (SteT-
Cysless). This mutated protein retains ~25% of 
the transport activity of the wild-type SteT (data 
not shown). Pretreatment with MTSET (1 mM 
for 5 min) did not affect L-serine transport in 
SteT-Cysless-PLs containing L-serine (data not 
shown). These findings indicate that L-serine 
transport in SteT-PLs containing L-serine is SteT-
mediated, whereas that in SteT-PLs containing 
Figure 6. Substrate specificity of SteT transport activity. a) Amino acid 
cis-inhibition pattern of SteT transport activity. Transport of 10 µM 
radiolabeled L-serine was measured in SteT proteoliposomes (SteT-
PLs) containing no amino acids or 4 mM L-serine for 5 min (linear 
conditions). Transport was measured in the absence (no amino acids) 
or presence of the indicated amino acids at 5 mM in the external 
medium (2 mM in the case of L-tyrosine). Trans-stimulated transport 
was calculated by subtracting transport in SteT-PLs containing no 
L-serine from that in SteT-PLs containing L-serine. Transport is 
expressed as the percentage of the transport in SteT proteoliposomes 
containing 4 mM L-serine and with no cis-inhibitors (no amino acids) 
(5.2 ± 1.2 pmol / µg protein . 15 min). Data are from 2-3 experiments 
with 3 replicates per condition. b) Trans-stimulation of SteT transport 
activity. Transport of 10 µM radiolabeled L-serine was measured in 
SteT proteoliposomes containing 4 mM of the indicated amino acids 
(2 mM in the case of L-tyrosine) for 5 min. L-arginine was used as 
a negative control because this amino acid did not inhibit L-serine 
transport via SteT (see Figure 6a). Transport is expressed in pmol / 
µg protein in 5 min. A representative experiment with 3 replicates per 
condition is shown. Two additional experiments gave similar results.
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L-arginine is not SteT-mediated. Taken together, 
all these results demonstrate that SteT is an 
obligate exchanger. 
The kinetics of L-serine/L-serine exchange 
in SteT-PLs were examined by varying L-serine 
concentrations inside and outside proteoliposomes 
(Figure 5a). Lineweaver-Burk plots showed 
straight lines with different slopes where internal 
and external apparent Km values were independent 
of the substrate concentration in trans. This 
kinetic behavior supports a sequential mechanism 
and rules out a ping-pong mechanism, which 
is characterized by a non-intersecting pattern 
(37). This initial kinetic analysis estimated the 
apparent Km values from inside and outside the 
proteoliposomes to lie in the range of 1-5 and 
1-3 mM, respectively. Subsequently, a second 
kinetic analysis was performed with 15 mM 
L-serine inside SteT-PLs and varying the external 
L-serine concentration (Figure 5b). In agreement 
with these previous results, the external apparent 
Km was 1.2 ± 0.2 mM. In these two experiments 
(with up to 15 mM L-serine inside SteT-PLs) the 
Vmax of L-serine/L-serine exchange was 67 pmol/ 
µg protein . min. Thus, the turnover rate of SteT 
L-serine/L-serine exchange was 0.06 s-1.
In order to test whether ions were cotransported 
via SteT, we studied the effect of membrane 
potential on L-serine/L-serine exchange (Suppl. 
Figure 3). A membrane potential (negative inside) 
was generated by inclusion of 120 mM KPi in 
the internal medium of the proteoliposomes 
followed by the addition of valinomycin to 
the external medium. PotE-PLs were used as a 
positive control. PotE exchanges putrescine and 
L-ornithine with 1:1 substrate stoichiometry (34). 
At neutral pH putrescine/L-ornithine exchange 
would be electrogenic (two charges (putrescine) 
will be exchanged for one charge (L-ornithine)). 
Consistent with this stoichiometry, imposing 
a membrane potential increased the putrescine 
(influx)/L-ornithine (efflux) exchange in PotE-
PLs by ~80%. In contrast, L-serine/L-serine 
exchange in SteT-PLs was independent of the 
membrane potential. Moreover, SteT exchange 
activity was independent of Na+ and Cl- in the 
external medium (i.e,. substitution by choline and 
acetate respectively had no effect), and was not 
affected by variation of the external medium pH 
(from 5.5 to 7.5; internal proteoliposome pH = 
7.4) (data not shown). Similarly, SteT exchange 
activity was independent of K+ gradient (i.e., 
equilibration of the K+ gradient by the addition 
of 120 mM K+ to the external medium; data not 
shown).
To further confirm that SteT mediates obligate 
exchange, the time-course of L-serine/L-
serine exchange via SteT was simulated (see 
Experimental Procedures). Transport of 10 µM 
radiolabeled L-serine into SteT-PLs containing 4 
mM L-arginine fitted well to a model of simple 
diffusion with a diffusion coefficient of 2.5 x 10-6 
min-1 and an internal SteT-PLs volume estimated 
at equilibrium of 62 nl / µg of purified protein 
(Figure 4a). Transport of 10 µM radiolabeled 
L-serine into SteT-PLs containing 4 mM L-serine 
Figure 7. Freeze-fracture TEM of purified SteT and PotE reconstituted 
in liposomes. a) control liposomes are devoid of intramembrane 
particles. b–c) SteT proteoliposomes prepared for transport assays 
at a protein-to-lipid ratio of 1:100 (b) and 1:40 (c). Intramembrane 
particles (arrows) appear in both concave (b) and convex faces (c) 
of unilamellar vesicles, indicating a random insertion of the protein in 
the bilayer. d) PotE proteoliposomes prepared for transport assays at 
a protein-to-lipid ratio of 1:100. Intramembrane particles (arrows) are 
visible. Scale bar: 100 nm. Insets: high magnification view of one SteT 
(c) and one PotE (d) particle. Scale bar in insets: 10 nm.
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was simulated using two transport components: 
a) electroneutral Ser/Ser exchange with 1:1 
exchange stoichiometry and apparent internal 
and external substrate affinities of 2.0 and 1.2 
mM respectively plus b) the simple diffusion 
component (Figure 4a). The internal SteT-PLs 
volume estimated at equilibrium was 62 nl / µg of 
protein. Interestingly, the best agreement with the 
experimental data was obtained when a decrease 
in transport activity over time was included in the 
simulation (Vmax from 70 to 22 pmols /µg protein 
. 
min within the first 2 h with a t1/2 of 21 min). The 
nature of this inactivation during time-course 
transport measurements is unknown. However, 
these simulations support an electroneutral 
and obligate exchange of L-serine by SteT, and 
indicate that this exchange is balanced (probably 
with 1:1 stoichiometry).
Finally, the amino acid specificity of SteT 
transport activity was characterized by cis-
inhibition experiments (Figure 6a). A 500-fold 
excess of the L-stereoisomers of serine and 
threonine almost completely abolished L-serine/
L-serine exchange. Amino acids structurally 
related to L-serine (D-serine and L-homoserine) 
also inhibited transport, but to a much lower 
extent. Similarly, the phosphorylated form of 
L-serine (L-phosphoserine) was a much poorer 
Figure 8. TEM of negatively stained SteT. The homogeneity of the 
DM-solubilized SteT proteins is reflected in the electron micrograph 
(a). The selected top view particles marked by broken circles were 
magnified and are displayed in the gallery (b). SteT proteins are 
elliptical (diameters: ~6 x ~7 nm) and donut-shaped with a central 
depression. The frame size of the magnified particles in the gallery 
is 12 nm.
inhibitor. Many other amino acids, including 
glycine, proline, arginine, cysteine, lysine and 
glutamate, inhibited transport very weakly 
or not at all. Surprisingly, L-aromatic amino 
acids (phenylalanine, tyrosine and tryptophan) 
significantly inhibited SteT transport. In order 
to confirm the role of threonine and the aromatic 
amino acids as substrates, SteT-PLs were filled 
with these amino acids and trans-stimulation of 
L-serine transport was measured (Figure 6b). 
Transport was clearly trans-stimulated by L-serine 
and L-threonine, and to a lesser extent by the 
L-aromatic amino acids. In contrast, L-arginine, 
used as a negative control, did not trans-stimulate 
L-serine transport.
The results presented demonstrate that SteT 
exhibits an obligate exchange activity for serine, 
threonine and aromatic amino acids. Because 
serine and threonine were the more efficiently 
transported, we propose that YkbA be re-
designated as a Serine/Threonine Exchanger 
Transporter (SteT).
Structure and oligomeric state of SteT and 
PotE – To ascertain whether SteT and PotE 
exist in a monomeric or oligomeric form, three 
independent methods were used: Blue native-
polyacrylamide gel electrophoresis (BN-PAGE), 
freeze-fracture TEM, and negative stain TEM. 
BN-PAGE results of SteT are summarized in 
Suppl. Figure 4. DM-solubilized and purified His-
tagged SteT migrated as a strong protein band at 
an apparent molecular weight (Mobs) of ~80 kDa. 
In addition, two faint bands at ~155 kDa and ~205 
kDa as well as a stronger one at ~40 kDa were 
detected. The latter band had a bright blue colour 
and corresponds to detergent/Coomassie brilliant 
blue G-250 micelles as demonstrated previously 
(38). In Western blot analysis the ~80 kDa, ~155 
kDa and ~205 kDa bands reacted with HisProbe-
HRP and therefore corresponded to SteT (data 
not shown). BN-PAGE with purified PotE was 
not successful because of its strong tendency to 
precipitate during gel electrophoresis.
In a second approach, freeze-fracture TEM 
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4.6 DISCUSSION
In this work we have provided, for the first 
time, information on the functional and structural 
features of SteT from B. subtilis. The first part 
of our extensive analysis shows that SteT is an 
excellent prokaryotic model for structural and 
functional studies of eukaryotic amino acid 
exchangers, in particular members of the LAT 
family: (i) Phylogenetic analysis clustered the 
SteT amino acid sequence together with LAT 
family members within the APC superfamily 
(Figure 1a); (ii) The putative membrane topology 
of SteT (Figure 1b and Suppl. Figure 1) is 
compatible with that experimentally determined 
for eukaryotic LAT transporters, i.e. the catalytic 
subunit of HATs (17); (iii)  SteT showed obligate 
amino acid exchange activity (Figs. 3b, 4 and 6b), 
which is characteristic of the catalytic subunits 
of HATs (14); (iv) Furthermore, kinetic analysis 
supports a sequential mechanism of exchange for 
SteT (Figure 5), which has also been described 
for the HAT system b0,+ in chicken small intestine 
(15). Thus, SteT is the first identified and 
characterized prokaryotic member of the LAT 
family of amino acid transporters.
In agreement with SteT amino acid exchange 
activity, and in support of our functional 
characterization protocol, the SteT ortholog in 
B. cereus (GenBank accession AAP11885, gi 
29898613, annotated as hypothetical protein in 
Ref. 40) showed the same L-serine/ L-threonine 
exchange activity when purified and reconstituted 
in proteoliposomes (data not shown). Other than the 
clear amino acid exchange activity detected here for 
both orthologues, to our knowledge a SteT-related 
transport activity still remains to be described in 
cells or membrane vesicles of Bacillus sp.
analysis was applied to estimate the size of 
functional His-tagged SteT and PotE reconstituted 
in proteoliposomes (SteT-PLs and PotE-PLs). 
Aliquots (5 µL) of proteoliposomes, as used for 
the transport assays, at a protein-to-lipid ratio 
of 1:100 and for these studies also at 1:40, were 
prepared for freeze-fracture TEM. SteT- and 
PotE-PLs at protein-to-lipid ratios of 1:100 and 
1:40 showed identical transport activity when 
corrected by µg of protein (data not shown). In 
the replicas after freeze-fracture, proteoliposomes 
appeared as concave or convex surfaces with 
diameter of 150-200 nm (Figure 7). The majority 
(90%) of the proteoliposomes fracture faces 
contained 0-2 and 0-6 intramembrane particles 
in SteT-PLs (1:100 and 1:40 protein-to-lipid 
ratios) (Figure 7b-c). A similar number of 
particles (0-2 and 0-7) were present in PotE-PLs 
fracture faces (Figure 7d). These particles were 
absent from control liposomes (Figure 7a). This 
finding demonstrates that the observed particles 
represented reconstituted SteT or PotE proteins. At 
high magnification SteT and PotE particles had a 
round shape (Figure 7c, d; insets). Measurements 
on 1:40 protein-to-lipid ratio proteoliposomes 
indicated single populations of particles with 
diameters of 7.4 ± 0.1 nm (n= 119) and 8.0 ± 0.1 
nm (n= 109) for SteT and PotE, respectively. As 
a control for our measurements we used lactose 
permease from E. coli and we found a similar 
particle size. Thus, freeze-fracture TEM analysis 
applied to the C154G lactose permease mutant 
(i.e., the same mutant protein used for the crystal 
structure resolution; ref. 39) reconstituted in 
liposomes (1:100 protein-to-lipid ratio) showed 
a particle diameter of 6.0 ± 0.1 nm (n= 72) (data 
not shown).
Finally, DM-solubilized His-tagged SteT 
protein was negatively stained and examined 
by TEM. The homogeneity of purified SteT is 
documented in Figure 8a. Single SteT proteins 
were distinguished and displayed an elliptic 
“donut-like” shape with diameters of ~6 nm 
by ~7 nm and a central stain-filled indentation 
(see gallery of well preserved SteT top views 
in Figure 8b). As already indicated from BN-
PAGE, PotE had a tendency to aggregate when 
solubilized in detergent. This behaviour was 
further supported by negative stain TEM which 
showed a heterogeneous population of particles 
(data not shown).
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Analysis of SteT in PLs by freeze-fracture TEM 
indicated that the protein is integrated in the lipid 
bilayer of unilamellar vesicles. Reconstituted 
SteT resides in two orientations in the bilayer, as 
suggested by freeze fracture TEM images of SteT-
PLs showing particle retention on concave as well 
as convex faces (Figure 7b, c). Distinct substrate 
affinities may be expected for the two orientations 
(up to 3 orders of higher apparent affinity for 
the external than the cytoplasmic side), as has 
been demonstrated for the reconstituted catalytic 
subunit (b0,+AT) of system b0,+ (16) and for other 
HATs expressed in oocytes (41). In contrast, 
curve fitting of kinetic data to Michaelis-Menten 
equations for two distinct affinities for L-serine 
outside SteT-PLs contraindicates a second Km for 
L-serine and gives a unique external apparent Km 
of 1.2 mM for L-serine (Figure 5). This suggests 
that SteT has similar apparent affinities at both 
sides of the membrane.
The blue native-gel of purified SteT indicates 
a strong and major band with an Mobs of ~80 kDa. 
This finding suggests that the majority of SteT 
molecules exist in monomeric form, given that 
the polypeptide has a molecular mass of ~49 kDa 
(based on its amino acid sequence) and migrates 
in BN-PAGE in association with a detergent/
Coomassie brilliant blue G-250 micelle. The 
use of the conversion factor (1.8) determined 
by Heuberger et al. (42) to estimate the mass of 
membrane proteins from the Mobs also supports 
the existence of SteT in monomeric form. In 
addition, experiments performed with a wide 
range of amino- (DSP, DST and DMS) and 
sulfhydryl-specific (BM(PEO)4) reagents did not 
yield cross-linking products (data not shown) in 
line with the results from BN-PAGE.
Freeze-fracture TEM of functional SteT and 
PotE in PLs showed homogeneous round-shaped 
particles with diameters of ~7.4 and ~8.0 nm, 
respectively. These values are only slightly 
higher than the diameter estimated for the lactose 
permease monomer (~6 nm, see results) and in 
agreement with previous studies (43). Lactose 
permease has 12 transmembrane segments and 
similar molecular mass to SteT and PotE, and 
its monomeric state is well established (39). 
This suggests that functional SteT and PotE are 
monomers. The thickness of the platinum-carbon 
film deposited to produce our replicas may 
have led to overestimation of the true particle 
diameter by ~2 nm, as described for freeze-
fracture TEM analysis of other transporters 
inserted in proteoliposomes (44). Thus, the 
diameter of the SteT and PotE particles can be 
assumed to be in the range of 5 to 6 nm. TEM 
of negatively stained SteT proteins revealed an 
elliptical donut-like structure with diameters of 
~7 nm by ~6 nm. Similar to freeze-fracture TEM, 
the measured dimensions are overestimated. 
With detergent-solubilized membrane proteins 
the additional mass arising from the detergent 
belt and endogenous lipid bound to the protein 
has to be considered. According to Dekker et al. 
(45) the true protein volume is about 20% smaller 
than the volume estimated from the negatively 
stained detergent-solubilized membrane protein. 
Thus, the corrected dimensions of SteT from 
negative stain TEM are in agreement with those 
from freeze fracture TEM. The “red permease” is 
a lactose permease fusion protein which consists 
of 12 transmembrane helices, has a comparable 
molecular mass to SteT, and forms monomers 
and trimers (46). The reported dimensions for the 
“red permease” monomer reconstituted into lipid 
membranes, as determined by negative stain TEM 
are about 5 x 4 nm (46) and therefore similar to 
the dimensions of SteT after correction for the 
detergent bound to the protein (see above and 
Ref. (45)). Besides the size, both proteins possess 
a similar overall structure and a pronounced 
central indentation. As control experiment and 
additional support for the monomeric nature of 
negatively stained detergent-solubilized SteT 
(Figure 8), its dimensions were compared with 
those of negatively stained detergent-solubilized 
glutamate transporter (GltP). GltP forms trimers 
and the molecular mass of the monomer is similar 
to that of SteT. The measured dimensions of the 
GltP monomer within the trimer are comparable 
to those of SteT reinforcing the conclusion that 
SteT is monomeric (data not shown).In summary, 
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our data suggest SteT and PotE to be functional 
in the monomeric form.
Little is known about the structure of the light 
subunits of HATs (LAT family). The elucidation 
of their structure is mainly limited by the low 
HAT expression in native cells and tissues, and 
the difficulty to overexpress these proteins in 
heterologues systems. An excellent alternative 
to understand the molecular mechanism of 
HATs represents the elucidation of the atomic 
structure of a prokaryotic transporter with high 
sequence identity to eukaryotic light subunits of 
HATs. To this end and for the first time we have 
identified, cloned, overexpressed and purified the 
SteT protein, a prokaryotic member of the LAT 
family. Functional and structural characterization 
of SteT has provided insights into the transport 
mechanism, kinetics, structure and oligomeric 
state of this important family of amino acid 
transporters. However, a high resolution structure 
is needed to fully understand the molecular 
mechanism of SteT and to relate the previous 
functional data. The first step towards the growth 
of 2D and 3D protein crystals suitable for high-
resolution structure analysis has been achieved 
here by the successful overexpression and 
purification of high amounts of functional SteT.
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5.1 ABBREVIATIONS
IPTG, isopropyl 1-thio-β-D-galactopyranoside; DTT, dithiotreitol; EDTA, ethylenedinitrilotetraacetic 
acid; BN-PAGE, blue native-polyacrylamide gel electrophoresis; DM, n-decyl-β-D-maltoside; TEM, 
transmission electron microscopy; TM, transmembrane regions; Ni-NTA, nickel-nitrilotriacetic 
acide; Mobs, apparent molecular mass.
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5.2 ABSTRACT
Cellular peptide uptake has been extensively 
studied in the past. In contrast, structural 
information on peptide transporters is sparse. 
Here,	we	have	cloned,	overexpressed,	purified	
and biochemically characterized the YbgH 
protein from Escherichia coli, a prokaryotic 
member of the peptide transporter (PTR) 
family. Two-dimensional (2D) crystallization of 
YbgH	yielded	first	tubular	crystals	that	allowed	
the determination of a projection structure at 
27 Å resolution. This low-resolution structure 
of	YbgH	 represents	 the	 first	 structural	 view	
of a member of the PTR family at the given 
resolution. Furthermore, the presented work 
sets the basis for future structural works 
with the peptide transporter YbgH using 2D 
crystals and electron crystallography.
5.3 INTRODUCTION
Peptide molecules are mostly disabled to cross 
lipid membranes by simple diffusion, because of 
size and polarity. Integral peptide transporters 
mediate the translocation of peptides of two to 
six residues through cell membranes in an energy 
dependent manner (1-5). The reflow of disposed 
peptides plays a crucial role in the energy balance 
of bacteria, fungi, plants and animals. Peptide 
uptake provides amino acids, nitrogen and carbon 
for the synthesis of new proteins and metabolites. 
In addition, peptide transport is involved in a wide 
variety of biological functions such as signalling 
process, regulation of gene expression, biological 
warfare and metabolic adaptation (6).
Based on function and sequence similarity 
peptide transporters can be classified in three 
main families: The ATP binding cassette (ABC) 
family (7), the oligopeptide transporter (OPT) 
family (8, 9) and the peptide transporter (PTR) 
family (10; 11). Peptide transporters of the 
ABC family are composed of multiple proteins 
with one or more ABC components. Bacterial 
ABC peptide transporters require additionally a 
substrate binding protein that is involved in the 
process of substrate shuttling (12-14). Proteins 
of the OPT family are found in yeast, fungi and 
plants only (15-17). Recently nine OPT orthologs 
were identified in Arabidopsis (AtOPT1 to 
AtOPT9) providing first evidences of multiple 
peptide transport systems in plants (18). The 
PTR family was uncovered by multiple sequence 
analysis, because a number of discovered 
peptide transporters distinct from the already 
known group of ABC transporters. Surprisingly, 
the sequence alignment of these transporters 
demonstrated a high number of similarity and 
identity. Two conserved motives were identified 
exclusively within this group of proteins which 
was designated the peptide transporter (PTR) 
family (11). The high conservation of these 
signature sequences suggests that they may play an 
important structural, functional or biogenic role. 
Subsequently members of the PTR family were 
found in other species from bacteria, yeast, plants, 
and invertebrates to vertebrates. Functionally 
well characterized peptide transporters of the 
PTR family are DtpT from Lactococcus lactis 
(19, 20), Ptr2 from Saccharomyces cerevisiae 
(21) and the mammalian transporters PEPT1 and 
PEPT2 (11, 22). In E. coli four PTR members 
are reported that contain the specific family 
motives: YdgR (TppB, DtpA), YhiP (DtpB), 
YjdL and YbgH (5, 23, 24). DtpA and DtpB 
from E. coli were functionally characterized 
as proton dependent oligopeptide transporters 
with substrate recognition patterns similar to 
mammalian PEPT1 (25, 26). Because all of the 
characterized members are proton dependent 
transporters driven by the proton motive force, 
the PTR family is also referred as POT or proton 
dependent oligopeptide transporter family (10). 
All PTR transporters share a molecular mass 
of about 450 to 600 amino acid residues with 
12 putative α-helical transmembrane segments 
(TMSs) predicted. In the case of the prokaryotic 
peptide transporter DtpT from Lactococcus lactis, 
the 12 TMS structure with cytoplasmic located N- 
and C- termini has experimentally been proven 
by a gene fusion approach (27).
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Functional data characterizing peptide 
transport systems is continuously increasing, 
while no structural information is available. 
The structure of membrane proteins is generally 
difficult to analyze using X-ray diffraction 
or NMR techniques, due to problems with 
crystallization or solubility. Cryo-transmission 
electron microscopy combined with electron 
crystallography of two dimensional (2D) crystals 
represents an attractive alternative to determine 
membrane protein structures (28). The advantage 
of 2D crystals is that the membrane protein 
is analyzed in its native environment, the lipid 
bilayer.
Here we report the cloning, expression, 
purification and the first low-resolution structure 
of YbgH, a PTR family member. Negative-
stain TEM and blue native-polyacrylamide 
gel electrophoresis (BN-PAGE) of detergent-
solubilized YbgH revealed a monomeric state. 
Crystallization experiments yielded well-
ordered tubular 2D crystals that were analyzed 
by transmission electron microscopy (TEM) 
techniques. Image processing of negatively 
stained crystals enabled us to derive a map of the 
structure in projection at 27 Å resolution. This 
work presents a solid step towards the structural 
analysis of YbgH at high-resolution using 2D 
crystals and electron crystallography. Importantly, 
prokaryotic YbgH presents an excellent model 
for understanding the molecular architecture of 
transporters from the PTR family.
5.4 MATERIALS AND METHODS
Cloning − Genomic DNA from E. coli strain 
O157:H7 was prepared with the Qiagen DNeasy 
Kit and ybgH was obtained by PCR using the 
primers AAAAAGCTTATGAATAAACACGCA-
TCACAG and AAACTCGAGAGACTCCAGC-
GCCAGCGC that add Hind III and Xho I for 
cloning. PCR products were digested with Hind 
III and Xho I and ligated into pET-21 vector (T7 
promotor, C-terminal hexahistidine-tag, Novagen/
Merck, Darmstadt, Germany). A ribosomal 
binding site (rbs) (AAGGAG) was added 7 bases 
5’ of the coding region to improve translation of 
the protein. The DNA construct was verified by 
sequencing.
Overexpression in E. coli − Expression experi-
ments were carried out with E. coli BL21(DE3)
pLysS (Novagen/Merck, Darmstadt, Germany) 
from freshly streaked glycerin stocks. Cultures 
were grown in LB Medium supplemented with 
100 µg/ml ampicillin to OD600 of about 0.8 
and protein production was induced by adding 
0.1 mM IPTG (final concentration). Cells were 
harvested by centrifugation (8000 x g, 8 min) 
after 3 h shaking incubation at 37 °C.
Membrane preparation − Cell pellets from 500 
ml culture were resuspended in 25 ml lysis buffer 
(10 mM Hepes/Tris pH 7.4, 1 mM DTT, 0.5 mM 
EDTA) and broken by sonication (10 cycles of 
30 s). After a short low speed centrifugation to 
separate unbroken cells (4,500 x g, 8 min) and 
a short high speed centrifugation to pellet the 
outer membrane (120,000 x g, 5 min) the inner 
membranes from the supernatant were collected 
by centrifugation at 120,000 x g for 1.5 h (all 
at 4 °C). The pellets were resuspended in 1 ml 
buffer (20% glycerol, 10 mM Hepes/Tris pH 7.4, 
0.5 mM Tris-2-carboxyethyl-phosphine (TCEP), 
frozen in liquid nitrogen and stored at -80 °C.
Purification of YbgH − Frozen E .coli 
membranes with overexpressed YbgH 
were solubilized in 2% DM (n-decyl-ß-D-
maltopyranoside), 20 mM Tris-HCl pH 8, 
300 mM NaCl, 10% glycerol and 0.01% NaN3 
for 1 hours at 4 °C under gentle agitation. The 
protein concentration during solubilization was 
2 mg/ml. After ultracentrifugation (100,000 x 
g, 50 min at 4°C) the supernatant was diluted 
two-fold with 20 mM Tris-HCl pH 8, 300 mM 
NaCl, 0.4% DM, 5 mM histidine, 10% glycerol, 
0.01% NaN3 (washing buffer) and bound to Ni-
NTA Superflow beads (Qiagen) for 2 h at 4 °C. 
The beads were then loaded onto a spin column 
(Promega), washed with washing buffer and 
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eluted with the same buffer containing 200 mM 
histidine. Concentration of purified YbgH was 
spectrophotometrically determined measuring 
the absorbance at 280 nm and using a molar 
extinction coefficient of 103,750 M-1 cm-1. This 
value was calculated from the amino acid sequence 
of recombinant YbgH using the ProtParam tool 
from the ExPASy proteomics server (http://www.
expasy.org/tools/protparam.html).
Blue native gel electrophoresis − Linear 5–12% 
gradient gels for blue native polyacrylamide gel 
electrophoresis (BN-PAGE) were prepared and 
run as previously described by Schägger et al. 
1991. Thyroglobulin (669 kDa), ferritin (440 
kDa), lactate dehydrogenase (140 kDa), and 
bovine serum albumin (66 kDa) were used as 
standard proteins.
Negative stain TEM − DM-solubilized YbgH 
protein at ~3 µg/ml was adsorbed for ~10 sec to 
parlodion carbon-coated copper grids rendered 
hydrophilic by glow discharge at low pressure in 
air. Grids were washed with three drops of double-
distilled water and stained with 2 drops of 0.75% 
uranyl formate. Grids of YbgH 2D crystallization 
trials were prepared similarly, but included a 
longer adsorption time of ~30 sec. Electron 
micrographs were recorded at a magnification 
of x50’000 on Eastman Kodak Co. S0-163 sheet 
films with a Hitachi H-7000 electron microscope 
operated at 100 kV.
2D crystallization of YbgH − Purified YbgH 
protein (3 mg/ml) solubilized in DM was mixed 
with lipids solubilized in the same detergent: 
5 mg/ml lipid in 1% detergent in 20 mM Tris-
HCl pH 8, 150 mM NaCl, 10% glycerol, 0.01% 
NaN3 at lipid-to-protein ratios (LPRs) of 0.2–0.8 
(w/w). The final protein concentration varied 
between 1.5 and 3 mg/ml depending on the LPR. 
The samples were dialyzed against detergent-
free buffer for five days at room temperature. 
The tested crystallization conditions are listed in 
Table 1.
Freeze-drying and heavy metal 
shadowing − Tubular 2D crystals of YbgH 
were adsorbed to glow-discharged carbon coated 
400 mesh grids, washed twice with double-distilled 
water, blotted on filter paper, and immediately 
frozen in liquid nitrogen. Submerged in liquid 
nitrogen at all times, the grids were transferred 
to the pre-cooled cold stage of the MIDILAB, 
a complete freeze-drying and shadowing unit 
that is mounted permanently onto the column 
of a Philips CM12 TEM (29). Freeze-drying, 
unidirectional heavy-metal shadowing with 
Ta/W at an elevation angle of 45°, operation of 
the TEM and image acquisition were performed 
as described (30).
Image processing  − Electron micrographs of 
negatively stained YbgH crystals were evaluated 
by optical diffraction. Micrographs of well 
diffracting tubular crystals were digitized with a 
Heidelberg Primescan D 7100 at 4 Å per pixel 
resolution. Image processing, i.e. measurement 
of lattice vectors, calculation of power spectra 
and correlation averages, was performed with the 
SEMPER image processing system (31).
Figure 1. SDS-PAGE and BN-PAGE of pure YbgH protein. (a) 
Purification of His-tagged YbgH by nickel affinity chromatography: 
low molecular mass standard (lane 1), DM-solubilized E. coli total 
membranes containing overexpressed YbgH (lane 2) and purified 
YbgH protein (lane 3). Denatured YbgH runs as a prominent band at 
~45 kDa by SDS-PAGE. (b) BN-PAGE of YbgH. Protein standard (lane 
1) and purified YbgH (lane 2). DM-solubilized YbgH protein migrates 
at ~85 kDa in the 5-12% linear gradient polyacrylamide gel. Applied 
amount of protein per lane: ~10 μg (lane 2, panel (a)), ~5 μg (lane 3, 
panel (a)), ~2 μg (lane 2, panel (b)).
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5.5 RESULTS
Cloning, expression and purification of 
YbgH − The ybgH gene from E. coli was 
amplified from genomic DNA by PCR using 
gene specific primers and cloned into the pET-
21 vector fused with a C-terminal hexahistidine-
tag (pET-21-ybgH-His6) as previously described 
for dtbA (ybgH) (25). For homologous over-
expression of YbgH the vector was transformed 
into E. coli BL21(DE3)pLysS. Isolated E. coli 
inner membranes were solubilized with DM 
and His-tagged YbgH was purified in a single 
step by nickel affinity chromatography. The 
yield was in the range of 2-3 milligrams of pure 
YbgH protein per litre of E. coli cell culture. 
SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) of DM-solubilized inner membranes and 
of purified YbgH protein is shown in Figure 1a, 
lanes 2 and 3. Denatured YbgH protein migrated 
as a single band with an apparent mass of ~45 
kDa in contrast to its molecular mass of 55.2 
kDa. The assignment of this band to YbgH was 
confirmed by Western blot analysis using an anti-
His antibody (data not shown).
Characterization of YbgH by BN-PAGE and 
negative-stain TEM − BN-PAGE was performed 
to unveil the oligomeric state of purified YbgH 
protein. The blue native-gel in Figure 1b revealed 
one single band with an apparent mass of ~85 
kDa for DM-solubilized YbgH. Furthermore, we 
performed negative-stain TEM to assess protein 
quality, shape, dimensions and low-resolution 
structure of YbgH. The homogeneity of purified 
YbgH is documented in Figure 2a. Well preserved 
top-view particles exhibited a donut-like shape 
with a central, shallow depression (see Figure 
2b, gallery) and had a diameter of 8.0±0.5 nm 
(n=100).
2D crystallization of YbgH − Purified, 
DM-solubilized YbgH was subjected to 2D 
crystallization in the presence of different lipids 
and additives, at different pHs, ionic strengths, 
temperatures and lipid-to-protein ratios (LPRs; 
see Table 1 for a summary). Most of the tested 
lipids were able to reconstitute YbgH into 
tubular crystals at LPRs between 0.3 and 0.4. 
LPRs higher than 0.4 produced densely packed 
vesicles while LPRs below 0.3 resulted in protein 
aggregation (data not shown). Interestingly, 
YbgH had the intrinsic tendency to form tubular 
crystals instead of planar 2D crystals. The crystal 
quality and length of the tubes was optimized by 
varying the crystallization parameters listed in 
Tabel 1. Furthermore, the stability of the YbgH 
protein could be improved by the presence 
of 10% glycerol and 250 mM mannitol in the 
dialysis buffer. From all tested parameters the 
best crystals were grown with E. coli polar 
lipids (LPRs 0.3-0.4) in 300 mM NaCl, 250 mM 
mannitol, 10% glycerol and 20 mM Tris-HCl pH 
8. Unfortunately, no crystallization condition was 
found to induce the growth of large vesicular or 
sheet-like 2D crystals suitable for high-resolution 
studies by TEM and electron crystallography.
Negative stain TEM of tubular YbgH 
crystals − Negative stain TEM of on parlodion 
carbon-coated electron microscopy grids 
adsorbed and flattened YbgH tubes revealed 
well-ordered 2D crystals (Figure 3a). The width 
of the tubes was 100-110 nm and quite constant. 
In contrast to the latter, the length of the tubes 
Figure 2. TEM of single purified YbgH proteins. (a) TEM of negatively 
stained YbgH proteins. The homogeneity of the purified protein is 
reflected in the electron micrograph. 
(b) Gallery of well preserved top-view particles. YbgH particles are 
donut-shaped with a central depression and have a diameter of 8.0±0.5 
nm (n=100). The scale bar represents 50 nm, and the frame size of the 
magnified particles in the gallery is 13 nm.
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varied from nano- to micrometers. Power spectra 
calculated from such flattened tubular crystals 
displayed a distinct periodic pattern arising from 
two superimposed collapsed layers (Figure 3b). 
Such power spectra represented therefore the 
superposition of two separate diffraction patterns. 
To distinguish between the two sets of diffraction 
spots, tubular crystals of YbgH were freeze-dried 
and unidirectionally shadowed with Ta/W (Figure 
3c). This method revealed only the top layer 
allowing the lattice parameters of the tubular 
crystals to be defined unambiguously from the 
diffraction pattern shown in Figure 3d. The unit 
cell had a rhombic shape and lattice parameters 
of a=110 Å; b=105 Å; γ=97°. 
From several dozens of micrographs of 
negatively stained YbgH tubes the best four 
images were selected by optical diffraction for the 
calculation of the correlation average displayed in 
Figure 4. Top and bottom layers of collapsed tubes 
were processed separately. Interestingly, one of the 
two layers very often indicated better diffraction, 
suggesting better conservation after adsorption. 
The four best correlation averages were merged 
together to yield a projection map at 27 Å (Figure 
4). The latter featured alternating horizontal rows 
of stronger and weaker intensities.
5.6 DISCUSSION
Peptide uptake in E. coli has been extensively 
studied during the last two decades. In contrast, 
structural information on peptide transporters is 
sparse. To our knowledge, only a low-resolution 
structure based on negative stain TEM of single 
DtpA (YdgR) peptide transporter particles 
has been reported so far (25). Here, we have 
presented the first projection structure of a PTR 
family member at 27 Å resolution determined 
by negative stain TEM of tubular YbgH protein 
crystals.
On our aim to elucidate the structure of peptide 
transport proteins, we have cloned, overexpressed, 
purified and biochemically characterized YbgH. 
Overexpression of YbgH yielded 2-3 milligrams 
Lipid abbreviations: DLPC, 1,2-dilauroyl-sn-glycero-3-phosphocholine; DMPC, 1,2-dimyristoyl-sn-glycero-3 phosphocholine; DMPS, 1,2-
dimyristoyl-sn-glycero-3-phospho-L-serine (sodium salt); DMPG, 1,2-dimyristoyl-sn-glycero-3-phospho-(1’-rac-glycerol) (sodium salt); DOPC, 
1,2-dioleoyl-sn-glycero-3-phosphocholine; DOPA, 1,2-dioleoyl-sn-glycero-3-phosphate (monosodium salt); DOPE, 1,2-dilinoleoyl-sn-glycero-3-
phosphoethanolamine; DOPG, 1,2-dioleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (sodium salt); DOTAP, 1,2-dioleoyl-3-trimethylammonium-
propane (chloride salt); POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; POPS, 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-L-serine] 
(sodium salt); POPE, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine; POPA, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate (monosodium 
salt). Used buffers: pH 5-5.5 (cirtic acide-NaOH), pH 6-6.5 (Mes-NaOH), pH 7-9 (Tris-HCl), pH 9.5-10 (CAPS-HCl)
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Figure 3. Negatively stained tubular crystals of purified YbgH. (a) Overview electron micrograph of crystalline YbgH Tubes. (b) The power spectrum 
calculated from a flattened tubular YbgH crystal indicates crystallinity and diffraction up to 27 Å resolution (arrowhead). Two separate sets of diffraction spots 
are distinct (one indicated by lattice lines) arising from the two superimposed collapsed layers. (c) Electron micrograph of a freeze-dried and unidirectionally 
shadowed YbgH tube. The white arrow indicates the shadowing direction. (d) The power spectrum calculated from (c) shows the diffractions spots derived 
from the top layer (indicated by lattice lines) of the collapsed tube. Scale bars 300 nm (a), (3 nm)-1 (b), 150 nm (c), (3 nm)-1 (d).
of pure protein per liter of bacterial cell culture 
setting the stage for 2D crystallization trials. SDS-
PAGE of purified YbgH indicated an apparent 
mass of ~45 kDa in contrast to its molecular mass 
of ~55 kDa. Such SDS-PAGE running anomalies 
of membrane proteins, where the abnormal 
migration behaviour causes an underestimation 
of the true protein mass, are frequently reported 
(32, 33). Interestingly, also two other PTR family 
members from E. coli, i.e. DtpA and DtpB, 
showed similar running behaviours by SDS-
PAGE (25, 26).
To ascertain whether YbgH exists in a 
monomeric or oligomeric form when solubilized 
in DM, we performed BN-PAGE. On BN gels, 
DM-solubilized YbgH migrated as a single 
band at an apparent molecular mass of ~85 
kDa. Assuming an average mass of ~55 kDa for 
recombinant YbgH and a DM/coomassie brilliant 
blue G-250 micelle of ~30 kDa (34) bound to 
the proteins during BN-PAGE, YbgH exists as 
monomer when solubilized in DM. The latter 
was further corroborated by TEM of negatively 
stained YbgH proteins that exhibited a donut-
like shape with a diameter of ~8.0 nm, similar to 
monomeric detergent-solubilized DtpA (YdgR) 
proteins (25).
The high amounts of pure and homogeneous 
YbgH protein formed an excellent basis for its 
Figure 4. Projection structure of YbgH at 27 Å resolution. (a) The unit 
cell is marked. The lattice parameters are a=110Å; b=105 Å; γ=97°. (b) 
The p1 projection map features alternating horizontal rows of stronger and 
weaker intensities. Eyeglasses-like structures, each containing two central 
depressions are discerned: see solid and broken ellipses. Scale bars represent 
100 nm (panels a and b).
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2D crystallization. As shown in Figure 3, YbgH 
had the propensity to form tubular crystals. 
Correlation averaging of flattened tubular crystals 
revealed alternating horizontal rows of stronger 
and weaker intensities (Figure 4). This suggests 
an upside down and downside up orientation 
of the YbgH proteins inside the lipid bilayer 
exposing cytoplasmic and periplasmic face. The 
unit cell of the YbgH crystal was rhombic with 
an area of ~11464 Å2. To estimate the number of 
YbgH monomers in the unit cell, we calculated 
the area per AdiC monomer in the previously 
reported 2D crystals (35): AdiC is the L-arginine/
agmantine antiporter from E. coli and member of 
the amino/polyamine/organocation superfamily, 
has a comparable mass to YbgH, i.e. ~49 kDa, 
and is also predicted to consist of twelve α-helical 
TMS. Thus in 2D AdiC crystals, one monomer 
occupied an area of 2737 Å2. Division of the 
total unit cell area in YbgH crystals (~11464 
Å2) by the area occupied by one AdiC protein 
(2737 Å2) results in ~4.2 YbgH monomers per 
unit cell. Considering that the molecular mass of 
AdiC is slightly below that of YbgH, four YbgH 
monomers are housed per unit cell. 
Projection maps featured alternating horizontal 
rows of stronger and weaker intensities (Figure 
4). Assuming uneven staining of the flattened 
2D crystals, this feature indicates rows of up 
and down oriented YbgH proteins, i.e. proteins 
exposing the cytoplasmic and periplasmic face, 
respectively. Such rows indicated eyeglasses-
like structures, each containing two central 
depressions: see solid and broken ellipses in 
Figure 4b. One unit cell contained two such 
eyeglasses-like structures, one with strong and 
one with weak intensities. This suggests that one 
unit cell contains four YbgH proteins in total, two 
exposing the cytoplasmic and two the periplasmic 
side. Furthermore, alternating horizontal rows of 
stronger and weaker intensities suggest that the 
peptide mass with respect to the membrane plane 
is asymmetric in the YbgH molecule, e.g. more 
peptide mass protruding out of the membrane on 
the cytoplasmic than on the periplasmic side, or 
vice versa.
This low-resolution projection map of YbgH 
has provided a first structural view of a member 
of the PTR family at 27 Å resolution. Obtaining 
a high-resolution structure of YbgH is crucial for 
the understanding of the function and mechanism 
of peptide transport proteins. Our present work 
with YbgH sets the basis for future structural 
analysis of a peptide transporter using 2D crystals 
and electron crystallography.
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6.1 ABBREVIATIONS
IPTG, isopropyl 1-thio-β-D-galactopyranoside; CCCP, carbonyl cyanide p-chlorophenylhydrazone; 
TCEP, Tris-2-carboxyethyl-phosphine; BN-PAGE, blue native-polyacrylamide gel electrophoresis; 
DDM, n-dodecyl-β-D-maltoside; TEM, transmission electron microscopy; TM, transmembrane 
regions; Ni-NTA, nickel-nitrilotriacetic acide; rbs, ribosomal binding site; TBS, Tris-buffered 
saline; AMCA, Nε-7-amino-4-methyl-coumarin-3-acetic acid; MES, 4-morpholineethanesulfonic 
acid; Mobs, apparent molecular mass.
93
AbstractProkaryotic proton-dependent peptide transporter
6.2 ABSTRACT
The ydgR gene of Escherichia coli encodes a 
protein of the proton-dependent oligopeptide 
transporter (POT) family. We cloned YdgR and 
overexpressed the His-tagged fusion protein in 
E. coli BL21 cells. Bacterial growth inhibition 
in the presence of the toxic phosphonopeptide 
alafosfalin established YgdR functionality. 
Transport was abolished in the presence 
of the proton ionophore carbonyl cyanide 
p-chlorophenylhydrazone, suggesting a 
proton-coupled transport mechanism. YdgR 
transports selectively only di- and tripeptides 
and structurally related peptidomimetics (such 
as aminocephalosporins) with a substrate 
recognition pattern almost identical to the 
mammalian peptide transporter PEPT1. The 
YdgR	protein	was	purified	to	homogeneity	from	
E. coli membranes. Blue native-polyacrylamide 
gel electrophoresis and transmission electron 
microscopy of detergent-solubilized YdgR 
suggest that it exists in monomeric form. 
Transmission electron microscopy revealed 
a crown-like structure with a diameter of 
~8 nm and a central density. These are the 
first	 structural	data	 obtained	 from	a	proton-
dependent peptide transporter and the YgdR 
proteins seems an excellent model for studies 
on substrate and inhibitor interactions as 
well as on the molecular architecture of cell 
membrane peptide transporters.
6.3 INTRODUCTION
Peptide transporters are integral membrane 
proteins that mediate the cellular uptake of di- and 
tripeptides and a variety of peptidomimetics (for 
review, see Refs. 1-4). They are found in bacteria, 
yeast, plants, invertebrates and vertebrates. In 
vertebrates, the two peptide transporter proteins 
PEPT1 (SLC15A1) and PEPT2 (SLC15A2) 
are expressed predominantly in brush border 
membranes of small intestine (PEPT1), kidney 
(PEPT1 and PEPT2) and lung (PEPT2). In these 
transport proteins substrate flux is coupled to 
proton movement down an electrochemical 
proton gradient with the membrane potential as 
the main driving force. PEPT1 and PEPT2 accept 
essentially all 400 possible dipeptides and 8000 
possible tripeptides composed of L-α amino acids 
as substrates. Moreover, they also transport a 
large spectrum of therapeutic drugs like β-lactam 
antibiotics, selected angiotensin-converting 
enzyme inhibitors and peptidase inhibitors 
and thereby determine their bioavailability 
and pharmacokinetics. Certain drugs with an 
intrinsic low oral bioavailability like L-DOPA 
and acyclovir have by coupling to an amino acid 
(L-DOPA-Phe and Val-acyclovir) turned into 
substrates of peptide transporters with markedly 
improved availability (5,6). Peptide transporters 
are therefore considered as important and potent 
drug delivery systems. Although functionally 
characterized in extenso, very little is known 
about the structure of peptide transporter 
proteins. Twelve trans-membrane domains are 
predicted (7) and amino acid residues critical 
for transport activity have been identified in 
particular in transmembrane domains 2, 3, 4 and 
10 by functional analysis of mutants (8-12).
Mammalian peptide transporters are part of 
the PTR2  family of membrane transporters 
characterised by two signatures that are 
conserved in all family members (13). The first 
is a region that begins at the end of the second 
putative transmembrane domain, including 
the following first cytoplasmic loop as well as 
the third transmembrane domain. The second 
motif corresponds to the core region of the fifth 
transmembrane region. Besides the mammalian 
PEPT1 and PEPT2 proteins, the PTR2 family 
includes the yeast peptide transporter PTR2, 
DtpT from Lactococcus lactis and numerous 
“orphan” transporters for which function is not 
known yet. Most orphan transporters are found 
in prokaryotic organism, e.g. the four members 
ybgH, ydgR, yhiP and yjdL in E. coli. Although 
these gene sequences belong to the same family, 
the function of the corresponding proteins may 
be quite different. 
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Here we describe the cloning of the ydgR gene, 
which was identified by sequence analysis as 
the E. coli homologue of tppB from Salmonella 
thyphimurium (14). Based on growth experiments 
with mutant bacterial strains tppB was identified 
already in 1984 as a tripeptide permease (15,16). 
However, neither TppB nor YdgR have been 
characterised biochemically nor with respect to 
mode of function. We overexpressed YdgR as 
a fusion protein with the IPTG-inducible pET-
expression system. YdgR encodes a proton-
dependent peptide transporter with a broad 
substrate specificity ranging from di- and 
tripeptides to a variety of related peptidomimetics 
like β-lactam antibiotics. The YdgR protein 
was purified to homogeneity and functionally 
reconstituted into proteoliposomes. Analysis by 
blue native polyacrylamide gel electrophoresis 
(BN-Page)  and transmission electron microscopy 
(TEM) of detergent-solubilized YdgR suggests a 
monomeric state of the protein. In addition, TEM 
provided the first structural data on a proton-
dependent di- and tripeptide transporter.
6.4 MATERIALS AND METHODS
Cloning and expression of the YdgR transport 
protein in E. coli - Genomic DNA from E. coli 
strain O157:H7 was prepared with the Qiagen 
DNeasy Kit. The ydgR gene was cloned from 
genomic DNA by PCR with primers (5’-3’) 
AGCTTATGTCCACTGCAAACCAAAAAC 
and AAACTCGAGCGCTACGGCTGCTTTC-
GC.  PCR products were digested with HindIII/
XhoI and ligated into pET-21 vector (T7 promotor, 
C-terminal hexahistidine tag, Novagen). A 
ribosomal binding site (rbs) (AAGGAG) was 
added 7 bases 5’ of the coding region to improve 
translation of the protein. DNA construct (pET-
21-rbs-YdgR-His) was verified by sequencing. 
Expression experiments were carried out with 
freshly transformed E. coli BL21(DE3)pLysS. 
Cultures were grown in LB Medium supplemented 
with 100 µg/ml ampicillin to A600 of ~1 and protein 
expression was induced by adding 0.1 mM IPTG 
(final concentration). After 3 h of incubation at 
37 °C cells were harvested for biochemical or 
functional analysis. A second expression vector 
(pET-21b-rbs-T7-YdgR-His) was constructed by 
cutting pET-21-rbs-YdgR-His with HindIII/XhoI 
and ligating the insert into pET-21b vector.
 
Western blot analysis -  For Western blot 
analysis, cells from 1 ml culture were pelleted 
and resuspended in lysis buffer (10 mM Hepes-
NaOH pH 7.4, 0.5 mM EDTA, 1 mM DTT and 
protease inhibitor cocktail 1:500 (Sigma)) with 
lysozyme   (1 µg) added. After 1 h of incubation 
on ice, bacterial DNA was degraded for 30 min by 
1 unit benzonase in the presence of 3 mM MgCl2. 
Membranes were pelleted by centrifugation at 
18000 x g for 30 min and solubilized in a buffer 
containing 10 mM Hepes-NaOH pH 7.4, 150 
mM NaCl, 0.5 mM EDTA, 1 mM DTT and 1% 
n-dodecyl-β-D-maltoside (DDM). After 15 min 
on ice unsolubilized material was removed by 
centrifugation at 40000 x g for 45 min. Proteins 
were separated by SDS-PAGE and blotted onto 
polyvinylidene difluorid membranes (Millipore). 
Filters were blocked by incubation for 1 h with 
1% (w/v) milk powder in Tris-buffered saline 
(TBS; 137 mM NaCl, 3 mM KCl and 25 mM 
Tris-Cl pH 7.5) followed by incubation for 60 
min with anti-His antibody (1:2000 dilution, 
Novagen) in TBS-T (TBS, 0.05% Tween-20). 
Filters were washed twice in the same buffer 
and then incubated for 30 min with secondary 
antibody (1:5000 dilution, goat anti-mouse-HRP, 
Santa Cruz). Filters were first washed twice in 
TBS-T and twice with TBS (10 min per wash). 
Labelled proteins were detected using the ECL 
system (Pharmacia).
Transport assays - Transport assays were 
performed in vivo with cells 3 h after induction with 
IPTG (see above) with the fluorescent dipeptide 
β-Ala-Lys-Nε-7-amino-4-methyl-coumarin-3-
acetic acid (β-Ala-Lys-AMCA) (custom-synthesis 
by Biotrend, Cologne, Germany). β-Ala-Lys-
AMCA was previously established as a reporter 
substrate for peptide transport (17,18). Around 5 
x 109 cells were harvested by centrifugation and 
resuspended in 1.5 ml modified Krebs-Buffer 
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(25 mM Hepes/Tris 7.4, 140 mM NaCl, 5.4 mM 
KCl, 1.8 mM CaCl2, 0.8 mM MgSO4 and 5 mM 
glucose). The assay volume of 100 µl was made 
up with 40 µl bacteria cells (1.3 x 108 cells), 10 
µl of a 500 µM β-Ala-Lys-AMCA stock solution 
(final concentration 50 µM), and 50 µl of Krebs-
Buffer (control) or a competitor solution. Uptake 
was performed for 15 min at 37 °C and stopped 
by washing the cells twice with ice-cold Krebs-
Buffer by centrifugation. Uptake of β-Ala-Lys-
AMCA was quantified by fluorescence (excitation 
at 340 nm and emission at 460 nm, Thermo 
Varioscan).
Purification of the YdgR protein -   Cell 
pellets from 600 ml culture were resuspended 
in 25 ml lysis buffer (10 mM Hepes/Tris pH 
7.4, 1 mM DTT, 0.5 mM EDTA and a Sigma 
protease inhibitor cocktail (1:500) and broken 
by sonification (10 cycles of 30 s). After a short 
low speed centrifugation to separate unbroken 
cells (4500 x g, 8 min) and a short high speed 
centrifugation to pellet the outer membrane 
(120000 x g, 5 min) the inner membranes from 
the supernatant were collected by centrifugation 
at 120000 x g for 1.5 h (all at 4 °C). The pellets 
were resuspended in buffer (20% glycerol, 10 mM 
Hepes/Tris pH 7.4, 0.5 mM TCEP, frozen in liquid 
nitrogen and stored at -80 °C. YdgR membranes 
were solubilized (60 min, 4 °C) in 20 mM Tris-
HCl pH 8, 300 mM NaCl, 1% DDM, 10% glycerol, 
0.01% NaN3 at protein concentrations of 1-3 mg/
ml. After centrifugation (100000 x g, 45 min) the 
supernatant was diluted two-fold with 20 mM 
Tris-HCl pH 8, 300 mM NaCl, 0.04% DDM, 2 
mM histidine, 10% glycerol, 0.01% NaN3 (wash 
buffer) and bound to Ni-NTA Superflow beads (2 
h,   4 °C; Qiagen). The beads were then loaded 
onto a spin column (Promega), washed with wash 
buffer and eluted with buffer containing 200 mM 
histidine.
Reconstitution into proteoliposomes - For 
functional reconstitution YdgR containing 
membranes were solubilized in buffer (10 mM 
Hepes/Tris pH 7.4, 150 mM NaCl, 30 mM 
imidazole, 1% DDM, 5% glycerol, 0.1 mM 
TCEP) at a protein concentration of 1 mg/ml for 
30 min on ice. After centrifugation (40000 x g, 30 
min) the supernatant was loaded onto a Ni-NTA 
column (HisTrap FF, Amersham) and washed 
with running buffer (10 mM Hepes/Tris pH 7.4, 
150 mM NaCl, 30 mM imidazole, 0.06% DDM, 
5% glycerol, 0.1 mM TCEP). Protein was eluted 
with a gradient from 30 to 250 mM imidazole 
in running buffer. YdgR elutes in a sharp peak 
at about 150 mM imidazole.  For reconstitution, 
E. coli lipids (500 µl, Avanti Polar Lipids) at a 
concentration of 20 mg/ml in CHCl3 were dried 
under vacuum and resuspended in 1 ml buffer 
(25 mM Hepes/Na pH 7.4, 150 mM NaCl). 
Liposomes were destabilized with 10 mg DDM 
and sonicated for 30 min. 400 µl purified YdgR 
protein as eluted from the Ni-NTA column was 
added at a concentration of 250µg/ml. After 10 
min incubation on ice, detergent was removed 
by adding 500 mg Bio-Beads SM-2 Adsorbants 
(BioRad) overnight at 4 °C. The detergent removal 
step was repeated with 200 mg Bio-Beads for 4 
h at 4 °C. 
Electrical measurements of reconstituted 
YdgR with the SURFE2Rone setup - Electrical 
measurements of YdgR transport were based on 
the solid-supported membrane technology, which 
allows detection of capacitively coupled currents 
(19). YdgR-loaded sensors were prepared as 
described by Zuber et al. (20) using YdgR 
proteoliposomes (see above) and SURFE2Rone 
gold electrodes from IonGate BioSciences 
GmbH. The measurements were performed with 
the commercially available surface electrogenic 
event reader SURFE2Rone setup (IonGate 
Biosciences). The measurements of transporter-
related currents on the chip are based on the shift 
of electrical charges as the transporters go through 
the transport cycle and the shift can originate 
from the movement of charged substrates or of 
protein moieties carrying (partial) charges. YdgR-
mediated transport was activated via rapid solution 
exchange from a so-called non-activating (off) 
(40 mM KCl, 50 mM Hepes, 50 mM MES, 2 mM 
MgCl2, pH 6.7) to an “activating” (on) solution 
(containing 30 mM glycine and 20 mM glycyl-
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glycine). In “activating” solutions with lower 
glycyl-glycine concentrations, the total osmolarity 
of the organic solutes glycine and glycyl-glycine 
together was adjusted to 50 mM. After a rapid 
fluid exchange to a peptide-containing solution 
the charging of the proteoliposomes on the sensor 
driven by the H+/peptide symport is measured. 
Previous comparisons of the characteristics 
of rheogenic transporters employing this new 
cell-free electrophysiological technique with 
findings from patch clamp studies revealed 
a very good correlation in all features (21).
Blue native gel electrophoresis -  Linear 5-12% 
gradient gels for BN-PAGE were prepared and 
run as previously described by Schägger and von 
Jagow (22). Thyroglobulin (669 kDa), ferritin (440 
kDa), catalase (232 kDa), lactate dehydrogenase 
(140 kDa), and bovine serum albumin (66 kDa) 
were used as standard proteins. 
Transmission electron microscopy -  DDM-
solubilized YdgR protein as eluted from the Ni-
NTA column was adsorbed for 10 s to parlodion 
carbon-coated copper grids rendered hydrophilic 
by glow discharge at low pressure in air. Grids 
were washed with four drops of double-distilled 
water and stained with 2 drops of 0.75% uranyl 
formate. Images were recorded on Eastman 
Kodak Co. SO-163 sheet films with a Hitachi 
H-7000 electron microscope operated at 100 kV.
Data analysis - All experiments were performed 
for the indicated number of observations (n). IC50 
values were obtained by nonlinear regression and 
the value is given ± standard error. The Ki were 
calculated from the IC50 using the equation from 
Cheng and Prusoff (23).
6.5 RESULTS
Cloning and functional expression of the 
YdgR protein from E. coli - The ydgR gene 
from E. coli was amplified from genomic DNA 
by PCR using gene specific primers. The gene 
FIGURE 1. Functional expression of YdgR. (A) Western Blot analysis 
of YdgR protein expressed in E. coli BL21(DE3)pLysS with pET-21-
rbs-YdgR-His. Soluble and membrane fractions of uninduced (lane 
1-3) and IPTG-induced (lane 4-6) E. coli cells were separated on a 
12.5% SDS-polyacrylamide gel, subsequently transferred on PVDF 
membrane and probed with an anti-His antibody (Novagen).  Each lane 
contains protein from an equivalent of 40 µl bacterial culture: soluble 
proteins (lanes 1 and 4), DDM solubilized membrane proteins (lanes 2 
and 5) and non-solubilized proteins (lanes 3 and 6). (B) Western Blot 
analysis of YdgR protein expressed with a C-terminal hexahistidine-
tag compared with YdgR exhibiting a C-terminal hexahistidine-tag and 
an N-terminal T7-tag. Membrane proteins of IPTG-induced E. coli cells 
were separated on a 12.5% SDS-polyacrylamide gel, subsequently 
transferred on PVDF membrane and probed with an anti-His antibody 
(Novagen, lanes 1 and 2) or an anti-T7 antibody (Novagen, lanes 3 and 
4).  Each lane contains protein from an equivalent of 100 µl bacterial 
culture. (C) Growth curve in the presence of 200 µg/ml alafosfalin. 
E. coli BL21 transformed with pET-21-rbs-YdgR-His were grown in 
the absence (a) and presence (b and c) of alafosfalin. At OD600= 1 
expression of YdgR was induced by 0.1 mM IPTG (a and c). 
was cloned into the pET-21 vector fused with 
a C-terminal hexahistidine tag (pET-21-ydgR-
His). The expression of the YdgR protein in E. 
coli BL21(DE3)pLysS was tested by Western 
blot analysis with an antibody derived against 
the hexahistine tag (Figure 1A). Proteins from 
non-induced (control, Figure 1A, lanes 1–3) 
and induced E. coli (Figure 1A, lanes 4-6) were 
fractionated in (i) soluble proteins, (ii) membrane 
proteins solubilized in 1% DDM and (iii) 
insoluble proteins, and separated by SDS-PAGE. 
The anti-His antibody detected a protein in the 
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membrane protein fraction of induced cells (lane 
5) with an apparent molecular weight of 39 kDa. 
Small amounts of the protein were detected in 
the insoluble protein fraction (lane 6) indicating 
some protein not properly solubilized or from 
inclusion bodies. Since no band was detected 
from extracts obtained from control cells, the 39 
kDa protein band represents the YdgR protein. 
The discrepancy between the expected molecular 
weight (55 kDa) as deduced from the amino acid 
sequence of YdgR and the apparent molecular 
weight as determined by SDS-PAGE might be due 
to the known abnormal migration behaviour of 
several membrane proteins. This often causes an 
underestimation of the true molecular weight. To 
test this hypothesis and to verify that the protein is 
not degraded we constructed a second expression 
vector with an N-terminal T7-tag (eleven amino 
terminal amino acids of the T7 gene 10 plus ten 
amino acids spacer) in addition to the C-terminal 
hexahistidine tag (pET-21b-rbs-T7-ydgR-His). 
The apparent molecular weight of the two 
proteins “YdgR-His” and “T7-YdgR-His” were 
compared by Western blot analysis with the anti-
His antibody (Figure 1B, lanes 1 and 2) and the 
anti-T7 antibody (Figure 1B, lanes 3 and 4). As 
expected, both proteins were detected by the anti-
His antibody (Figure 1B, lanes 1 and 2), while 
the anti-T7 antibody detected only “T7-YdgR-
His” (Figure 1B, lane 4). Since both antibodies 
detected the same protein (“T7-YdgR-His”) and 
the apparent molecular weight of this protein 
is only slightly icreased compared to “YdgR-
His” we conclude that the overall deduced low 
apparent molecular weight is due to an abnormal 
migration behaviour, but not proteolysis. 
All further experiments were performed 
with the pET-21-rbs-ydgR-His construct. 
To assess the functionality of the expressed 
YdgR protein, simple growth experiments were 
conducted (Figure 1C). In Salmonella typhimurium 
the toxic phosphonopeptide alafosfalin is taken 
up by the tripeptide permease TppB and mutants 
in TppB show resistance to alafosfalin (16). We 
therefore grew E. coli carrying the vector (pET-
21-rbs-YdgR-His) in the presence of a non-toxic 
concentration of alafosfalin (200 µg/ml, curve 
b). As compared to E. coli grown in the absence 
of alafosfalin (curve a) growth rates were only 
slightly reduced. When expression of YdgR was 
induced at an A600 of  ~1 (curve c) the peptide now 
caused cell death. This indicates that YdgR was 
functionally expressed in the membrane, loading 
the cells with the toxic agent. Transport function 
of YdgR was also determined using the fluorescent 
dipeptide reporter β-Ala-Lys-AMCA as a substrate 
(Figure 2A). Cells expressing YdgR showed only 
minor autofluorescence in the absence of β-Ala-
Lys-AMCA (bar 4), but fluorescence increased 
significantly after incubation of cells with 50 
µM β-Ala-Lys-AMCA (bar 5). Fluorescence was 
abolished by addition of an excess amount of the 
FIGURE 2. Transport function of the YdgR protein with the fluorescent 
dipeptide β-Ala-Lys-AMCA serving as a substrate. (A) Control cells 
transformed with pET-21 vector (bars 1-3) and cells expressing 
the YdgR protein (bars 4-6) were incubated in Krebs-Buffer alone 
(bars 1 and 4) or Krebs-Buffer containing 50 µM β-Ala-Lys-AMCA 
(bars 2 and 5) or 50 µM β-Ala-Lys-AMCA together with 10 mM of 
the competitor Gly-Gln (bars 3 and 6) (n=6). (B) The Na+ and H+ 
dependence of β-Ala-Lys-AMCA uptake by YdgR was assessed 
by incubating E. coli expressing YdgR with 50 µM β-Ala-Lys-AMCA 
in the presence (left-most) and in the absence (center bar) of Na+ 
(by replacing sodium with choline) or by exposing cells (n=4) to 
10 µM of the selective proton-ionophore CCCP (right-most bar). 
(C) Uptake of β-Ala-Lys-AMCA as a function of substrate concentrations 
showed saturation kinetics with an apparent Kt of 0.44 ± 0.05 mM. (D) 
Inhibition of β-Ala-Lys-AMCA uptake by the amino acid L-Ala and the 
corresponding di-, tri- and tetrapeptides of L-Ala. Uptake of β-Ala-Lys-
AMCA (50 µM, final concentration) was determined in the presence 
of 10 mM L-Ala (bar 1), L-Ala-L-Ala (bar 2), L-Ala-L-Ala-L-Ala (bar 3), 
L-Ala-L-Ala-L-Ala-L-Ala (bar 4) (n=6).
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non-labelled dipeptide Gly-Gln (bar 6). When 
β-Ala-Lys-AMCA uptake was determined as a 
function of its concentration, transport was found 
to be saturable with an apparent Kt of 0.44 ± 0.05 
mM (Figure 2C). Control experiments with pET-
21 vector transformed E. coli showed no uptake 
of β-Ala-Lys-AMCA (bars 1-3) indicating 
that no other endogenous transport system in 
E. coli mediates β-Ala-Lys-AMCA uptake. For 
further characterization of transport, we studied 
the requirements of Na+ and H+ as cotransport-
ions (Figure 2B). The replacement of Na+ by 
choline had no significant effect on the uptake of 
β-Ala-Lys-AMCA, but the presence of CCCP, a 
proton ionophore, caused complete inhibition of 
transport. Thus, peptide uptake via YdgR depends 
on the proton-motive force and is most likely as 
described for the other family members mediated 
by a coupled proton-substrate cotransport. 
Studies on substrate specificity of YdgR - To 
determine the transporter’s substrate specificity, 
E. coli cells overexpressing YdgR were incubated 
with 50 µM β-Ala-Lys-AMCA in the presence 
of an excess (200-fold) of L-alanine either as 
free amino acid or as a di-, tri- and tetrapeptides 
(Figure 2D). Alanine and tetra-alanine did not 
inhibit uptake of β-Ala-Lys-AMCA, while 
di- and tri-alanine completely inhibited β-Ala-
Lys-AMCA uptake. Inhibition of transport by 
increasing concentrations of di- and tri-alanine 
allowed apparent affinities (IC50 values) of 0.52 
± 0.03 mM and 0.24 ± 0.01 mM to be determined 
(Figure 3A). Stereospecificity of YdgR-mediated 
flux was assessed by determining IC50 values 
of dipeptides carrying L- or D-alanine residues 
FIGURE 3. Substrate specificity of the YdgR protein. (A) Inhibition of β-Ala-Lys-AMCA uptake by the di- and tripeptides of L-Ala. Uptake of β-Ala-
Lys-AMCA (50 µM) was determined in the presence of increasing concentrations (0.05 - 10 mM) of either L-Ala-L-Ala (circles) with an IC50 of 
0.52 ± 0.03 mM, or L-Ala-L-Ala-L-Ala (triangles) with an IC50 of 0.24 ± 0.01 mM; (B) Stereoselectivity of transport was determined by inhibition of 
β-Ala-Lys-AMCA (50 µM) uptake by 0.1 - 10 mM of D-Ala-L-Ala (triangles) with an IC50 of 0.48 ± 0.05 mM, or 0.8 - 80 mM of L-Ala-D-Ala (circles) 
with an IC50 of 4.10 ± 0.33 mM, or 5 - 80 mM of D-Ala-D-Ala (squares). (C) Interaction of peptidomimetics with YdgR was tested by uptake (n=4; 
*n=2) of 50 µM β-Ala-Lys-AMCA in the absence (bar 1) and in the presence of 10 mM of the following competitors: Gly-Gln (bar 2), cefadroxil 
(bar 3), cefalexin (bar 4), cephradine (bar 5), cephamandole (bar 6), cefuroxime (bar 7), ampicillin (bar 8), amoxicillin (bar 9), captopril (bar 10) 
or enalapril (bar 11).
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(Figure 3B). Substitution of the N-terminal L-Ala 
for the D-isomer did not alter affinity significantly, 
but when the C-terminal L-Ala was replaced by a 
D-isomer affinity of the competitor was reduced 
about 8-fold (Figure 3B). D-Ala-D-Ala did not 
show detectable affinity for interaction with 
YdgR (Figure 3B).
Transport characteristics of differently charged 
dipeptide substrates - To further characterise 
substrate specificity of YdgR, we determined 
IC50 values of various other compounds ranging 
from differently charged dipeptides consisting of 
L-amino acids, to ω-amino-fatty-acid and a known 
mM). Modifying the peptide bond nitrogen by 
a CH3 group like in glycyl-sarcosine, yielded a 
moderate affinity (IC50 = 1.16 ± 0.09 mM). The 
highest affinity of all test compounds displayed 
the inhibitor of mammalian peptide transporters 
Lys-Z-Nitro-Pro with an IC50 value of 0.033 ± 
0.006 mM. Mammalian peptide transporters do 
not require a peptide bond for recognition of a 
substrate (25). To test whether this holds true also 
for the YdgR protein, we used 5-aminolevulinic 
acid as a substrate which carries only the two 
oppositely charged head groups separated by four 
carbon units and a backbone carbonyl. Its apparent 
affinity was 1.69 ± 0.14 mM and therefore higher 
inhibitor of mammalian peptide transporters (see 
Table I). Neutral dipeptides represented by Gly-
Gln or cationic peptides such as Lys-Gly showed 
relatively high affinities with IC50 values of 0.51 
± 0.06 mM and 0.43 ± 0.02 mM, respectively. 
Introducing the positively charged amino acid at 
the C-terminal position (Gly-Lys) resulted in a 
7-fold reduction of affinity represented by an IC50 
of 2.83 ± 0.27 mM as compared to 0.43 mM for 
Lys-Gly. This indicates an asymmetric substrate 
binding site in YdgR similar to that described for 
the mammalian peptide transporters (24). This 
observation is strengthened by experiments with 
the anionic dipeptide Asp-Gly. When Asp instead 
of Lys is placed in the first position affinity 
decreases by 10-fold (Asp-Gly, IC50 = 4.46 ± 
0.45 mM) whereas when placed in the second 
position affinity increases again when compared 
to a Lys residue (Gly-Asp, IC50 = 1.92 ± 0.13 
FIGURE 4. Purification, BN-PAGE and TEM of the YdgR protein. (A) 
Purification of YdgR. SDS-PAGE of the different purification steps: 
DDM-solubilized membranes (lane 1), pellet (lane 2) and supernatant 
(lane 3) after ultracentrifugation of the DDM-solubilized membranes, 
Ni2+-NTA flowthrough (lane 4), Ni2+-NTA wash (lane 5), Ni2+-NTA elution 
(lane 6, 5 µg loaded). (B) BN-PAGE of purified YdgR. Protein standard 
(lane 1) and purified YdgR protein (lane 2, 9 µg loaded). The YdgR 
protein migrates as a ~85 kDa band in the 5-12% linear gradient gel. 
(C) TEM of negatively stained purified YdgR proteins. The homogeneity 
of the purified YdgR proteins is reflected in the electron micrograph. 
The selected particles marked by arrowheads were magnified and are 
displayed in the gallery. The scale bar represents 60 nm and the frame 
size of the magnified particles in the gallery is 10.8 nm.
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than that of most charged dipeptides. 
Transport of peptidomimetics - Beside di- and 
tripeptides mammalian peptide transporters accept 
a broad spectrum of peptidomimetics like β-lactam 
antibiotics and ACE-inhibitors as substrates. 
We have tested selected peptidomimetics 
as known substrates of mammalian peptide 
transporters for analysis of their interaction 
with the YdgR protein in competition assays 
(Figure 3C). Compared to the dipeptide Gly-
Gln (bar 2), which inhibited β-Ala-Lys-AMCA 
uptake by 97%, similar inhibition rates of 86%, 
79% and 79%, respectively were observed for 
the three aminocephalosporins cefadroxil (bar 
3), cefalexin (bar 4) and cephradine (bar 5) at 
10 mM concentration. Cefuroxime (bar 6) and 
cefamandole (bar 7) showed markedly reduced 
affinities with modest inhibition of only 21% and 
32%, respectively, which results from the lack 
of an α-amino group important for high affinity. 
Whereas the two aminopenicillins ampicillin (bar 
8) and amoxicillin (bar 9, 5 mM concentration) 
seemed not to serve as substrates, the ACE-
inhibitors captopril (bar 10) and enalapril (bar 
11) also showed only low affinity type inhibition 
of  β-Ala-Lys-AMCA uptake.
 
Purification and functional reconstitution 
of YdgR - Inner membranes of E. coli were 
solubilized with DDM and YdgR was purified 
by nickel affinity chromatography. The SDS 
polyacrylamide gel displayed in Figure 4A 
summarizes the different purification steps. The 
purified YdgR protein migrated as a single band 
with an apparent mass of ~39 kDa that is identical 
to that observed by Western blot analysis for the 
non-purified protein (see Figure 1A). Typically 
2–4 mg of YdgR protein could be purified from 
1 liter of bacterial culture. The functionality of 
purified YdgR was assessed after its reconstitution 
into liposomes using the commercially available 
SURFE2Rone setup (IonGate Biosciences). The 
SURFE2Rone setup is based on the solid-supported 
membrane technology and allows detection of 
capacity-coupled currents induced by movement 
of charged molecules across lipid bilayers 
(19,20). To measure YdgR-specific transport, 
proteoliposomes containing YdgR were adsorbed 
to SURFE2Rone sensors and transport was 
activated by rapid exchange of a “non-activating” 
solution containing glycine against an “activating 
solution” containing the dipeptide glycyl-
glycine (Gly-Gly). Figure 5A demonstrates that 
Gly-Gly induced significant currents in YdgR-
proteoliposomes with increasing currents at 
increasing substrate concentrations (1 to 20 mM). 
No Gly-Gly-induced currents were observed when 
YdgR-free liposomes were loaded onto the sensor 
(Figure 5B trace d). Additon of 5 mM Gly-Gly 
in both, the “non-activating” and the “activating 
solutions”, partially inhibited the YdgR- 
response to the 20 mM Gly-Gly concentration 
jump (Figure 5B, trace b), whereas 10 mM Gly 
in both solutions did not have any significant 
effect on the YdgR response (Figure 5B, trace 
c). This demonstrates that only dipeptide Gly-
Gly but not the free glycine causes the currents. 
Since the transport studies were performed with 
Na+-free buffers of pH 6.2 the observed currents 
must originate from proton movement coupled to 
dipeptide translocation in a symport mechanism 
as demonstrated for the mammalian peptide 
transporters PEPT1 and PEPT2.  
Characterization of the purified YdgR protein 
by BN-PAGE and TEM - To determine whether 
YdgR exists in a monomeric or oligomeric state, 
the purified protein was subjected to BN-PAGE. 
The results are summarized in Figure 4B and 
provide a strong protein band at an apparent 
molecular weight (Mobs) of ~85 kDa. In addition, 
DDM-solubilized YdgR protein was negatively 
stained and examined by TEM. The homogeneity 
of the purified YdgR is documented in Figure 
4C. Single YdgR proteins are distinguished and 
display a crown-like structure with a typical 
diameter of ~8 nm. In addition, a plug-like 
density was discerned in the centre of the protein 
(see gallery of well preserved YdgR top views in 
Figure 4C, lower panel).
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6.6 DISCUSSION
The genome of E. coli contains four yet 
uncharacterized members of the family of 
proton-dependent oligopeptide transporter (POT-
family) named ydgR, ybgH, yhiP and yjdL as 
identified by sequence analysis. Because of 
lack of functional data they are still classified as 
hypothetical proteins. We have cloned the ydgR 
gene from genomic DNA and overexpressed the 
protein in E. coli BL21 cells. Coomassie stained 
SDS-PAGE and Western blot analysis identified 
the YdgR protein, and uptake experiments with 
the fluorescent dipeptide β-Ala-Lys-AMCA in 
bacterial cells demonstrated its function as a 
dipeptide transporter with features similar to 
mammalian peptide transporters. Moreover, 
employing the SURFE2Rone sensor technology we 
demonstrate for the first time rheogenic transport 
by a prokaryotic peptide transporter.
The bacterial peptide transport system tppB 
(tripeptide permease) was genetically characterised 
in mutants of Salmonella typhimurium. Deficiency 
in the locus for tppB conferred resistance to the 
toxic phosphonopeptide alafosfalin and this 
was classified as a characteristic tppB activity 
(16). By locus analysis, the ydgR gene of E. coli 
was identified as a similar tripeptide permease 
(tppB) (14) but had not been functionally 
characterised. By growth experiments with the 
toxic phosphonopeptide alafosfalin we could 
experimentally confirm that YdgR represents the 
E. coli homolog of tppB. However, our functional 
data on substrate specificity of YdgR reveal that 
not only tripeptides but also dipeptides serve as 
substrates. Moreover, transport was proven to 
be Na+-independent and completely abolished 
in the presence of the proton ionophore CCCP 
suggesting a proton-coupling of substrate transport 
in analogy to other members of the family such 
as PEPT1 or PEPT2. These two proteins operate 
as electrogenic proton-coupled symporters with a 
variable flux-coupling stoichiometry for proton to 
substrate cotransport and the main driving force 
being provided by membrane voltage. Via the 
SURFE2Rone measurements of YdgR reconstituted 
into proteoliposomes we could experimentally 
verify that dipeptide transport by YdgR is also 
of electrogenic nature and occurs in the absence 
FIGURE 5. Functional reconstitution of YdgR. (A) Electrical response of YdgR reconstituted into liposomes to a dipeptide solution. YdgR-
containing proteoliposomes were adsorbed to SURFE2Rone sensors and perfused with Na+-free “activating” solution (on) containing different 
concentrations of the dipeptide Gly-Gly (n=3). (B) The response of YdgR-containing liposomes is inhibited by Gly-Gly but not by free glycine. For 
traces a-d, the “activating solution” (on) contained 20 mM Gly-Gly. The electrical response of the YdgR-containing liposomes on the sensor to a 
20 mM Gly-Gly concentration jump is shown in trace a. Addition of 5 mM Gly-Gly to the “non-activating” (off) and “activating” (on) solutions blunts 
the response to 20 mM Gly-Gly (trace b) whereas the addition of 10 mM glycine to the “non-activating” and “activating” solutions does not change 
the YgdR-response (trace c). Trace d shows the recording from a sensor loaded with YdgR-free liposomes serving as a negative control.
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FIGURE 6. Homology model of YdgR to human PEPT1. The proposed topology model of human PEPT1 was modified to show the homology to 
YdgR calculated by Clustal W. From the 500 amino acids of YdgR 22% are identical in PEPT1, 28% are conserved and 13% are semi-conserved. 
29% of PEPT1 is missing in YdgR. 
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of Na+ ions, most likely in analogy to PEPT1 and 
PEPT2 as proton-peptide symport. 
The substrate recognition pattern of YdgR 
shows a remarkable and unexpected similarity 
to the mammalian PEPT1 in various aspects. All 
known substrates of PEPT1 that were tested with 
YdgR also interact with the substrate binding site 
of the bacterial protein with very similar affinities. 
Moreover, the observed stereoselectivity of 
transport and differences in affinities of charged 
peptides with identical side chains but in 
different spatial position (N- versus C-terminal) 
are also characteristic for PEPT1. Finally, even 
peptidomimetics such as the aminocephalosporins 
interact with the YdgR substrate binding site with 
similar affinities as determined for PEPT1. YgdR 
represents in its substrate recognition pattern 
in all aspects a mammalian PEPT1-phenotype. 
This suggests that YdgR possesses a similar 
architecture in the substrate binding domain. 
There is a moderate degree of sequence 
homology between YdgR and mammalian 
PEPT´s. We have projected the YdgR amino acid 
sequence onto the proposed topology model of 
PEPT1 (Figure 6) on the basis of a ClustalW 
analysis (26). Highest sequence identity can be 
found in the first half of the protein especially in 
the transmembrane regions (TM) 1-6 and the first 
extracellular loop. A modest sequence identity 
is also found in TM10–12 and as suggested 
by functional analysis of mammalian PEPTs 
based on chimeric proteins and by side directed 
mutagenesis; these regions are involved in 
substrate binding and transport (8-12,27). Some 
of the amino acid residues in these regions were 
identified as essential for transport by PEPT1 
and are well conserved in the YdgR protein 
including Trp295 in TM7 and Glu595 in TM10. The 
amino acid His121 in TM4 is not conserved, but 
there is an alternative His residue nearby in the 
primary structure of YdgR. Surprisingly the His57 
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residue that is described as essential for proper 
function in the mammalian peptide transporters 
is not conserved in YdgR and is replaced by a 
serine residue. The lowest homology found 
between the mammalian proteins and YdgR is 
in transmembrane regions 7–9 together with the 
loops in between. These regions are thought to 
contribute to the different kinetic phenotypes of 
PEPT1 and PEPT2 (28). Most strikingly, YdgR 
does not possess the large extracellular loop 
between TM 9 and TM 10 found in PEPT1 and 
PEPT2 which suggests that the loop domain is 
not important at all for the transport process.
Nothing is known about the 3D structure 
of any peptide transporter protein of the PTR-
family. Protein expression is low in native cells 
and tissues, and heterologous expression of 
mammalian PEPT1 in Pichia pastoris did not 
yield enough protein for structural analysis (29). 
The discovery of a bacterial homologue with 
essentially identical transport characteristics to 
the mammalian proteins that can be expressed 
and purified with high yield represents therefore 
an important step towards structural analysis 
of the protein and insights into the transport 
mechanism. We were able to obtain 2–4 mg of 
pure and stable YdgR membrane protein from 1 
liter of bacterial culture. BN-PAGE of purified 
YdgR  displayed a strong band with a Mobs of 
~85 kDa (Figure 4B). This Mobs is composed 
of the molecular mass of YdgR (~55 kDa) and 
the mass of the DDM-Coomassie brilliant blue 
G-250 micelle and lipids attached to the protein. 
Thus the Mobs indicates that YdgR may exist as 
a monomer. The use of the conversion factor 
determined by Heuberger et al. (30) to estimate 
the mass of membrane proteins from the Mobs 
also supports the monomeric nature of YdgR. 
Chemical crosslinking experiments performed 
with the amino-specific reagents disuccinimidyl 
suberate and bis-sulfosuccinimidyl-suberate did 
not yield specific crosslinking products (data not 
shown) in line with the results from BN-PAGE. 
TEM of negatively stained DDM-solubilized 
YdgR proteins revealed a crown-like structure 
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with a central density. The measured diameter 
of the YdgR particles was ~8 nm. Assuming a 
boundary layer of ~ 1.5 nm (31) for DDM attached 
to the hydrophobic part of the protein the resulting 
diameter is similar to that of the red permease 
monomer when embedded into the lipid bilayer; 
Red permease is a lactose permease fusion protein 
which forms monomers and trimers. It consists of 
twelve transmembrane helices and has a similar 
molecular weight to YgdR (32).
In summary we have cloned, overexpressed 
and characterized biochemically, functionally 
and structurally the prokaryotic proton-dependent 
peptide transporter YdgR. The substrate 
recognition pattern of YdgR shows a remarkable 
similarity to the mammalian PEPT1 protein 
and therefore YdgR could serve as a paradigm 
for the mammalian peptide transporters. To 
understand the biophysical principles underlying 
transmembrane peptide transport, a high-
resolution structure is indispensable. Our present 
work with YdgR sets the basis for further 
structural analysis using 2D and 3D crystals, and 
electron and X-ray crystallography studies of 
the first peptide transporter protein. Obtaining a 
high-resolution structure of YdgR is crucial for 
any exploitation of the architecture of this class 
of transport proteins that are unique amongst 
the solute carriers with respect to their ability to 
transport literally thousands of substrate differing 
in size, polarity and charge.
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7.1 ABBREVIATIONS
IPTG, isopropyl 1-thio-β-D-galactopyranoside; CCCP, carbonyl cyanide p-chlorophenylhydrazone; 
TCEP, Tris-2-carboxyethyl-phosphine; DDM, n-dodecyl-β-D-maltoside; TEM, transmission 
electron microscopy; TM, transmembrane regions; Ni-NTA, nickel-nitrilotriacetic acide; rbs, 
ribosomal binding site; TBS, Tris-buffered saline; AMCA, Nε-7-amino-4-methyl-coumarin-3-acetic 
acid; MES, 4-morpholineethanesulfonic acid; Mobs, apparent molecular mass.
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7.2 ABSTRACT
The genome of E. coli contains four genes 
assigned to the PTR (peptide transporter) 
family.	 Only	 one	 gene	 was	 identified	 as	 a	
tripeptide permease (TppB, YdgR), whereas 
the functions of the other three genes (yhiP, 
ybgH and yjdL) remain unknown. Here 
we describe the over-expression of yhiP 
as a His-tagged fusion protein in E. coli. 
With glycyl-sarcosine (Gly-Sar) as a tracer 
substrate	 an	 apparent	 affinity	 constant	 of	
6.5	 mM	 for	 saturable	 influx	 was	 obtained	
and over-expression of the protein increased 
markedly the susceptibility of cells to the 
toxic phosphonopeptide alafosfalin. Transport 
activity in cells was strongly decreased in the 
presence of a protonophore but unaffected by 
sodium depletion, suggesting H+-dependence. 
Competition experiments established the 
protein to transport di- and tripeptides with 
a	 slightly	 different	 specificity	 than	 TppB.	
Western blot analysis revealed YhiP to posses 
an apparent mass of ~40 kDa. Negative-stain 
transmission	 electron	 microscopy	 of	 purified	
YhiP revealed a donut-like shape of ~8 nm in 
diameter with a distinct central depression. 
Functional	 reconstitution	 of	 purified	 YhiP	
and TppB into proteoliposomes allowed their 
transport to be studied and compared in vitro. 
In	the	presence	of	an	artificial	proton	gradient	
both transporter proteins showed Gly-Sar 
influx	and	when	immobilized	on	a	chip-based	
sensor also generated transport currents. 
Taken together, yhiP encodes a protein that 
mediates a proton-dependent electrogenic 
transport process for di- and tripeptides with 
similarities to the mammalian PEPT1-proteins. 
Based on our results we propose to rename 
YhiP to DtpB (di- and tripeptide permease B) 
and TppB to DtpA.
7.3 INTRODUCTION
Uptake of peptides into E. coli cells is thought 
to be mediated by three different transport systems 
represented by the dipeptide permease Dpp, the 
tripeptide permease TppB and the oligopeptide 
permease Opp (1-3). Despite the fact that these 
proteins seem to discriminate according to the 
backbone length of the peptides they do show 
some overlapping substrate specificity. Their 
prime physiological role lies in the uptake of 
amino acids in peptide form as an economic 
process to provide energy substrates and building 
blocks for cellular metabolism, but peptide uptake 
seems to also be involved in signalling events 
and metabolic adaptation (4). Whereas Opp and 
Dpp are ATP binding cassette (ABC) transporters 
with periplasmatic binding proteins (5-7) TppB 
belongs to the family of proton-dependent peptide 
symporters that utilize the proton gradient as 
driving force and lack cognate binding proteins 
(8). After identification of the corresponding 
gene ydgR (8,9) it was genetically classified as 
member of the peptide transport (PTR) family 
(also called proton-dependent oligopeptide 
transporter or POT family). These transporters 
are found essentially in all living organisms from 
bacteria to man, with examples such as DtpT from 
Lactococcus lactis, Ptr2 from Saccharomyces 
cerevisiae or the mammalian transporters PEPT1 
and PEPT2 (10,11). First attempts to functionally 
characterize TppB in Salmonella typhimurium 
(12,13) and in E. coli employing deletion mutants 
(14,15) revealed some information on substrate 
preferences and demonstrated up-regulation 
of transport upon anaerobiosis and by leucine 
(13,16). Although TppB, like Dpp, was shown to 
transport di- and tripeptides, it seemed to prefer 
tripeptides and in particular those of hydrophobic 
nature. The transport mode of TppB, however, 
was poorly characterized. 
We recently cloned ydgR encoding TppB 
and over-expressed the transport protein for a 
detailed functional analysis and initial structural 
characterization. We observed a striking functional 
similarity to the mammalian PEPT1 protein 
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despite the fact that the E. coli and mammalian 
proteins share only very low sequence homology 
(17). Bacterial PTR transporters are not only 
interesting for defining their functional features 
and physiological importance but also as they 
are more easily purified in large amounts for 
crystallisation approaches to derive structural 
models. These might then be applied also to the 
human proteins, which are of prime importance 
for example for delivery of peptidomimetic drugs 
in the intestine. 
Three of the four E. coli members of the 
PTR family (yhiP, ybgH and yjdL) have not 
been studied yet. Here we report the cloning, 
purification, and structural and functional 
characterization of the yhiP gene product. 
Negative-stain transmission electron microscopy 
(TEM) of detergent-solubilized YhiP revealed its 
low-resolution structure suggesting a monomeric 
state of the protein. Furthermore, we compared 
the YhiP activity with that of TppB to improve 
our understanding of the multitude of peptide 
transport processes in prokaryots. We establish 
that ydgR and yhiP code for prototypical H+-
coupled symporter proteins that are specific 
for di- and tripeptides. In analogy to similar 
transporters in other prokaryotes we propose to 
name them Dtp (di- and tripeptide permeases) 
with the first one identified DtpA (former TppB, 
YdgR) and DtpB (YhiP) described here as the 
second member of the PTR family in E. coli. 
7.4 MATERIALS AND METHODS
Cloning and expression of the transport 
proteins in E. coli – dtpB (yhiP) was cloned 
into the pET-21 vector (T7 promotor, C-terminal 
hexahistidine-tag, Novagen) using the primers 
AAAAGCTTATGAATACAACAACACCCATG 
and AAACTCGAGATGGCTTTCCGGCGTC-
GC as described before for dtpA (ydgR) (17). 
Expression was performed as described (17).
Western blot analysis –  E. coli inner membranes 
were prepared as described for purification in 
(17). From a sample corresponding to 250 µl 
culture the proteins were separated by SDS-PAGE 
and blotted onto PVDF membranes (Millipore) 
following detection as described (17). 
Transport assays in intact cells – Transport 
assays were performed 3 h after induction with 
IPTG with radioactively labelled glycylsarcosine 
([14C]Gly-Sar, custom-synthesis by Biotrend, 
Cologne, Germany). Around 3 × 109 cells were 
harvested by centrifugation and resuspended in 
1 ml buffer (25 mM Hepes/Tris 7.4, 150 mM 
NaCl, 5 mM glucose). The assay volume of 50 
µl was made up with 20 µl cells (6 × 107 cells), 
5 µl of a 10 mM Gly-Sar (containing 0.1 µCi 
[14C]Gly-Sar, final concentration 1 mM, 2 mCi/
mmol), and 25 µl of buffer (control) or a 20 mM 
competitor solution (final concentration 10 mM). 
The cells were incubated with the substrate for 30 
s at 37 °C, followed by filtration (0.45 µm mixed 
cellulose esters, ME25 Whatman) and washing 
twice with ice-cold buffer. Uptake of [14C]
Gly-Sar was quantified by liquid scintillation 
counting. Significance (p < 0.05) was determined 
by t-test using SigmaPlot. For determination 
of apparent Kt values uptake rates at different 
substrate concentrations were determined by 
linear regression of time course experiments (10, 
20, 40, 60 s). Then Kt values and maximal uptake 
rate were determined by nonlinear regression of 
the rates versus concentration using SigmaPlot.
Growth experiments – Cells were grown in LB 
to OD600=1 and transferred to a 12 well plate (1 
ml/well) and IPTG (0.1 mM) and alafosfalin (500 
µg/ml) were added. Growth was continuously 
recorded by measuring the OD600 while shaking 
at 37 °C in a plate reader (Varioscan, Thermo).  
Purification of the His-tagged-proteins – Cell 
pellets from 500 ml culture were resuspended 
in 20 ml lysis buffer (10 mM Hepes/Tris pH 
7.4, 1 mM DTT, 0.5 mM EDTA) and broken by 
sonification (10 cycles of 30 s). Membranes were 
prepared as described for purification in (17) and 
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solubilized (60 min, 4 °C) in 10 mM Hepes/Tris 
pH 7.4, 150 mM NaCl, 1% DDM, 5% glycerol, 
0.1 mM TCEP, 30 mM imidazole at a protein 
concentrations of 1-3 mg/ml. After centrifugation 
(40000 × g, 20 min) the supernatant was loaded 
to a Ni2+-NTA column (HisTrap FF, GE) with 
a FPLC (ÄKTA, Amersham) and washed with 
running buffer (10 mM Hepes/Tris pH 7.4, 150 
mM NaCl, 30 mM imidazole, 0.06% DDM, 5% 
glycerol, 0.1 mM TCEP). Protein was eluted 
with a gradient from 30 to 250 mM imidazole in 
running buffer. Elution yielded a sharp peak at 
about 150 mM imidazole, which was shown by 
SDS-PAGE and Western Blotting to contain the 
purified transporters.
Negative-stain transmission electron micros-
copy – Purified DtpB protein at ~6 µg/ml was 
adsorbed for 10 seconds to parlodion carbon-
coated copper grids rendered hydrophilic by 
glow discharge at low pressures in air. Grids were 
then washed with three drops of double-distilled 
water and stained with two drops of 0.75% uranyl 
formate. Electron micrographs of purified DtpB 
were recorded with a Hitachi H-7000 TEM 
operated at 100 kV.
Reconstitution into proteoliposomes – For 
reconstitution, 250 µl E. coli lipids at a 
concentration of 20 mg/ml in CHCl3 (total extract, 
Avanti Polar Lipids) were dried to a thin film 
under a stream of N2 and further incubated for 30 
min in vacuum. The lipids were resuspended in 
500 ml buffer (50 mM KPO4 pH 6.3), sonicated 
until clearing (3 × 3 s, probe type sonifier) and 
destabilized with 0.5% DDM. 100 µg (about 
100 µl) purified protein as eluted from the Ni2+-
NTA column was added. After 10 min on ice, the 
detergent was removed by adding 200 mg Bio-
Beads SM-2 (BioRad) and incubation for 4 h at 
4 °C. The detergent removal step was repeated 3 
times with new Bio-Beads and incubation at 4 °C 
for a total of 24 h. 
Uptake with cytochome c oxidase energized 
vesicles – To generate a proton gradient, membrane 
vesicles or proteoliposomes were fused with 
proteoliposomes containing cytochome c oxidase 
(18,19). Cytochrome c oxidase (1 mg, purified 
from bovine heart (20))  was reconstituted with 
40 mg E. coli lipids and 12 mg octyl-glucoside in 
2 ml buffer (50 mM KPO4 pH 6.3) and detergent 
was removed by dialysis. These proteoliposomes 
were mixed with E. coli membranes (usually 2 
mg lipid + 100 µg membrane protein) or with 
other liposomes containing purified transporter 
(usually 27 µg protein) in a final volume of 250 
µl. After addition of 1 mM MgSO4 a cycle of 
freezing (liquid nitrogen) and thawing (room 
temperature) was performed, which was followed 
by sonification for 3 s with a probe type sonifier. 
For the uptake assay, 2.5 µl [14C]Glycylsarcosine 
(2.5 µCi, 175 µM final concentration, 57 mCi/
mmol) was added to the proteoliposomes, which 
were stirred at 37 °C. At indicated times, 25 µl 
aliquots were withdrawn, diluted with 2 ml 100 
mM LiCl, and filtered (0.45 µm, mixed cellulose 
esters: ME25, Whatman). The filters were 
washed with 2 ml 100 mM LiCl followed by 
scintillation counting. Proton gradient generation 
was started by the addition of 20 mM ascorbate, 
200 µM TMPD (N,N,N’,N’,Tetramethyl-p-
phenylendiamine) and 20 µM cytochrome c 
(Sigma). Fresh ascorbate was added (1:50) 
when the assay solution had turned blue due 
to oxidized TMPD. CCCP (Carbonyl cyanide 
3-chlorophenylhydrazone, Sigma) was used at a 
final concentration of 10 µM to destroy the proton 
gradient.
Electrical measurements of reconstituted 
transporters with the SURFE2Rone setup – Basis 
is the solid-supported membrane technology, 
which allows detection of capacitively coupled 
currents (21). They are caused by the shift of 
electrical charges as the transporters go through 
the transport cycle and the shift can originate 
from the movement of charged substrates, co-
transported ions or of protein moieties carrying 
partial charges. Experiments were conducted as 
described in (17) with the following modification: 
The transport was activated via rapid exchange of 
a buffer without substrate (30 mM glycine, 140 
mM KCl, 25 mM Hepes, 25 mM MES, 2 mM 
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7.5 RESULTS
Functional over-expression of DtpB in 
E. coli –  In a similar approach as previously 
reported for dtpA (tppB, ydgR) (17) we amplified 
the dtpB (yhiP) gene of E. coli from genomic 
DNA by PCR using gene specific primers. The 
gene was cloned into the pET-21 vector fused 
with a C-terminal hexahistidine-tag (pET-21-
dtpB-His). The expression of the DtpB protein 
in E. coli BL21(DE3)pLysS was tested by 
Western blot analysis with an antibody against 
the hexahistidine-tag (Figure 1A). The anti-His 
antibody detected a protein with an apparent 
molecular weight of about 40 kDa in membrane 
preparations of DtpB over-expressing cells. Since 
no signal was obtained with IPTG-induced cells 
carrying an empty vector (17) this band clearly 
represents DtpB. The expected molecular weight 
based on the amino acid sequence of DtpB is 55 
kDa. A similar increased mobility in SDS-PAGE 
was observed for DtpA, where we provided 
evidence that the protein was complete by 
probing it with a second antibody that recognized 
an added N-terminal tag (17).
 
To assess the function of the over-expressed 
DtpB protein we performed uptake experiments 
using radio-labelled [14C]glycylsarcosine (Gly-
Sar), which is a commonly used reporter substrate 
for mammalian peptide transporters (Figure 1B). 
Cells expressing DtpB showed a higher uptake 
of Gly-Sar than control cells. This was also the 
case for DtpA, indicating that both proteins are 
mediating efficient Gly-Sar uptake. As a second 
approach to assess the functionality of the 
over-expressed transport protein we performed 
growth experiments (Figure 1C) with the toxic 
phosphonopeptide alafosfalin, a known substrate 
of DtpA. E. coli cells carrying the expression 
vector for DtpB or the empty vector were pre-
grown in the presence of a non-lethal concentration 
of alafosfalin (500 µg/ml) and protein expression 
was induced by addition of IPTG. Cells over-
expressing DtpB showed a strong growth 
inhibition one hour after induction. Since non-
induced cells or cells carrying the empty vector 
showed no growth inhibition, this demonstrates 
DtpB-mediated uptake of alafosfalin. In similar 
experiments with DtpA, lower alafosfalin 
concentrations (200 µg/ml) were needed for 
growth inhibition (17) suggesting that DtpB may 
have a lower affinity to alafosfalin than DtpA. To 
compare the relative substrate affinities of DtpB 
and DtpA, we determined the uptake rates in 
cells over-expressing the proteins as a function 
of Gly-Sar concentration (Figure 1D). Transport 
was found to be saturable at a vmax of 0.21 nmol/s 
with an apparent Kt of 6.5 mM in case of DtpB 
and 0.17 nmol/s and an apparent Kt of 1 mM in 
MgCl2, pH 7.0) to the same buffer containing 
the substrate glycyl-glycine (30 mM) instead 
of glycine. After a rapid fluid exchange to the 
Gly-Gly containing solution, the charging of the 
proteoliposomes on the sensor driven by the H+/
peptide symport was measured.
Uptake of Gly-Sar in % ± standard deviation (n ≥ 2). Competitor was 
10 mM (10-fold excess) except otherwise indicated. 30 s uptake 
time. *: significant (p < 0.05) reduction relative to assay containing no 
competitor. 100% for DtpA = 40 pmol*s-1*0.2 OD-1, 100% for DtpB = 10 
pmol*s-1*0.2 OD-1
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case of DtpA. Despite similar maximal transport 
rates there are marked difference in affinities with 
DtpB representing a system of lower affinity. We 
next asked whether transport requires Na+ or H+ 
(Figure 1E). When we replaced Na+ in the buffer 
by choline, this had only a minor effect on uptake 
of Gly-Sar, whereas the presence of the proton 
ionophore CCCP caused a complete inhibition 
of transport. This suggests that uptake via DtpB 
depends on the proton-motive force and that DtpB 
may function as a proton-peptide cotransporter.
Substrate specificity – To determinate the 
substrates transported by DtpB (and for 
comparision with DtpA), we performed 
competition experiments with 1 mM Gly-Sar as 
a substrate and 10 mM of the competitors in E. 
coli cells over-expressing either DtpB or DtpA. 
The residual uptake rates in the presence of the 
competitor are presented in Table 1. The substrate 
specificity data presented here for DtpA essentially 
match those previously determined with β-Ala-
Lys(AMCA), a fluorescent dipeptide analogue 
used as a substrate in our previous study (17). 
Similar to DtpA, neither the amino acid Ala nor the 
tetrapeptide Ala-Ala-Ala-Ala caused significant 
inhibition of DtpB-mediated transport. In the 
case of DtpB, essentially all tested competitors 
reduced transport to a lower extent than with 
DtpA, which reflects its generally lower affinity: 
Despite this, there were differences between DtpB 
and DtpA when inhibitory effects of individual 
Figure 1. Over-expression of dtpB in E. coli. (A) Anti his-tag Western blot (upper panel) and Coomassie stained (lower panel) SDS-gel (12.5% 
acrylamide) of E. coli membranes of control cells (lane 1, 50 µg total protein) or membranes containing over-produced DtpB (lane 2, 50 µg total 
protein) or purified YhiP (0.5 µg upper panel, 1.5 µg lower panel). (B) Uptake of [14C]Gly-Sar (1 mM) by E. coli cells carrying the expression 
plasmid for dtpA, dtpB or the empty vector 3 hours after induction with IPTG. Over-expression of either gene causes increased Gly-Sar transport 
relative to the control. n=2, ±SD. (C) Growth inhibition by alafosfalin. Induced (+IPTG) or not induced cells, carrying either the expression 
plasmid for dtpB or an empty plasmid, were grown in the presence of 500 µg/ml (2.55 mM) alafosfalin (+a) or without alafosfalin. n=2, ±SD. 
(D) Saturation kinetics for DtpA and DtpB. Uptake assays were performed with E. coli cells over-expressing dtpA or dtpB, in the presence of 
various concentrations of Gly-Sar. The uptake velocities were determined using four time points (10, 20, 40, 60 s). Kt-values were determined 
by nonlinear regression analysis of the presented data. n≥2, ±SD. (E) Sodium and proton dependence of Gly-Sar uptake. For E. coli cells over-
expressing dtpB, Gly-Sar (50 µM) uptake rates were determined from a 10-min time course. The rates were determined in buffers containing 150 
mM NaCl (+Na+), cholinechloride (150 mM) or in the presence of NaCl and the protonophore CCCP (10 µM). 100% corresponds to 3.3 pmol x 
s-1 x OD-1. n=2, ±SD.
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peptides were compared. When for DtpA L-Ala 
in dipeptides was substituted by D-stereoisomers, 
the competitor affinity was less impaired when 
the D-isomer was present in the N-terminal 
position. Virtually no competition was seen when 
both residues are D-isomers. In the case of DtpB, 
D-Ala in N-terminal position resulted in a very 
low competitor affinity, while L-Ala-D-Ala and 
D-Ala-D-Ala did not cause any inhibition. We 
also assessed the effects of charged amino acid 
residues and their spatial position on the uptake of 
Gly-Sar. In the case of DtpA, a positively charged 
amino acid at the N-terminus caused stronger 
inhibition than when located in the C-terminus. A 
negatively charged residue was clearly preferred 
at the C-terminus. This also was observed with 
DtpB but here inhibition was higher with Gly-
Asp than in case of DtpA. Selected β-lactam 
antibiotics are known substrates of mammalian 
peptide transporters (peptidomimetics). DtpA 
showed efficient inhibition when an excess of 
cefadroxil, cefalexin and cephradine was added, 
whereas only cephradine significantly reduced 
Gly-Sar uptake via DtpB. 
Assessing the transport mode in reconstitution 
experiments – Although transport inhibition by 
the protonophore CCCP (Figure 1E) suggested 
H+-dependence, we attempted to characterize the 
transport mode in more detail by reconstitution 
in a cell-free system. Membranes of E. coli 
containing the over-expressed transport proteins 
were prepared and fused with proteoliposomes 
containing bovine cytochrome c oxidase. A 
transmembrane proton gradient (inside negative) 
was generated, when cytochrome c oxidase was 
supplied with electrons, which are transferred 
from reduced ascorbate via TMPD and 
cytochrome c. Before addition of ascorbate, we 
observed a slow influx of Gly-Sar into all types of 
vesicles. Addition of ascorbate caused a marked 
increase in Gly-Sar influx into vesicles containing 
either DtpA or DtpB, but not into control vesicles 
(Figure 3A/B). Efflux of Gly-Sar was observed 
when the proton gradient was dissipated by 
addition of CCCP, indicating accumulation of 
Figure 2. Purification of DtpB (A) Coomassie stained SDS-gel 
(12.5% acrylamide) of a Ni2+-NTA purification of DtpB.Lanes: 1) DDM 
solubilized membranes, 2) pellet after solubilization, 3) supernatant 
after solubilization, 4) Ni2+-NTA flow-through, 5) wash, 6) elution at 
about 150 mM imidazole. 
Figure 3. In vitro transport studies of DtpB and DtpA. (A) Uptake of Gly-
Sar (175 µM) in membrane vesicles generated by fusion of membranes 
from DtpB over-expressing or control cells with cytochrome c oxidase 
containing proteoliposomes. A proton gradient was established by 
addition of ascorbate/TMPD/cytochrome c and destroyed by addition 
of 10 µM CCCP as indicated. (B)  like (A) with DtpA instead of DtpB. 
(one of two similar experiments). (C) Uptake of Gly-Sar (175 µM) 
in liposomes containing purified DtpB and cytochrome c oxidase. 
Generation of proton gradient was started by addition of ascorbate/
TMPD/cytochrome c and destroyed by addition of 10 µM CCCP as 
indicated. (one of two similar experiments). (D) like (C) with purified 
DtpA instead of DtpB. (one of two similar experiments)
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substrate above the extravesicular concentration 
in the presence of the proton-gradient. 
Next we purified DtpB and DtpA from E. coli 
membranes. The membranes were solubilized with 
the detergent n-dodecyl-β-D-maltoside (DDM) 
and the proteins were purified by metal-affinity 
chromatography making use of the C-terminal 
His-tags. This procedure yielded about 2-3 mg 
of relatively pure protein per liter of cell culture 
(Figure 2). For reconstitution into liposomes the 
detergent was removed by adsorption to BioBeads. 
Subsequently the liposomes containing the peptide 
transporters were fused with vesicles containing 
cytochrome c oxidase using a freeze-thaw-
sonication cycle. Gly-Sar uptake after initiation 
of the proton gradient increased almost 10-fold in 
case of DtpB and 60-fold in case of DtpA (Figure 
3C/D) and substrate efflux was observed after 
addition of CCCP. To unequivocally demonstrate 
the electrogenic nature of the transport process 
we next used a chip-based assay system, in which 
the proteins were adsorbed onto a gold surface 
of the SURFE2Rone setup (IonGate Biosciences 
GmbH, Germany). This system is based on the 
solid-supported membrane technology and allows 
detection of capacity-coupled currents induced 
by movement of charged molecules across a lipid 
bilayer (21,22). Transport was initiated by rapid 
Figure 4. Electrophysiology on proteoliposomes. Electrical response 
of liposome reconstituted DtpB (dashed line) and DtpA (dotted line) 
to a change from solution without substrate (Gly) to solution with 
substrate (Gly-Gly). The solid line shows the recording from a sensor 
loaded with protein-free liposomes. The current peaks indicate proton 
co-transport. (one of >10 similar experiments using ≥2 sensors)
Figure 5. Negative-stain TEM of purified DtpB protein. The homogeneity 
of the purified DtpB proteins is reflected in the electron micrograph. 
DtpB proteins are donut-shaped with a central depression and have a 
diameter of 8.0±0.3 nm (n=120). The scale bar represents 50 nm, and 
the frame size of the magnified particles in the gallery is 13 nm.
exchange of a buffer containing glycine against a 
buffer containing the dipeptide substrate glycyl-
glycine. Figure 4 demonstrates that Gly-Gly 
induced significant currents in DtpA- and DtpB 
containing proteoliposomes but not in control 
liposomes lacking the transport proteins. Since 
the transport studies were performed with Na+-
free buffers at pH 7.0, the observed currents 
must originate from proton movement coupled to 
dipeptide translocation in a symport mechanism. 
Like in the cytochrome c oxidase energized 
vesicles, DtpA caused a higher signal than DtpB, 
suggesting that DtpA has either a higher turn-over 
rate or higher stability in vitro. In intact cells, 
however, both transporters possessed similar 
maximal transport rates.
Characterization of DtpB by TEM – To unveil 
the low-resolution structure of DtpB, DDM-
solubilized His-tagged protein was negatively 
stained and examined by TEM. The homogeneity 
of purified DtpB is displayed in Figure 5. Single 
DtpB proteins are discerned as donut-like 
particles with a diameter of 8.0±0.3 nm (n=120) 
and a central stain-filled indentation (see gallery 
of well preserved YhiP top views in Figure 5).
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7.6 DISCUSSION
Despite the fact that peptide uptake in E. coli 
has been studied for more than 20 years (1-3), 
essentially no biochemical characterization has 
been performed on DtpA. Another prokaryotic 
member of the PTR family, DtpT from 
Lactococcus lactis  has been characterized in 
more detail and some features of its membrane 
topology are known (23). With the focus on the 
four E. coli genes encoding proteins that carry 
the typical PTR-family motif (11) we first cloned, 
purified and characterized the mode of action of 
the DtpA (YdgR) protein (17). Here we provide a 
detailed functional analysis of DtpB as the second 
yet uncharacterised PTR member in E. coli. To 
assess the differences between DtpA and DtpB 
and better understand why there are four putative 
peptide transporters in E. coli, we compared 
the transport features of DtpA and DtpB under 
identical experimental conditions. 
Substrate specificity – DtpB was already 
cloned and expressed in a global membrane 
proteome analysis approach of E. coli, where by 
GFP and PhoA fusion constructs the C-terminus 
was found to be localized in the cytoplasm 
(24). We here show that DtpB over-expressed 
in E. coli possesses an apparent molecular 
weight of 40 kDa in SDS-PAGE and can be 
purified in quantities sufficient for reconstitution 
experiments with conservation of function 
(Figure 2). Gly-Sar, a commonly used radiotracer 
substrate for mammalian peptide transporter 
proteins, showed saturation kinetics for uptake 
into cells over-expressing DtpB with a fairly low 
affinity (6.5 mM) and transport was sensitive to 
a protonophore suggesting proton-coupling. A 
previous study with E. coli mutants lacking the 
two major peptide transporters Opp and Dpp but 
containing DtpA could not detect Gly-Sar uptake 
(25). Since we clearly show Gly-Sar uptake in 
cells over-expressing DtpA and in liposomes 
containing the purified protein  (Figs. 1B/D, 3D), 
this finding may result from low endogenous 
expression of DtpA in native cells. The apparent 
affinity of DtpA for Gly-Sar (1 mM) is in the 
same range as for many other model dipeptides 
(17). Alafosfalin, a known toxic substrate for 
bacterial peptide transporters, was described to 
be specifically transported by DtpA (12). We here 
show that DtpB also confers alafosfalin-toxicity 
in E. coli cells over-expressing the protein, but 
higher concentration of alafosfalin are needed 
than for DtpA (500 instead of 200 µg/ml) to 
obtain toxicity. This indicates a lower affinity of 
DtpB for alafosfalin which already was observed 
for Gly-Sar. 
The substrate specificity was addressed by 
competition experiments with Gly-Sar as substrate 
(Table 1). The inhibition pattern observed for 
DtpA confirmed previous data obtained by using 
the fluorescent substrate β-Ala-Lys(AMCA) (17). 
Since DtpB failed to transport β-Ala-Lys(AMCA) 
we here employed Gly-Sar and compared substrate 
specificity for both proteins under identical 
experimental conditions. DtpB, like DtpA, has a 
clear preference for di- and tripeptides composed 
of L-amino acids. The chain length restriction 
and the distinct stereoselectivity with a tolerance 
of D-alanine in N-terminal position matches well 
with data of the mammalian PEPT1 and PEPT2 
proteins (26,27). DtpB, like DtpA, discriminates 
dipeptides based on the position of charges within 
the substrate.  Peptides containing a positively 
charged side chain in N-terminal position are good 
competitors, but ability to compete is lost when the 
charge is present at the C-terminus. The reverse 
pattern was observed for negatively charged 
side chains, which are generally better tolerated 
at the C-terminal position. A similar charge 
preference is found in the mammalian peptide 
transporters (28,29). Of the ß-lactam antibiotics 
tested, only cephradine and cefalexin showed 
modest inhibition of Gly-Sar influx via DtpB 
whereas for DtpA best inhibition was seen with 
cefadroxil followed by cephradine and cefalexin. 
The mammalian peptide transporter PEPT1, 
which is expressed in the intestine, also clearly 
prefers those substrates but does not transport 
cefamandole or cefuroxime that are considered to 
be inactive when administered orally (30). Taken 
together, DtpB shows essentially the prototypical 
117
AcknowledgementsProton-dependent peptide transporters of E.coli
substrate characteristics of a di-/tripeptide 
transporter of the PTR-family. Despite its lower 
affinity for Gly-Sar and alafosfalin, it is similar to 
DtpA in the substrate recognition pattern and also 
shows similarities to the mammalian transporters 
of the PEPT-subgroup. 
Transport mode – Inhibition of substrate influx 
via DtpB in E. coli cells in the presence of CCCP 
already suggested proton-coupling. This was 
confirmed by reconstitution of the purified protein 
into proteoliposomes containing cytochrome 
c oxidase for energization as previously shown 
for the Lactococcus lactis orthologue DtpT (31). 
When an electrochemical proton gradient was 
generated, uptake via DtpB as well as DtpA 
proceeded until the gradient was collapsed by 
adding a protonophore. Moreover, capacity-
coupled currents obtained with immobilized 
proteoliposomes on the SURFE2Rone chip 
document the electrogenic nature of the DtpB and 
DtpA mediated transport process, in similarity to 
on-chip recordings with membranes containing 
the mammalian PEPT transporters (32). This 
unequivocally establishes that dipeptide transport 
by the two bacterial transporters occurs by H+- 
symport. 
Structure and oligomeric state of purified 
DtpB – TEM of negatively stained DDM-
solubilized DtpB proteins revealed a donut-
like structure with a distinct central depression 
(Figure 5). The measured diameter of the YhiP 
particles was ~8 nm similar to that of DtpA (17) 
suggesting a monomeric state of the protein.
Conclusions – DtpB is shown here to 
represent the second proton-dependent di- and 
tri-peptide transporter of E. coli, with functional 
features similar to other PTR family members 
including those from mammals. Although DtpB 
appears to represent a system of lower affinity 
there is an obvious redundancy in substrate 
specificity compared with DtpA. This includes 
Gly-Sar, for which we here clearly show that it 
is a DtpA substrate. The question why E. coli 
has two proteins with similar functional features 
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will likely be resolved when their regulation 
and expression under different environmental 
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8. General Discussion and Conclusion
Scope of the thesis – The main scope of this 
thesis was to gain insights into the structure of 
amino acid and peptide transport proteins. To this 
aim, we selected bacterial amino acid and peptide 
transporters with high amino acid sequence 
homology and identity to the human counterparts. 
This was AdiC from E. coli and SteT from Bacillus 
subtilis as representatives from the APC family, 
and the E. coli proteins YbgH, YdgR (TppB, DtpA) 
and YhiP (DtpB) as representatives from the PTR 
family. For each protein an optimized purification 
protocol was established to obtain high protein 
amounts, purity and homogeneity suitable for 
structural analysis. Structure determination was 
performed by transmission electron (TEM) and 
atomic force microscopy (AFM). To elucidate the 
oligomeric state of purified detergent-solubilized 
amino acid and peptide transporters, blue native-
polyacrylamide gel electrophoresis (BN-PAGE) 
and analysis by TEM of single negatively stained 
protein particles was performed. BN-PAGE and 
negative stain TEM revealed for the first time 
the oligomeric state as well as first structural 
information for APC and PTR family members. 
Furthermore, we established protocols for the 
successful 2D crystallization of AdiC (APC) and 
YbgH (PTR). The analysis of highly ordered 2D 
crystals provided the first projection structure of an 
APC and PTR family member. Besides structure 
determination using single protein particles and 
2D crystals, we developed a new methodological 
approach for the semi-automated analysis of 
membrane proteins by high throughput single 
molecule force spectroscopy (HT-SMFS).
BN-PAGE – To determine whether APC and 
PTR proteins exists in a monomeric or higher 
oligomeric state, detergent-solubilized proteins 
were subjected to BN-PAGE. The power of this 
technique was nicely demonstrated for the dimeric 
AdiC (chapter 2), and the monomeric SteT protein 
(chapter 4), and the monomeric YbgH (chapter 
5) and YdgR (chapter 6) proteins. Furthermore, 
the results from BN-PAGE were corroborated by 
negative stain TEM of single protein particles, 
gel filtration and chemical cross-linking.
Single particle analysis – TEM of negatively 
stained single protein particles represents 
another well-established method to determine 
the oligomeric state of detergent-solubilized 
proteins. Similar to BN-PAGE, results from 
TEM were in line with other techniques such 
as BN-PAGE, gel filtration and chemical cross-
linking. In addition, TEM of single detergent-
solubilized transporters provided dimensions, 
shape and low-resolution structure of the protein 
under investigation. Electron micrographs of the 
monomeric SteT revealed a slightly elliptical 
particle with the dimensions of ~6 x ~7 nm 
(chapter 4), while the AdiC dimer exhibited 
dimensions of ~7.5 x ~12 nm (chapter 2). Also 
the three monomeric PTR members matched 
perfectly with the results from the APC proteins, 
when the slightly higher molecular weight for the 
PTR proteins was considered. YbgH, YdgR and 
YhiP had a diameter of ~8 nm (chapter 5, 6 and 
7). As stated above, single particles analysis is a 
powerful technique to reveal structural features. 
The two ring-like structures of the AdiC dimer 
in our single particle studies were confirmed by 
the calculated projection map (chapter 2) from 
2D crystals. Furthermore, single particle studies 
on SteT (chapter 4), YdgR (chapter 6) and YhiP 
(chapter 7) present the first structural data at low-
resolution for these proteins and transport protein 
families.
2D crystallization – Highly ordered 2D crystals 
were reported for AdiC and YbgH (chapter 2 
and 5). For AdiC, the introduction of the point 
mutation (i.e., AdiC-W293L) represented the 
breakthrough that enabled us the growth of 
highly-ordered crystals and the collection of 
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high resolution data by cryo-TEM. We suggest 
that the point mutation induced a stabilization of 
AdiC protein leading to the adoption of a fixed 
conformation. For AdiC-W293L, we managed to 
calculate a projection map at 6.5 Å resolution. 
The exact arrangement of the transmembrane 
helices could not be revealed in the projection 
structure. However, we showed that most of the 
transmembrane helices must be tilted with the 
exception of one (chapter 2). Also a member of 
the PTR family was successfully crystallized. 
Well-ordered tubular crystals of YbgH were 
analyzed by negative stain TEM. The calculated 
YbgH low resolution projection map represents 
the first structural view of a member of the PTR 
family (chapter 5).
Single molecule force spectroscopy – AdiC 
reconstituted in E. coli polar lipids was used 
to demonstrate that single molecule force 
spectroscopy (SMFS) can be automated to a larger 
extent. SMFS was used to screen for molecular 
interactions between AdiC and its substrates. The 
recorded force spectra of AdiC in the absence and 
presence of L-arginine, D-arginine and agmatine 
showed no significant differences. Considering 
that the unfolding process of AdiC is not affected 
by ligand binding we proposed that the protein 
substrate interaction is of weak nature (chapter 
3). The establishment of the high throughput 
SMFS approach will open new avenues for the 
structural analysis of other membrane proteins.
Conclusion – The AdiC and YbgH proteins 
represent excellent models for the understanding 
of the molecular architecture of transporters 
from the APC and PTR family. Improvement of 
the present 2D crystals in the near future will 
allow the determination of the AdiC and YbgH 
structures at high-resolution. These structures will 
contribute to our understanding of the function 
and mechanism of APC and PTR transport 
proteins and will facilitate the development of 
novel drugs by structure-based drug design.
General Discussion and Conclusion 
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